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Abstract 
Background: Assessment of lung function by spirometry is helpful for evaluating lung health. It 
provides precise measurements of air volumes and flows useful for diagnosis and monitoring of 
respiratory diseases. Respiratory diseases (including asthma and COPD) are some of the major 
causes of school and work absenteeism, hospital admission, disability, and death. Diet is a 
modifiable risk factor that has been associated with various respiratory outcomes but has been 
studied minimally in relation to lung function.  
Purpose: The purpose of this study was to explore the impact of dietary factors and nutrient 
biomarkers on lung function among Canadian adults (18 years and older).  
Methods: The Canadian Health Measures Survey (CHMS) is a national and ongoing health survey 
of Canadians led by Statistics Canada. CHMS uses a repeated cross-sectional multi-stage survey 
design. Data collection included a combination of a computer-assisted personal interview and 
physical assessment. The first Cycle (2007-2009) included N=3726, the second Cycle (2009-2011) 
included N= 3873, and the third Cycle (2012-2013) included N= 3397 adult Canadians. The 
physical measures were conducted at Mobile Examination Centers (MEC) specifically designed 
for the study. Spirometry measurement was completed by the eligible participants following 
spirometric guidelines of the American Thoracic Society (ATS). The household and clinic 
questionnaires were used to assess individual dietary factors, Canada Food Guide, and Modified 
Mediterranean Diet Score separately for each of the Cycles. Biomarker assessment was done by 
using blood samples. Association analyses were completed using multiple linear regression 
adjusting for age, sex, and height as well as other confounders using sampling weights. 
Bootstrapping variables supplied by Statistics Canada were used to calculate variances. 
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Results: The overall mean percent predicted values for FVC and FEV1 were 98% and 95%, 
respectively. The associations between dietary consumption and lung function were relatively 
inconsistent. However, in both Cycles 1 and 2, consumption of dietary fat was associated with 
higher FVC (p<0.05). In all Cycles, most of the participants did not meet the daily requirement of 
Canada Food Guide and the “not meeting” the requirements were inconsistently associated with 
the lower lung function. The modified Mediterranean Diet Score was significantly associated with 
lower lung function in Cycle 3. Among the biomarkers, chloride was associated with higher FVC 
and FEV1 for all three Cycles (p<0.05). C-reactive protein was associated with lower FVC, FEV1, 
and FEF25-75% (Cycle 1, 3. p<0.05). Vitamin D was associated with higher FEV1 (Cycle 1, 3. 
p<0.05). Finally, Vitamin B12 was associated with lower FEV1 (Cycle 1, 3. p<0.05). 
Conclusion: Lung function characteristics shows good lung health of the general adult population 
based on the mean percent predicted values. Our study provides evidence that there is an 
association between dietary factors and lung function though there were some inconsistencies with 
different Cycles (Cycles 1, 2, 3) mostly within the report of dietary intake. 
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Chapter 1 : Introduction 
1.1 Background 
Chronic respiratory diseases can be defined as a group of chronic diseases which affect the 
airways and other structures of the lungs (1). The most common chronic respiratory diseases are 
asthma and chronic obstructive pulmonary disease (COPD) (1). For most lung diseases, evaluation 
of lung function by using spirometry is helpful in diagnosing lung disease, assessing severity, and 
determining prognosis. This is considered a standard method of lung health investigation. The 
specific etiology of these lung diseases is still unknown due to its multi-factorial nature, but both 
personal/genetic and environmental factors play a role, and this may also be true for predictors of 
lung function. Dietary intake is a modifiable behaviour. It has been shown to be a risk or protective 
factor for a number of respiratory diseases (2–7). By extension, lung function may also be affected 
by dietary intake.  
1.2 Spirometry 
Assessment of lung function can be conducted using spirometry which is the most common 
tool for clinical assessment of pulmonary function (8). A spirometer gives precise measurements 
of air volumes and flows useful for the diagnosis and monitoring of asthma and COPD (9). 
Forceful blowing into a spirometer while coached by a trained technologist provides various lung 
function parameters including Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 
second (FEV1), Forced Expiratory Flow 25-75% (FEF25-75%), and the FEV1/FVC ratio 
(FEV1/FVC). It is important to note that lung function results can be influenced by both the 
individual as well as by the coaching of the technician. Validity and reliability of the testing must 
be considered. Through this assessment, abnormalities in lung function can be detected and used 
in the evaluation of lung health including the diagnosis and monitoring of various conditions. 
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Interpretation of spirometry results can include a comparison between a person’s measured value 
and reference or predicted values. It can also be considered as an absolute value (10). 
1.3 Dietary factors and its relationship to respiratory health 
Diet is one of the factors that can be modified by an individual's socio-economic status, 
lifestyle, environment, and ethnicity (11,12). Individual dietary choices and habit may play a 
significant role in health (12). Similarly, dietary factors such as consumption of meat, fish, 
vegetables, fruits, and so on may have an impact on lung function. Recently, there has been 
increased attention on the role of diet in respiratory diseases (13–18). While some work has been 
conducted looking at the relationship between diet and specific disease conditions (14–23) there 
have been few studies conducted looking at diet in relation to lung function worldwide. 
Investigation into this work can be used for generating hypothesis and recommendations for further 
studies. 
1.4 Rationale 
Diet and nutrition are modifiable factors and if shown that they can contribute to the 
development and progression of chronic diseases (e.g. asthma, COPD), may be a potential 
intervention to improve health. Vegetables and fruits are beneficial for conditions related to 
respiratory system because these consist of antioxidants, vitamins, minerals, fibre, and 
phytochemical. Dietary antioxidants protect the airway against damaging effects of oxidative 
stress (24). There are several gaps in the scientific literature that should be addressed. These 
include: 
• A very limited number of studies examining the relationship between diet and lung function 
(FEV1, FVC, FEV1/FVC, and FEF25-75%) have been conducted with the general population 
(25–27). 
3 
 
• In Canada, specifically, there have been no studies performed to explore the impact of 
dietary factors and biomarkers on lung function in a representative population of adults.  
Statistics Canada is an ideal source for conducting this cost effective nutritional assessment 
in relation to lung function. Statistics Canada has collected a great deal of health and health 
behaviour information using standardized questionnaires as well as objective measurements (lung 
function and biomarkers) in a representative population through the Canadian Health Measures 
Survey (CHMS). CHMS is a multistage cross-sectional survey and has several Cycles (Cycles 1, 
2, and 3). The main goal of the CHMS is to collect health information through a household 
interview and direct physical measures at a Mobile Examination Center to help improve health 
programs and services in Canada. It can also be used to help identify relationships between risk 
factors and health status, to explore emerging public health issues and to evaluate new 
measurement technologies. 
1.5 Research objectives 
The overall objective of this thesis is to identify the association between dietary factors and 
levels of lung function among adults. More specifically:  
1. What are the characteristics/status of lung function (FEV1, FVC, FEV1/FVC, and FEF25-
75%) in Canadian adults (18-79 years)?  
2. A) Are dietary factors (e.g. food types), dietary patterns (e.g. Mediterranean Diet), or 
biomarkers associated with lung function levels based on spirometry in a nationally 
representative Canadian population of adults? 
B) Is there effect modification between dietary factors and asthma or COPD in the 
relationship with lung function?  
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Chapter 2 : Literature review 
2.1 Scope of literature review 
 The aim of the literature review was to explore the existing literature to describe and 
discuss what is already known about diet in relation to lung function. Similarly included in this 
literature review is a description of the methods used to assess lung function (spirometry), the 
prevalence of respiratory diseases, current knowledge about diet and lung function, and the 
evidence of beneficial and harmful effects of diet contributing to lung health. 
2.2 Methodology of the literature review 
 The literature search was conducted between December 2014 and September 2017. 
Common search engines were used including Google Scholar, PubMed, Ovid MEDLINE, and 
Google search to look for current scientific publications and reports. Relevant scientific articles 
were also checked and included if they appeared in the reference section of a selected article. The 
keywords for the search were “lung function”, “FVC”, FEV1, “asthma”, “COPD”, “respiratory 
disease”, “diet”, “dietary factors”, “Mediterranean Diet”, “Canada Food Guide”, “food intake”, 
“spirometry” meat”, “fish”, “egg”, “milk”, “beans”, “vegetables”, “fruits”, and “soft drinks” 
“Vitamin D”, “calcium”, “chloride”, “C-reactive protein”, “red blood cell folate”, “Vitamin B12”, 
“potassium”, “sodium” and combinations of these terms. The search was limited to humans only. 
2.3 Lung function background 
Spirometry is an objective measure of lung health and can be used for the assessment of 
diagnosis and monitoring. Various types of equipment can be used to conduct spirometry which 
requires cooperation between the individual and examiner. Interpretation of spirometry results can 
include a comparison between a person’s measured value to the reference or predicted values based 
on similar age, sex, height, and ethnicity. Based on the use of cut-off points of percent predicted 
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values, values can also be used as “normal” or “abnormal”. Results can also be considered as an 
absolute value but should be adjusted for, at minimum, age, sex, and height. 
Two of the more important aspects of spirometry are FVC and FEV1. FVC is a measurement 
of lung size (in liters) and represents the volume of air expired forcefully after taking a full and 
deep inspiration, while FEV1 is the volume of air delivered forcefully in the 1
st second of an FVC 
maneuver (28), (29).  
The FEV1/FVC is the percent of lung volume (FVC) that can be exhaled in the 1
st second of 
forced expiration (28). This ratio can be used to help determine the diagnosis of obstructive and 
restrictive lung diseases (30). In obstructive lung disease, FEV1 is decreased due to the obstruction 
of air escaping from the lungs which leads to a lower FEV1/FVC ratio (8). The lower limit of 
normal for FEV1/FVC varies broadly. At a median age of between 42 and 48 years the lower limit 
of normal for FEV1/FVC is below 0.70 (30). Diagnosis of COPD can be confirmed if the 
FEV1/FVC ratio is below 0.70 and the FEV1 is below 80% of predicted (31). The FEV1/FVC ratio 
can also be used to aid in the diagnosis of asthma (32). The FEV1/FVC ratio is the most significant 
measure when evaluating obstruction (10) as well as predicting morbidity and mortality even 
though the FEV1 may be high (33). In restrictive lung disease such as lung fibrosis or other 
pathology (not obstructive), both FEV1 and FVC are reduced (8). 
If the measured values of forced expiratory volume in the 1st second (FEV1) and forced vital 
capacity (FVC) are above 80% of the predicted value then generally this can be considered as 
“normal” and if it is below 80% then it can be considered as “abnormal” (10). Results of spirometry 
can be used to detect the presence and severity of respiratory diseases (e.g., asthma, COPD) by 
classifying the value of FEV1 into different stages such as from mild to very severe (10,34) as well 
as through inspection of other characteristics of the spriometric output. Forced expiratory flow 25-
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75% (FEF25-75%) is the average flow that is expired in the middle half of the FVC which represents 
the status of the small and medium airways (29). The value of FEF25-75% can be decreased in the 
earlier stage of obstructive lung disease (e.g. asthma) (35). FEF25-75% values are more variable than 
FEV1 and FVC. In addition, FEF25-75% is dependent on FVC. Therefore, use of this measure is not 
as valid as FEV1 and FVC (29). 
2.4 Burden of major respiratory diseases and the importance of lung function with regard 
to these diseases 
Asthma and COPD are important respiratory diseases due to high prevalence, morbidity, 
mortality, economic costs, and loss of productivity (36–38). Details about the burden of these two 
respiratory diseases are discussed below: 
2.4.1 Asthma 
According to the Global Initiative of Asthma (GINA) 2015 definition, asthma “is a 
heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the 
history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough 
that vary over time and in intensity, together with variable expiratory airflow limitation” (39).  
The prevalence of asthma has been increasing during the last few decades (40). Asthma is the 
twenty-second most important disorder in the world in terms of disability adjusted life years 
(DALYs) (1). Based on the recent report of the “Global Asthma Report 2014”, the burden of 
asthma is highest for children aged 10-14 years and the older persons aged 75-79 years and lowest 
for those aged 30-34 years as measured by disability and premature death (41). The high 
prevalence of asthma symptoms among the older population might also be due to the presence of 
other respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) (41). 
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The global prevalence of asthma among young adults (18-45 years) is approximately 8.6% 
(41). Among the Canadian population, more than 2.4 million (8.4%) people aged 12 years or older 
had asthma in 2009-2010 (42). About 7.0% of males and 9.8% of females are living with asthma 
in Canada (42). Asthma is one of the major causes of school and work absenteeism as well as 
hospital admission (36). 
In British Columbia, the estimated direct asthma-related health care costs including 
hospitalization, physician visits, and medication use were $315.3 million between 2002 and 2007 
(43). Annual costs per patient with current asthma were $311 and for patients who ever had asthma, 
it was $159 (43). 
2.4.2 COPD 
According to the Global Initiative for Chronic Obstructive Lung Diseases (GOLD) 2017, 
COPD is defined as “a common, preventable, and treatable disease that is characterized by 
persistent respiratory symptoms and airflow limitations that are due to airway and/or alveolar 
abnormalities usually caused by significant exposure to noxious particles or gases” (44).  
COPD is the tenth most important disorder in the world in terms of disability adjusted life 
years (DALYs) (1). Globally, COPD was estimated as the 5th leading cause of death in 2001 and 
will be the 3rd leading cause of death by 2020 as stated by the World Health Organisation’s (WHO) 
Global Burden of Disease Project  (45). The prevalence ranges in women from 5.1% (China) to 
16.7% (South Africa) and in men from 8.5% (Iceland) to 22.2% (South Africa) (46). The 
prevalence of COPD in Canada (Vancouver) is approximately 7.3% in women and 9.3% in men 
(46). 
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The average excess costs due to COPD were about $5,452 per patient per year which was 2.73 
times higher than non-COPD patients (47). It was estimated in British Columbia that the total 
excess costs for COPD patients were $600 million in 2010 (47). 
2.5 Importance of lung function/spirometry 
Use of spirometry is helpful for severity assessment of respiratory diseases (48). Spirometry 
provides acceptable results and accurate interpretations which can be incorporated in medical 
practice in the management of patients with previously diagnosed asthma or COPD. To assess the 
impact of spirometry in the management of asthma and COPD patients, an introduction of office 
spirometry was established in community based family medicine practices in USA by using a 
before and after quasi-experimental design (9). The researchers randomly selected 12 non-
academic family medicine practices without prior use of in-office spirometry and introduced an 
EasyOne Spirometer (ndd Medizintechnik AG; Zurich, Switzerland). The researchers enrolled 
patients aged >7 years and previously diagnosed with asthma or COPD for spirometry as an 
everyday practice. The “pre” data was the recommended therapy without use of spirometry and 
the “post” was the interpretation of the spirometry results by using complete assessment of the 
patients’ condition with spirometry, symptoms, and a medication checklist questionnaire. Based 
on the spirometry results, the physicians interpreted and changed the medications as required. The 
investigators sent the spirometry results with the family physician’s interpretation to the experts 
for reviewing. This was to evaluate the consistency of the current medication changes based on 
spirometry. The combination of before and after information regarding patient reported symptoms, 
spirometry results, and before and after medications helped them in judging the consistency in 
changing medication therapy to the standard guidelines. They found consistent management 
(overall 86% of the medication changes after using spirometry) which support the Global Initiative 
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Chronic Obstructive Lung Disease guidelines for the management of COPD and National Asthma 
Education and Prevention Program guidelines for the management of asthma (9).  
2.6 Predictors of lung function 
Several factors are predictors of lung function. The value of FVC increases with increasing 
age until 24 years, then it remains stable through the age of approximately 34 years until decreasing 
in older age (49).  It was found that rising age is associated with decreasing FEV1 and FVC among 
adults aged ≥65 years (50) and declining lung function may accelerate after the age of 70 years 
(51). This association has been observed in Caucasian and African-American population (50). On 
average, African-American persons have lower FVC and FEV1 compared to Caucasian persons at 
all ages and sexes (49). Height is another important predictor of lung function where lung function 
increases with increasing height (52). The growth of lung function is better observed in relation to 
height rather than age in children and adolescents (boys aged 7-17 years, girls aged 7-14 years) 
(49). Greater values of lung function are observed in young males than young females with the 
same standing height (52). Again, African-American persons had lower values of lung function 
(FVC) for the same sex and height groups than Caucasian persons (49). Immigration status may 
have an impact on lung function as lung function varies in different ethnicities and geographic 
areas (53). Lower socioeconomic status acts as a risk factor for asthma and other chronic diseases 
(54,55). Similarly, lower socio economic status is associated with lower lung function (54,55). The 
presence of chronic bronchitis, pneumonia, emphysema, and asthma are also associated with 
decreasing levels of lung function (50). Many studies have been reported that lower respiratory 
tract infection and smoking (active and passive) by healthy children, adolescents, and adults are 
associated with reduced levels of lung function (56–62). The effect of smoking may slow the 
growth of lung function in both sexes, with a greater effect observed in girls than boys (62). 
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Bronchial hyper-responsiveness may be associated with accelerated reducing of FEV1 (63,64). 
Recently a population based study in 2015 among adults aged ≥20 years has shown that weight, 
body mass index, waist circumference, waist-hip ratio, and abdominal height is associated with 
the higher FEV1/FVC ratio (65). In this study, BMI was the strongest predictor of FEV1/FVC ratio 
in both men and women (65). Obesity may cause difficulty in respiration by providing limited 
space for descending of the diaphragm and compromises chest wall may lead to diminishing 
functional residual capacity and total lung capacity followed by reducing lung function levels (66). 
Obesity may occur in improper dietary consumption, malnutrition, and lack of physical activity.  
2.7 Dietary factors as a predictor of lung function 
Changing dietary habits may act as a factor to explain the increase in severity and prevalence 
of asthma (2,67). The prevalence of asthma has increased in parallel with changes in diet, 
urbanization, and westernization in the past few decades (13,68). The prevalence of COPD has 
also increased with smoking, dietary habit, urbanization, and westernization (69–74). One 
interpretation requiring further research is that the rising prevalence of lung disease may be due to 
the altering of dietary habits (4–7). For example, in the UK, the most common dietary pattern 
identified in an observational study by Devereux and Seaton was a lower intake of fruits and 
vegetables, and higher intake of fatty food (e.g. margarine) (75). They showed a trend in the UK 
dietary pattern between 1942 and 2000 suggesting that consumption of fresh green vegetables, 
total vegetables, and potatoes had been reduced (75). Their review also showed that there are 
beneficial associations in the consumption of dietary antioxidants (Vitamin A, E, and C) and lipids 
(e.g. fatty fish) with asthma and atopy according to the epidemiologic studies (75–77).  
Dietary consumption may vary from person to person due to socio-demographics, social status, 
geography, ethnicity, and lifestyle (11,12). Given the recognized importance of diet, there has been 
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increased attention on the health effects of dietary factors with regard to lung health recently, 
including lung function. A description of dietary characteristics as an exposure and lung function 
as an outcome from various studies is presented in Table 2.1.   
  
    
1
2
 
 
Table 2.1 Characteristics and results of studies investigating the association between dietary factors and lung function 
First author 
reference# (Year 
published) 
Location 
Study 
Design 
Study population 
(Sample size) 
Diet exposure Outcome and strength of association 
Sorli-
Aguilar, M 
(78) 
2016 
Spain 
Cross-
sectional 
Adults 35-70 
years (n=207) 
without 
respiratory 
symptoms, 
smoker, 
previously 
diagnosed with 
respiratory 
disease were 
excluded. 
45 item of food (grouped 
into 19 based on the 
similarity of food) 
frequency questionnaire. 
The score for the dietary 
patterns was characterized 
into tertiles. 
The alcohol consumption pattern was associated with impaired lung 
function in both men and women. But higher odds ratio was observed in 
women (OR: 11.47, 95% CI: 2.25–58.47, p-value: 0.003). 
The westernized pattern was associated with a higher risk of impaired 
lung function only in women (OR: 5.62, 95% CI: 1.17–27.02, p-value: 
0.031). 
The Mediterranean Dietary like pattern was associated with preserved 
lung function (OR: 0.71; 95%CI: 0.28–1.79). 
Hanson, C 
(27) 
2016 
USA 
Cross-
sectional 
Adults 40-79 
years (n=1,921). 
NHANES Cycle 
2009 to 2010 who 
had pre-
bronchodilator 
spirometry. 
Dietary intake of total 
fiber was calculated based 
on 24 hours recall 
interview of the 
participants 
Higher fiber intake was associated with higher proportion of normal lung 
function (p-value 0.001). 
There was no association between daily intake of whole grains and lung 
function. 
Niruban, S J 
(79) 
2015 
Canada 
 
Cross-
sectional 
Adolescents and 
adults aged 13-69 
years 
(n=3,735) with 
25(OH)D 
measurements 
and valid lung 
function 
measurements. 
Serum 25-hydroxy 
Vitamin D {25(OH)D} 
level (categorized into 
≤49nmol/L as low, 50-
70nmol/L as moderate, 
and ≥75nmol/L as high) 
There was statistically insignificant association detected in the mean 
values of actual and percent predicted FEV1, FVC, and FEF25%-75% and the 
three categories of 25(OH)D, while the mean FEV1/FVC was lowest in the 
high 25(OH)D and highest in the low 25(OH)D which was not observed in 
the percent predicted FEV1/FVC ratio. Non- significant results were found 
with low 25(OH)D category and lower mean values of FVC, FEV1, 
FEV1/FVC, and FEF25%-75% after adjusting for age, gender, height, weight, 
smoking status, and race. Significant association found between high 
category of 25(OH)D and lower mean values of FEV1/FVC (p-value 0.02) 
than moderate category of 25(OH)D with mean values of FEV1/FVC 
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Wroblewska, 
I 
(80) 
2015 
Poland 
 
Medical 
document 
(spirometry) 
analysed 
(between 
January and 
December 
2012) 
Hospitalised 
patients ≥65 years 
with respiratory 
system disorder 
(n=217). 
Normal diet, easily 
digestible diet, diabetic 
diet, liver disease diet 
No impact of diet on FVC (p-value >0.05) or FEV1 (p-value >0.05). 
Martin, M R 
(81) 
2014 
USA 
Cross-
sectional 
Adults 45-64 
years (n= 15,567). 
Modified semi-
quantitative food 
frequency questionnaire. 
Nutrient composition was 
calculated based on the 
dietary information. 
Higher intake of whole grains was associated with higher FEV1/FVC 
ratio, while saturated and solid fats were associated with lower FEV1/FVC 
ratio. 
Bentley, AR 
(82) 
2012 
USA 
Prospective 
cohort 
70-79 years old 
Community-
dwelling older 
adults (n=3,075) 
History of 
smoking 
No history of 
prevalent lung 
disease (asthma 
or COPD). 
 
Dietary antioxidant 
(Vitamin C and E, and β-
carotene) measured by 
whole food intake and by 
calculation of antioxidant 
from all dietary sources 
Higher intake of antioxidant rich food (higher Vitamin C, fruits, and 
vegetables) associated with slower rate of declined FEV1 (in current 
smokers). 
In continuing smokers, high intake of Vitamin C or E were associated 
with slower rate of decline FEV1 (18 and 24 ml/yr.) p-value <0.001 and 
<0.003 respectively, while low intake of these nutrients had a higher rate 
of decline FEV1 (43 and 42 ml/yr.). Intake of β-carotene did not vary in 
this association. 
FEV1 increased by ~1-2% in high consumption group and declined by 
~2.5% in low consumption group. 
Little or no association was found in diet and rate of decline FEV1. 
Results of FVC were less consistent than FEV1. 
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Hirayama, F 
(83) 
2010 
Japan 
Case-control Case: 
278 referred 
patients (men= 
244, women= 34) 
Adults 50-75 
years. 
Diagnosed with 
COPD (within the 
past 4 years). 
Control: 
340 community 
based controls 
(men=272, 
women= 68), 
Assessed for 
dyspnea and have 
spirometric 
measurements  
Frequency of food by 
using 138-item food 
frequency questionnaire 
classified by nine 
categories. The categories 
were ranging from 
“almost never” to “seven 
or more times per day” 
Higher folate intake was associated with higher FEV1 (β=1.02, 95% CI 
0.35-1.70) and FVC (β= 0.84, 95% CI 0.13-1.55). 
Higher intake of daily folate associated with decrease prevalence of 
COPD. 
Lower intake of folate associated with breathlessness (p-value <0.001). 
Jiang, R 
(84) 
2007 
USA 
Cross-
sectional 
Adults ≥45 years 
(n=7,352), 
Excluded persons 
with missing 
values of cured 
meat, fish, fruits 
or vegetable 
consumption, 
Also, excluded 
persons without 
acceptable 
spirometry 
curves. 
Cured meat consumption: 
The total onsumption of 
bacon, sausage, and 
luncheon meats. 
Food frequency 
questionnaire was used 
including frequency of 
consuming meats, fish, 
fruits, and vegetables over 
the past month. 
Higher consumption of cured meat was associated with lower FEV1, FVC, 
and FEV1/FVC after adjusting demographics and height. 
Consumption of cured meat 14 times or more per month was associated 
with decreased FEV1 (-110 ml, p-value= <0.001) and FEV1/FVC (-2.13%, 
p-value= <0.001) compared to those who never consumed cured meats. 
Increased each time of cured meat intake per month was associated with 
decreased FEV1 (3.85 ml) and decreased FEV1/FVC (-0.07%). 
FVC did not vary significantly through the different categories of cured 
meat. 
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Butland, BK 
(85) 
2000 
UK 
Prospective 
cohort study 
Men aged 45-59 
years (n=2,512) 
living in 
Caerphilly 
Semi quantitative food 
frequency questionnaire 
was used for dietary 
information included 
frequency of intake 
(number of times/week in 
phase I and number of 
times/day in phase II). 
The quantity of intake 
was asked for some type 
of foods including a 
number (bread, eggs), size 
(bread, milk, 
butter/margarine), and 
portions (meat, fish). 
Multiple regression models were fitted to find out the association between 
dietary factors (exposure) and maximum FEV1 (outcome). In the cross-
sectional analysis, the maximum FEV1 was associated with higher 
Vitamin C, Vitamin E, and β-carotene (p-value < 0.001, 0.0009, and 0.031 
respectively) which is reduced when unconfounded by BMI and lost 
significance when the model was adjusted for smoking and social class. A 
significant negative association was found between magnesium and total 
energy intake and lung function while a positive association was observed 
with frequent consumption of citrus fruit, fruit juices/squashes, and apples. 
After adjusting for smoking, BMI, social class, exercise, and total energy 
intake, only apple consumption remained statistically significant. No 
statistically significant association was found between the frequency of 
fatty fish intake and lung function. In the longitudinal analysis, no 
statistically significant association was found between the total number of 
apples per week, Vitamin E, and Vitamin C and change in lung function 
between phase I and II. 
Hu, G 
(86) 
2000 
USA 
Cross-
sectional 
Adults >17 years 
old (n=18,162) 
With spirometry 
results and dietary 
data 
Dietary antioxidant 
(Vitamin C, Vitamin E, β-
carotene, and selenium) 
intake and serum 
biomarkers stratified by 
smoking status 
Serum antioxidant was associated with lung function (FEV1) 
independently. Joint effect of dietary antioxidant was higher than the 
single nutrient, but the only carotene was statistically significant. Dietary 
consumption of Vitamin C, Vitamin E, and carotene was highly 
correlated. 
When stratified by smoking status: 
Serum Vitamin E and FEV1 was weakly associated in former smokers (p-
value= 0.01), while β-carotene was more weakly associated (p-
value=0.03), and selenium was strongly associated (p-value=0.01) in a 
current smoker group than a non-smoker and former smoker group. 
Carey, IM 
(87) 
1998 
UK 
Prospective 
cohort 
Caucasians 18-73 
years with 
satisfactory 
spirometric 
measurements in 
both examinations 
(n= 2,171) 
30 different items of fresh 
fruits (summer and 
winter), salads or raw 
vegetables (summer and 
winter), and pure fruit 
juice. For each food item, 
a consumption score was 
used (from 5 to 0 
A person who consumed an average level of fresh fruit was not significant 
in changing FEV1 (p-value= 0.446), compare to a person who consumed a 
decreased level of fresh fruit. This was observed in all healthy individuals 
(overall p-value= 0.002), in female (p-value <0.001) and in current 
smokers (p-value= 0.013). 
In comparing the cohort prospectively, 
Individuals who did not change fruit intake in 7 years, FEV1 was alike and 
little variation with the level of fruit intake. 
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accordingly): >1 per day, 
one per day, most days, 
once or twice a week, less 
than once a week, or 
never. 
Individuals who reduced their fruit consumption in 7 years, showed a 
decreased FEV1. 
Individuals who increased their fruit consumption in 7 years, showed an 
increased FEV1. 
Schwartz, J 
(88) 
1994 
USA 
Cross-
sectional 
Adults aged (≥30-
70) years 
(n=2,526) 
Excluded: 
pregnant, acute or 
chronic medical 
conditions, and 
inappropriate 
spirometry 
maneuver  
Usual consumption of fish 
in the past three months. 
Consumption of fish was 
coded as portions per 
week.  
Intake of fish and FEV1 showed protective association in the baseline 
model included ln (age), [ln (age)]2, height, BMI, race, sex, pack years, 
Cigarettes/day, working (β= 0.0088±0.004, p-value= 0.28).  
Impact of fish on FEV1 was intact when patients with asthma or bronchitis 
were excluded from this model (β= 0.0088±0.004, p-value=0.06). After 
excluding smokers from the model fish intake was increased 
(β=0.011±0.01, p-value= 0.06).  
A dose-response relationship (subjects who consumed one portion per 
week had 1.35% higher FEV1 while those who consumed more than one 
portion had 2.51% higher FEV1) was observed when dietary intake of fish 
was divided into categories. Little effect was noticed in between fish 
intake and FEV1 after controlling for family income. There was no 
different slope found in female (p-value=0.46) and older individual (p-
value=0.60). 
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It can be seen from Table 2.1 that these studies were conducted outside of Canada (in the 
USA, Poland, Japan, UK, and Spain) with the exception of Niruban, SJ et al (2015) (79). Cross-
sectional methods were used in the majority of the studies (27,78,79,81,84,86,88). The other 
methods of study designs were prospective cohort (82,85,87), case-control (83), and analysis of 
medical documents (80). Considerable variability is observed among the study population as well. 
Some researchers included a wide range of ages (aged 13-69, >17, and 18-73 years respectively) 
(79,86,87) whereas others included a smaller age range of adults (aged 35-70, 40-79, 45-64, ≥65, 
70-79, 50-75, ≥45, 45-59, and ≥30-70 years respectively)  (27,78,80–85,88). As such, most of the 
studies included adults with a limited range of ages.  
The exposure of interest varied between these studies from the use of a single nutrient 
(Vitamin D or dietary fiber) to multiple nutrients (Vitamin A, C, and E) and different food 
categories (e.g. meat, fish, and fruits). Only one of the studies included both nutritional bio-
markers and various types of food categories obtained from food frequency questionnaire (86). 
The remaining studies used either serum biomarker (79) or food frequency questionnaire for 
dietary information as a measure of exposure (27,78,80–85,87,88). 
Over several years, reduced consumption of fresh fruits has been associated with changing 
lung function where increased fruit consumption was associated with improved lung function (87). 
Also, frequent consumption of cured meat has been associated with lower FEV1 and FEV1/FVC 
(84). Reduced consumption of dietary fiber was associated with lower lung function (27). A 
significant positive association has been observed between serum Vitamin D and FEV1/FVC in 
adults including older adults (79). A higher intake of antioxidants and fruits have also been found 
to be associated with the slower decline of FEV1 (82,85,86) suggesting that antioxidants can play 
an important role in slowing the decline of FEV1 in this population. Dietary intake of folate has 
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been associated with higher FEV1 and FVC (83). Also, higher consumption of fish has shown a 
positive dose-response relationship with FEV1 (88).  
Although not entirely consistent (80), various studies have indicated that dietary exposure 
has an influence on lung function (87,84,27,79,82,85,86,83,88,78,81). The Wroblewska et al. 
study (80) was a hospital based study and included only an older population (≥65 years), it cannot 
be generalised to the total population.  
2.8 Dietary types and lung function 
2.8.1 Canada Food Guide 
 The Canada Food Guide (CFG) is a dietary guide for Canadians produced by Health 
Canada (89). The first CFG was first introduced in 1942 to prevent nutritional deficiency and to 
improve the health of Canadians (89). This food guide has been transformed several times and 
updated including the most recent in 2007 to reach today’s look of “Eating Well with Canada’s 
Food Guide” (89). The CFG is a government produced and sponsored guideline for eating the right 
food group among the specified age group and gender with the main purpose to identify and 
promote a healthy dietary pattern to reduce the risk of nutrition related diseases (e.g. obesity, 
Cardiovascular disease) (89). Therefore, it is important to investigate the impact of the CFG on 
the Canadian population. Based on a person’s age and sex, the actual food consumed can be 
compared to CFG to determine if the person meets or does not meet the suggested criteria. This 
assessment of the association between the Canada Food Guide and lung function or respiratory 
diseases has not previously been completed.   
2.8.2 Mediterranean Diet 
The Mediterranean Diet is a unique dietary pattern of the people living in the Mediterranean 
region which has previously shown to be able to improve asthma and lung function and has also 
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been shown to beneficial with regard to other diseases (90). The Mediterranean Diet is composed 
of large quantities of fresh fruits, vegetables, legumes, nuts, whole grains, and olive oil; moderate 
to high quantities of fish; moderate quantities of dairy products (mostly cheese and yogurt); and 
low quantities of meat, poultry, and ω=6 fatty acids (91). A modified Mediterranean Diet Score 
was established by Garcia-Marcos et al. (2007) (92) based on Psaltopoulou et al.(93). In this 
modified Mediterranean Diet Score, fish, fruits, vegetables, pulses, cereals, pasta, rice, and 
potatoes were considered as “pro-Mediterranean” food rated as 0, 1, or 2 points ranging from less 
frequent to more frequent consumption while milk, meat, and fast-food was considered as “anti-
Mediterranean” food rated as 0, 1, or 2 ranging from more frequent to less frequent consumption 
(92). 
2.9 Biological mechanism of diet on lung function 
 Oxidative stress produced by reactive oxygen species (ROS) can be generated in the lungs 
in response to several triggers including air pollution, irritants inhalation (smoking), and response 
by the inflammatory cells (94). Fat soluble antioxidants (Vitamin E, carotenoids (α- and β-
carotene, lycopene, lutein and β-cryptoxanthin) also act as scavengers to remove ROS and decrease 
oxidative stress (95,96). Antioxidants (Vitamin C, Vitamin E, carotenoid, and flavonoid) are found 
in high quantities in fruits and vegetables (broccoli, spinach, tomatoes, citrus fruits, beans, and 
mangoes), mayonnaise, vegetable and seed oil, butter, eggs, nuts, cocoa, and green tea (95,96). 
Another antioxidant, Lycopene (carotenoid) is predominantly present in tomatoes and shown to 
improve lung health (higher FEV1) by eliminating ROS and suppress airway inflammation (95,96).  
 Vitamin D can be found from dietary sources and supplementation although the main 
source of Vitamin D is from sun exposure (97). Vitamin D protects the airway by reducing the 
susceptibility and severity of the respiratory infections (98). 
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 Minerals have also been found to protect against respiratory conditions. Inverse 
associations were observed between the increased intake of minerals (magnesium, calcium, 
potassium) and asthma prevalence (99). 
2.10 Inflammation and lung function 
Airway inflammation is a feature of lung diseases, especially in asthma and COPD (39,44). 
Although the mechanism of the inflammatory process (e.g. type of inflammation, inflammatory 
cells, mediators, consequences of inflammation), etiology, and symptoms are dissimilar for 
different lung diseases (e.g. asthma, COPD) (100,101), inflammation affects the airway and causes 
airway limitation and breathlessness (102–104). Airway limitation and breathlessness caused by 
inflammation may contribute to reducing the lung function (102–104). 
2.11 Biomarkers and their relationship to lung function  
Biomarkers are objective measurements whose presence is indicative of some phenomenon 
such as disease, infection, or environmental exposures. Biomarkers are used to represent dietary 
or nutrient intake (105). Various biomarkers can be used to explain nutritional status e.g. nutrient, 
food component, and an indicator of the development of diseases (106).  
A significant association was found between higher serum folate and decreased risk of reduced 
lung function (FEV1/expected FEV1 <80%) (107) while low dietary consumption of folate was 
significantly associated with reduced lung function (107). Serum folate and Vitamin B12 
(cobalamin) may be associated with asthma and atopy. Decreased serum atopy was associated with 
atopy, elevated total IgE levels, and wheezing (108). A population based prospective cohort study 
(January 2001 to April 2006) was conducted in Denmark among adults aged 30-60 years to obtain 
in depth knowledge about the role of folate and Vitamin B 12 in atopic diseases showed that higher 
level of serum folate was associated with self-reported doctor diagnosed asthma and lower airway 
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symptoms (107). A cross-sectional survey was conducted in 2005 among the US adults (≥20 years) 
to determine the association between serum concentration of 25-hydroxy Vitamin D and 
pulmonary function with a dose-response relationship observed between Vitamin D and FEV1 
(109). 
C-reactive protein (CRP) is a blood test marker which is produced in the liver in response to 
inflammation in the body (110). The level of CRP increases if there is systemic inflammation in 
the body due to infections or other medical conditions (110). In chronic lung diseases (e.g. asthma, 
COPD), colonization of lung by bacteria, smoking, obesity, and air pollution may stimulate the 
CRP production by producing more interleukine-6 (102,111). The damaged lung tissue may itself 
act as a source for triggering synthesis for CRP as well (111). The Mediterranean dietary pattern 
is made up of anti-inflammatory components (e.g. fresh fruits, vegetables, fish, whole grains) 
which deliver omega-3 fatty acids. These foods, therefore, contain anti-inflammatory properties 
which reduces the inflammation and CRP (90). It is important to consider CRP since it may be 
associated with dietary patterns and may have an impact on aspects of lung disease including lung 
function. 
2.12 Potential for effect modification 
 Based on previous studies, diet has been associated with asthma (112–121) and COPD 
(22,69–74). There are several plausible biological mechanisms that exist to explain the effects of 
diet on asthma such as antioxidants protecting the airways by reducing airway inflammation from 
oxidants from both exogenous and endogenous sources (122). Endogenous sources include 
activated inflammatory cells and exogenous sources include smoking as an example (122). Foods 
rich in antioxidants (Vitamin A, C, and E) are fruits, vegetables, and whole grain products. 
Consumption of fish oils (specifically, n-3 polyunsaturated fatty acids, eicosapentaenoic acids, and 
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docosahexaenoic acid) are the precursor for the production of pro-inflammatory mediators 
(eicosanoids include prostaglandins and leukotrienes). Higher intake of n-3 fatty acids moves the 
balance towards the eicosanoids which are less active biologically (123). The lack of fish oils in 
westernized diets may promote airway inflammation and contribute to asthma. In COPD, 
antioxidants from food may protect the lung from oxidative damages and prevent air pollution 
induced oxidative stress (96). Also, a higher intake of fruits and vegetables may improve the lung 
function and decrease the COPD risk (72), (23). 
No previous studies had investigated the interaction between diet and comorbidity of 
asthma and COPD. Because diet does have the potential to be associated with lung disease and 
lung function results can vary by the presence of these diseases. It is possible that effect 
modification between dietary factors and asthma or COPD may exist. 
2.13 Summary of literature review 
 Respiratory diseases are associated with a large and increasing burden of morbidity and 
mortality globally. Lung function is an important assessment tool for respiratory disease and can 
be independently associated with a number of personal and environmental factors. Given the 
importance of spirometry and that many conditions may be associated with dietary factors, further 
research should be conducted to investigate the association between diet and lung function. 
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Chapter 3 : Methods 
3.1 Data sources 
The data used for this thesis was from the Canadian Health Measures Survey (CHMS) 
(124–126). The CHMS is a national health study in Canada. It is led by Statistics Canada in 
partnership with Health Canada and the Public Health Agency of Canada. It is a repeated cross-
sectional study using both questionnaire report and clinical measures. Cycles 1 to 3 of the CHMS 
have been used for this thesis. 
3.2 Target population 
The target population for the CHMS was children, adolescents, and adults (6 to 79 years in 
Cycle 1 and 3 to 79 years in Cycles 2 & 3). The data collection took place for Cycle 1 between 
March 2007 and February 2009, for Cycle 2 between August 2009 and November 2011, and for 
Cycle 3 between January 2012 and December 2013. The representative survey coverage excluded 
4% of the population who were living in the three territories, Aboriginal reserves, full time 
members of the Canadian Forces, institutionalised populations, and residents living in remote 
regions.  The data related to the adult component of the survey (ages 18 to 79 years) is the focus 
of this thesis. The reason for excluding children is the pattern of lung function development varies 
in younger age (children and adolescents) compared to adults. Also, it is more difficult to obtain 
accurate lung function results by spirometry among younger children. Furthermore, dietary 
requirements will vary in children and adolescent age group and their growth. 
3.3 Study design and sampling procedure 
A cross-sectional multi-stage survey design was used for the Canadian Health Measures 
Survey (CHMS).  Each collection site was defined as a geographic area with the presence of a total 
population of at least 10,000. The Labour Force Survey (LFS) was used to create the collection 
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site lists. The LFS used clusters which were small geographic units containing approximately 200 
dwellings as a sampling frame. About 360 reporting units/sites per collection site were created by 
using LFS frame in Cycles 1 to 3. The reporting units (data collection area) were restricted to a 
radius (around the Mobile Examination Center located near the houses of collection sites) of about 
50 km (up to 75 km for rural areas). To define the collection sites, geographic units were used, 
which were also grouped into provincial boundaries, census metropolitan-area boundaries, health 
regions and population density criteria. 
The sites were sorted within each region according to their population size. They were first 
sorted by province within the Prairies and Atlantic regions. By using a systematic sampling method 
with a probability proportional to the size of each site’s population, the sites were randomly 
selected. In the survey, approximately 5,700 participants across all the sites contributed data and 
represented approximately 96% of the Canadian population. 
The 2011 census was used as a frame within each of the 16 Cycle 3 selected collection 
sites. To improve the coverage, new dwellings from Statistics Canada’s address register were used 
as well. Using the census time date of birth and more current information from other administrative 
sources, the people living in the dwellings were stratified into six age groups. The samples were 
allocated in such a manner that each stratum obtained target numbers of respondents by age group. 
3.4 Methods of data collection (CHMS) 
The CHMS collects health information and direct physical measurements such as blood 
pressure, height, weight, physical fitness, and biomonitoring components (e. g. blood samples) of 
Canadians. At the beginning of this analysis for the thesis, three Cycles had been completed and 
used. These are repeated cross-sectional studies that have independent participants. The CHMS 
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collected data from multiple collection sites stratified in 5 regions. The regions were Atlantic, 
Quebec, Ontario, Prairies (Alberta and Manitoba), and British Columbia. 
Cycle 1 (2007-2009): Cycle 1 included approximately 5,604 Canadians at 15 collection sites 
throughout the country. The collection sites were: Atlantic-1, Quebec-4, Ontario-6, Prairies-2, and 
British Columbia-2. The adult sample included 3726 people which represented 24,531,089 
Canadians. 
Cycle 2 (2009-2011): Cycle 2 included approximately 6,395 Canadians at 18 collection sites 
throughout the country. The collection sites were: Atlantic-2, Quebec-4, Ontario-6, Prairies-3, and 
British Columbia-3. The adult sample included 3873 people which represented 25,327,408 
Canadians. 
Cycle 3 (2012-2013): Cycle 3 included approximately 5,785 Canadians at 16 collection sites 
throughout the country. The collection sites were: Atlantic-2, Quebec-4, Ontario-6, Prairies-2, and 
British Columbia-2. The adult sample included 3397 people which represented 25,974,338 
Canadians. 
The methods of data collection for all three Cycles are similar except for variations with 
collection sites and age ranges. Cycle 1 had 15 collection sites with an age range of 6-79 years, 
whereas Cycle 2 had 18 collection sites with an age range of 3-79 years, and Cycle 3 had 16 
collection sites with an age range of 3-79 years. The spirometry measurements were collected from 
age 6 years and above in all three data collection Cycles. 
For the adult population, information was collected directly from the respondents and was 
voluntary. The collection included a computer assisted personal interview (CAPI) followed by a 
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physical assessment. The physical measures were completed at Mobile Examination Centers 
specifically designed for the survey. 
The CHMS Mobile Examination Centers stayed in each site for five to seven weeks 
gathering direct measures from the respondents. Several steps were followed during data 
collection. The data collection steps were as follows (124–126): 
• A letter was sent by mail as the first contact. The letter was written to inform the potential 
participant about the survey and stated that an interviewer would visit their home for data 
collection.  
• The data collection then began with the personal interview at the household. At home, one or 
two respondents were selected randomly, and the interviewer conducted separate interviews 
with each person. The duration of the interview was about 45-60 minutes per respondent. The 
interviewer then helped the respondent set an appointment for the physical measures at the 
CHMS Mobile Examination Centers. 
• The next step was to visit the CHMS Mobile Examination Centers. The Mobile Examination 
Centers consisted of two trailers linked by an enclosed pedestrian walkway. One trailer served 
as a reception and administration area and the other worked as a physical measures room and 
laboratory. For each respondent, the duration of the CHMS Mobile Examination Centers visit 
was about two hours. The respondents were provided a waterproof activity monitor at the end 
of their visit. This small device was for recording information regarding their physical activity 
patterns.  
3.5 Analytical framework 
The framework below (Figure 1) illustrates that evaluation needs to assess the association 
between dietary factors and lung function. In the box on the left, the dietary factors and biomarkers 
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were the primary exposures of interest in this study. In the top middle box, demographic 
characteristics, co-morbidity, and environmental factors were potential confounders and 
considered as covariates. In the middle lower box, interaction terms for diet and asthma and diet 
and COPD were considered. In the box on the right, lung function was the outcome variable of 
interest. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Analytical framework for dietary factors and lung function 
 
Exposure: 
 
1. Dietary factors: 
Food frequency (e.g. meat, fish, 
milk, vegetables, fruits, grains, 
soft drinks, water consumption) 
2. Canada Food Guide 
3. Mediterranean Diet Score 
4. Biomarkers: (e.g., Vitamin 
B12, D, red blood cell folate, C-
reactive protein) 
 
Outcome: 
Lung function: 
FVC, FEV1, 
FEV1/FVC, 
FEF25-75% 
Covariates: 
1. Demographic 
2. Co-morbidity 
3. Environmental 
Interaction: 
 
Diet*Asthma 
Diet*COPD 
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3.6 Operational definitions 
1) FEV1: Forced Expiratory Volume in the 1st second. This is the volume (L) of air expired in 
the first second during the maximal expiratory effort. The largest FEV1 from the acceptable 
trials was used for analysis. 
2) FVC: Forced Vital Capacity. This is the total volume (L) of air expired after a full 
inspiration during a forced expiratory maneuver. The largest FVC from the acceptable trials 
was used for analysis. 
3) FEV1/FVC: This is the percentage of the forced vital capacity that is expired in the first 
second of maximal expiration.  
4) FEF25-75%: This is the average flow expired during the middle half of the FVC collected 
from acceptable trials & largest sum of FVC + FEV1 
5) Ever asthma: Presence of long term asthma expected to last or already have lasted for six 
months or more than that and have been diagnosed by a health professional. It is based on 
the question: “Do you have asthma? Yes/No which came after the following preamble: 
“Now I’d like to ask about certain chronic health conditions which you may have.” 
(Household questionnaire, Statistics Canada). Current asthma was assessed from the 
household questionnaire, “Have you had any asthma symptoms or asthma attacks in the 
past 12 months?” Answered as: yes or no. 
6) Other respiratory diseases: 
• COPD: “Do you have chronic obstructive pulmonary disease (COPD)?” Answered as: 
yes or no. 
• Chronic bronchitis: “Do you have chronic bronchitis?” Answered as: yes or no. 
• Emphysema: “Do you have emphysema?” Answered as: yes or no. 
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7) Dietary factors: The frequency of consuming different amounts of meat, fish, fruits, 
vegetables, grains, milk and milk products, dietary fat, water and soft drinks consumption 
was measured. The specific items and questions to determine the type of foods eaten are 
located in Appendix 1. The question for each food category was: “How often do you 
usually eat…?” The answer categories for these questions were for example: twice a day, 
three times a week, once a month. The total number of times consuming the food was then 
calculated for the year (derived by Statistics Canada) then divided by 52 to calculate a 
weekly value. The dietary variables were divided into tertiles (low, medium, and high) 
based on Ye, M et al. (2015)(127). 
8) Canada Food Guide: Dietary categories were developed based on the recommendation of 
Canada Food Guide serving requirements. Four variables based on categories of dietary 
factors were created: a) vegetables & fruits, b) Grains, c) Milk and milk alternatives, and 
d) Meat and meat alternatives.  
a) Vegetables and fruits: This variable included vegetables, fruits, and potatoes. Based on 
the Canada Food Guide, the following cut-offs were used to categorize meeting or not 
meeting the recommended guidelines. 
For male age 51 years and above: 7 servings or more per day was recommended. 
For male age below 51 years: 8 servings or more per day was recommended. 
For female age 51 and above: 7 servings or more per day was recommended. 
For female age below 51 years: 7 servings or more per day was recommended. 
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b) Grains: This variable included cereal, bread, rice, and pasta. Based on the Canada Food 
Guide, the following cut-offs were used to categorize meeting or not meeting the 
recommended guidelines.  
For male age 51 years and above: 7 servings or more per day was recommended. 
For male age below 51 years: 8 servings or more per day was recommended. 
For female age 51 and above: 6 servings or more per day was recommended. 
For female age below 51 years: 6 servings or more per day was recommended. 
c) Milk and milk alternatives: This variable included milk, cottage cheese, yogurt, and ice 
cream and frozen yogurt. Based on the Canada Food Guide, the following cut-offs were 
used to categorize meeting or not meeting the recommended guidelines. 
For male age 51 years and above: 3 servings or more per day was recommended. 
For male age below 51 years: 2 servings or more per day was recommended. 
For female age 51 and above: 3 servings or more per day was recommended. 
For female age below 51 years: 2 servings or more per day was recommended. 
d) Meat and meat alternatives: This variable included red meat, fish, eggs, and beans. 
Based on the Canada Food Guide, the following cut-offs were used to categorize 
meeting or not meeting the recommended guidelines. 
For male age 51 years and above: 3 servings or more per day was recommended. 
For male age below 51 years: 3 servings or more per day was recommended. 
For female age 51 and above: 2 servings or more per day was recommended. 
For female age below 51 years: 2 servings or more per day was recommended. 
9) Mediterranean Diet Score: A modified Mediterranean Diet Score was used based on the 
article by Garcia-Marcos (92). In the original computation of the Mediterranean Diet Score 
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the variables used in its calculation were based on the following categories: a) never, b) 1-
2 times per week, and c) 3 times or more per week. Based on these categories, the dietary 
factors considered as protective (fish, vegetables, fruits, cereal, pasta, rice, and potato) were 
assigned the highest score (score 2) for consuming 3 times or more per week. The dietary 
factors considered as not protective (meat, milk) based on the above scoring were assigned 
the lowest score (score 0) for consuming 3 times or more per week. All dietary factors were 
assigned a middle score (score 1) for consuming 1 to 2 times per week. Each type of score 
was summed to get a total score for a person. In the past, Psaltopoulou et al. (93) and 
Trichopoulou et al. (91) used Mediterranean Diet Scoring which included monounsaturated 
lipid (mainly olive oil), polyunsaturated lipids (vegetable-seed oils), saturated lipids, and 
ethanol intake. However, we did not have these information available, which is the reason 
for our modified score. 
3.7 Co-variates 
Variables used for the statistical analysis were determined directly from the survey 
questionnaire and clinical testing. The variables that were used as co-variates included: age 
(continuous), sex (male/female), height (continuous), race (Caucasian/other), BMI 
(obese/overweight/not overweight or obese), immigration status (yes/no), marital status (married, 
common-law/widowed, separated, divorced, single), educational status (less than secondary 
school graduation/secondary school graduation/some post-secondary/post-secondary), income 
(CAD <30,000/ 30,000-<50,000/ 50,000-<80,000/ ≥80,000), smoking (never/occasional/ daily), 
smoking exposure (never/occasional/ everyday), alcohol drinker (never/former/occasional/ 
regular), current asthma (yes/no), family history of asthma (yes/no), other respiratory diseases 
(yes/no), total physical activities (continuous), and sedentary activity (continuous). The variables 
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were chosen based on previous studies (49,62,50–52,56,57,65,66). See details description of 
covariates in Appendix 1. 
3.8 Data collection 
3.8.1 Questionnaires 
a) Household questionnaire 
The household questionnaire was completed by in-person interviewing assisted by a 
computer. The household questionnaires were developed in such a way that there was logical flow 
into and out of the questions programmed. This method was comprised of specifying the type of 
answer needed, the minimum and maximum values along with what to do in non-response cases. 
The questions included were fully reviewed several times during development. The household 
questionnaire included information on socio-demographic characteristics, dietary factors, personal 
factors, and chronic conditions. The detailed description of the information collected from the 
questionnaires is located in Appendix 1. 
b) Clinic questionnaire 
The clinic questionnaires were completed by the participant during their visit to the CHMS 
Mobile Examination Centers to assess the eligibility for collecting physical measures (e.g. height, 
weight, spirometry, and so on) and bio-samples. The interview administered clinic questionnaires 
included different screening questions for laboratory analysis of biological specimens (these 
biological specimens are the indicators of general health, chronic disease, infectious disease, 
nutritional status and environmental biomarkers).  
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3.8.2 Health visits 
a) Spirometry Procedures 
The most important aspects of spirometry are FVC (Forced Vital Capacity) and FEV1 
(Forced Expiratory Volume in 1st second). Spirometry measurement was taken from all the eligible 
participants by following the 1994 update of the standardization of spirometry article by the 
American Thoracic Society (ATS) (28).  
Forced expiratory manoeuvres were used to measure the lung function values of interest. 
In sitting position, the participant was asked by a coach to take the deepest breath in and then 
exhale into the spirometer as hard as possible. The maneouver was expected to last at least 6 
seconds. In the maneuver, a soft nose clip was used to prevent air escaping through the nose. 
b) Objective lab measures 
Specific participants were selected for zero (if not eligible for a specific sample), one, two 
or three laboratories samples. The laboratory technician performed specimen collection (blood and 
urine).  Both fasting and random blood samples were collected independently. The complete blood 
count (CBC) analysis was conducted. After that, biological samples for storage and shipment to 
the reference laboratories were processed for further analysis. For the biomarker assessment, 
collected samples were analysed for: 
In blood: Vitamin B12 and D, red blood cell folate, chloride, potassium, C-reactive 
protein, high density lipoprotein (HDL), total cholesterol, total protein, sodium, and calcium. 
3.9 Statistical Analyses 
The statistical analysis was completed using SAS 9.4 and STATA 14 statistical software. 
Weighting variables for population sampling weights and boot-strapping for variance were used 
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in the analysis. These were supplied by Statistics Canada. Bootstrapping is a method that depends 
on random sampling with a replacement. It allows assigning measures of accuracy (bias, variance, 
confidence intervals, prediction error or some other such measure) to sample estimates (128). The 
data was checked by using basic descriptive statistics. Means and standard deviations were used 
for continuous variables, while frequencies and proportions were used for categorical variables.  
3.9.1 Analysis for research question 1 (What are the characteristics/status of lung function 
(FEV1, FVC, FEV1/FVC ratio, and FEF25-75%) in Canadian adults (18-79 years)?): 
The outcome was lung function status as described above. A descriptive analysis was 
performed for research question 1. Means and standard deviations were used for continuous 
variables, while frequencies and proportions were used for categorical variables. Analysis of 
covariance was performed to compare absolute lung function by different variable categories after 
adjusting for age, sex, height, and ethnicity. See descriptive statistics by age group in Appendix 2. 
A separate descriptive analysis was also performed examining percent predicted lung function 
results. Percent predicted values were based on Hankinson’s prediction equations (129) computed 
by Statistics Canada as per the equation below:  
% predicted= (measured / predicted) X100. (129) 
3.9.2 Analysis for research question 2.A (Are dietary factors (e.g. food types), dietary 
patterns (e.g. Mediterranean Diet), or biomarkers associated with lung function levels based 
on spirometry in a nationally representative Canadian population of adults?): 
Multiple linear regression models were fitted to investigate to what extent dietary factors were 
associated with lung function levels in Canada while controlling for the various confounders 
identified above. The main effects models including only the demographic variables for each 
outcome are located in Appendix 3. 
Model building and variable selection: 
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a) Univariate analysis: We performed a linear regression between each potential 
independent variable and lung function levels (FEV1, FEV, FEV1/FVC, and FEF25-75%) 
while adjusting for age, sex, height, and ethnicity. Variables with a p-value <0.25 will be 
kept in the subsequent model. 
b) Multivariate analysis: After univariate selection, multiple linear regression analysis was 
performed with eligible variables. In this stage, variables with a p-value <0.05 were kept 
in the model for further analysis. 
c) Potential confounders: Based on previous literature, age, race, sex, BMI, family history, 
place of residence, socioeconomic status, conditions presence, physical activity, and 
smoking were considered as confounders (79,130–134). We could not keep the place of 
residence in the analysis because including it in the model made the model unstable 
(bootstrapping variables could not replicate efficiently). For the assessment of the 
confounding effect of a variable, two multivariable models were fitted; one model did not 
include that particular variable and another model included that particular variable. Then a 
comparison between these two models was made, evaluating the changes in the beta 
coefficients of other variables. If the change was >15% then confounding was considered 
present and it was kept in the model (135,136).  
Confounding = 
𝛽 (𝑚𝑜𝑑𝑒𝑙 𝑤𝑖𝑡ℎ 𝑝𝑎𝑟𝑡𝑖𝑐𝑢𝑙𝑎𝑟 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒)− 𝛽 (𝑚𝑜𝑑𝑒𝑙 𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑝𝑎𝑟𝑡𝑖𝑐𝑢𝑙𝑎𝑟 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒)
𝛽 (𝑚𝑜𝑑𝑒𝑙 𝑤𝑖𝑡ℎ 𝑝𝑎𝑟𝑡𝑖𝑐𝑢𝑙𝑎𝑟 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒)
 X 100 
(135,136) 
3.9.3 Analysis for research question 2.B (Is there effect modification between dietary factors 
and asthma or COPD in the relationship with lung function?): 
The potential effect modification between dietary variables and asthma/COPD was assessed to 
answer the Research Question 2B. A series of interaction terms (dietary variable*asthma) were 
fitted with the main effects model fitted for research question #2 to test the significance of that 
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interaction term. If the interaction term was statistically significant at α=0.05, then the interaction 
was considered to be present.  
3.10 Ethical considerations 
To respect the privacy and maintain confidentiality, Statistics Canada is prohibited by law 
from discharging any information that could identify any person except when consent is provided 
by the participant or permitted by the Statistics Act. Statistics Canada has various rules to maintain 
the confidentiality of the respondent. One such method is to allow access to the data through 
approved Research Data Centres (RDC). At the University of Saskatchewan, this is the SKY-RDC. 
Access to the data is not allowed until the investigator undergoes a thorough screening procedure 
and being sworn in as a deemed employee of Statistics Canada. All result files were vetted prior 
to release from the RDC by an RDC analyst.  
3.11 Access to SKY-RDC 
Upon approval of the research pre-proposal by the committee of the Department of 
Community Health and Epidemiology, an application was submitted in conjunction with Dr. 
Joshua Lawson (Associate Professor, Canadian Center for Health and Safety in Agriculture) to the 
SKY-RDC for accessing the data of Canadian Health Measures Survey (CHMS), Statistics 
Canada. After receiving access to the data, analysis of this study began. 
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Chapter 4 : Results 
4.1 Descriptive characteristics of the study population 
4.1.1 Demographic and personal characteristics 
Table 4.1 shows the overall demographic, behavioral, and personal characteristics for the 
study population for three Cycles (Cycles 1, 2, and 3) of the CHMS. The descriptive results were 
consistent throughout the Cycles except for sedentary activity in Cycle 1 (mean 188.48±2.81 
minutes/day) which was lower compared to the other Cycles (mean 493.80±4.83 mins/day and 
mean 502.55±4.92 mins/day for Cycle 2 and 3, respectively). Within educational status, secondary 
school graduation was more common in Cycle 3 (25.02%) compared to Cycles 1 and 2 (18.76% 
and 15.83% for Cycles 1 and 2 respectively). However, in the survey, there was no category for 
“some post-secondary education” in Cycle 3. Demographic characteristics by age group are 
located in Appendix 2. A 5% difference in the observation can be considered as important (137). 
The following patterns were observed when comparing Cycles overall. 
• The proportion of participants within “Caucasian” ethnicity gradually decreased from 
Cycle 1 to 3.  
• The proportion of participants within “never” exposure to second hand smoke gradually 
decreased from Cycle 1 to 3. 
• The mean values of sedentary activity were gradually increased from Cycle 1 to 3. 
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Table 4.1 Descriptive statistics (overall) of socio-demographic, behavioral, and personal characteristics represented in each of the 
Cycles 
Characteristics Cycle 1 
Overall 
(n*= 24,531,089) 
% 
Cycle 2 
Overall 
(n*= 25,327,408) 
% 
Cycle 3 
Overall 
(n*= 25,974,338) 
% 
Age • ≥ 18 to <40 years 
• ≥40 to <65 years 
• >=65 years 
40.09 
47.30 
12.62 
 
39.33 
47.62 
13.06 
 
39.24 
47.06 
13.70 
 
Sex • Male 
• Female 
49.31 
50.69 
49.48 
50.52 
49.64 
50.36 
Race/ethnicity • Caucasian 
• Other 
82.29 
17.71 
77.64 
22.36 
75.13 
24.87 
Immigrant • Yes 
• No 
23.26 
76.74 
27.30 
72.70 
27.54 
72.46 
Region • Atlantic 
New Brunswick 
Newfoundland and Labrador 
Nova Scotia 
• Quebec 
• Ontario 
• Prairie 
Alberta 
Manitoba 
• British Columbia 
 
 
 
 
 
 
7.21 
- 
- 
23.59 
38.92 
 
16.73 
- 
13.55 
 
- 
3.59 
3.34 
23.61 
38.83 
 
12.70 
4.46 
13.47 
 
3.41 
- 
3.37 
23.21 
39.24 
 
17.23 
- 
13.54 
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Marital status • Married/ Common-law 
• Widowed, Separated, Divorced, Single, 
never married 
66.18 
33.82 
63.95 
36.05 
62.93 
37.07 
Educational status • Post-secondary graduation 
• Some post-secondary 
• Secondary school graduation 
• Less than secondary school graduation 
59.09 
9.42 
18.76 
12.73 
60.22 
10.50 
15.83 
13.45 
62.31 
- 
25.02 
12.67 
Family income • CAD ≥80,000 
• CAD ≥50,000 to <80,000 
• CAD ≥30,000 to <50,000 
• CAD <30,000 
39.97 
25.86 
18.86 
15.31 
41.14 
24.97 
17.74 
16.15 
41.58 
23.02 
20.34 
15.06 
Height • Mean (cm) / Standard error (SE) 168.62± 0.27 168.45± 0.34 168.91± 0.40 
Weight • Mean (kilogram) / Standard error (SE) 77.35± 0.72 77.61± 0.92 78.35± 1.16 
BMI • Obese 
• Overweight 
• Not overweight or obese 
23.92 
36.72 
39.36 
26.23 
34.22 
39.55 
26.39 
35.60 
38.00 
Smoking • Daily smoker 
• Former smoker 
• Never 
21.71 
29.68 
48.62 
20.65 
28.73 
50.62 
22.92 
26.10 
50.97 
Exposure to 
second hand 
smoking 
• Every day 
• Occasional 
• Never 
16.11 
36.51 
47.38 
15.71 
38.81 
45.49 
22.48 
37.59 
39.94 
      
 
 
4
0
 
 
Alcohol drinker • Regular drinker 
• Occasional drinker 
• Former drinker 
• Never drunk 
68.69 
16.83 
8.92 
5.57 
67.11 
15.47 
10.53 
6.89 
69.68 
12.77 
9.91 
7.63 
Ever asthma • Yes 
• No 
7.63 
92.37 
10.07 
89.93 
9.35 
90.65 
Current asthma • Yes 
• No 
4.28 
95.72 
4.54 
95.46 
4.44 
95.56 
Obstructive lung 
disease (Chronic 
bronchitis, 
Emphysema, 
COPD) 
• Yes 
• No 
3.24 
96.76 
4.22 
95.78 
2.98 
97.02 
Family history of 
asthma 
• Yes 
• No 
22.23 
77.77 
23.65 
76.35 
21.98 
78.02 
Total physical 
activity 
• Mean (minutes/day) / Standard error 
(SE) 
248.58± 4.44 217.47± 4.55 228.33± 6.40 
Sedentary activity • Mean (minutes/day) / Standard error 
(SE) 
188.48± 2.81 493.80± 4.83 502.55± 4.92 
*n=this is the weighted population number 
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4.1.2 Dietary factors 
Descriptive statistics of the dietary factors are presented by tertile in Table 4.2. Each of the 
Cycles had a consistent pattern of dietary consumption where there were minimal differences in 
the proportion of people (i.e. <5% difference between Cycles) consuming the different amounts of 
food with the exception of the following: consuming egg, fruit, potato, dietary fat, and water. 
Below are the highlights of the differences between cycles while descriptive statistics of dietary 
factors by age group and by region/provinces are located in Appendix 2. 
• In Cycle 3, the proportion of participants in the middle tertile of egg consumption was higher 
(40.6%) compared to Cycles 1 (26.8%) and 2 (24.6%) while the proportion of participants in 
the high tertile of egg consumption was lower in Cycle 3 (37.9%) compared to Cycles 1 
(48.5%) and 2 (54.4%).  
• In Cycle 2, the proportion of participants in the middle tertile of fruit consumption was lower 
(4.5%) compared to Cycles 1 (38.6%) and 3 (35.5%) while the proportion was higher for the 
high tertile (63.0%) compared to Cycles 1 (31.3%) and 3 (29.9).  
• In Cycle 2, the proportion of participants in the low tertile of potato consumption was lower 
(30.0%) compared to Cycles 1 (35.1%) and 3 (34.6%).  
• In Cycle 3, the proportion of participants in the low tertile of dietary fat consumption was 
higher (37.0%) compared to Cycles 1 (33.1%) and 2 (30.7%) while increased in the high tertile 
of dietary fat consumption in Cycle 2 (38.6%) compared to Cycles 1 (33.2%) and 3 (31.6%).  
• In Cycle 1, the proportion of participants in the low tertile of water consumption was higher 
(30.5%) compared to Cycles 2 (25.0%) and 3 (23.1%) while the proportion of participants in 
the middle tertile of water consumption was lower (31.1%) compared to Cycles 2 (40.3%) and 
3 (40.7%).  
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Table 4.2 Descriptive statistics of dietary factors (tertiles) represented in each of the Cycles 
Dietary factors  Tertiles 
Times/week 
Cycle 1 
(n*= 24,531,089) 
Overall 
% 
Cycle 2 
(n*= 25,327,408) 
Overall 
% 
Cycle 3 
(n*= 25,974,338) 
Overall 
% 
Red meat • Low 
• Medium 
• High 
32.97 
31.55 
35.48 
32.42 
31.33 
36.25 
35.55 
32.05 
32.40 
Fish and shellfish • Low 
• Medium 
• High 
33.61 
31.11 
35.28 
31.01 
33.32 
35.66 
30.97 
34.42 
34.60 
Eggs and eggs dishes • Low 
• Medium 
• High 
24.67 
26.82 
48.51 
20.98 
24.58 
54.43 
21.41 
40.65 
37.93 
Beans and nuts • Low 
• Medium 
• High 
31.36 
36.35 
32.30 
30.49 
32.80 
36.70 
33.31 
33.35 
33.34 
Milk and dairy products • Low 
• Medium 
• High 
33.89 
33.05 
33.05 
37.26 
32.14 
30.60 
35.19 
33.16 
31.65 
Grains • Low 
• Medium 
• High 
33.66 
32.83 
33.50 
33.07 
31.30 
35.63 
34.48 
35.48 
30.03 
Fruits • Low 
• Medium 
• High 
30.04 
38.65 
31.31 
32.48 
4.48 
63.04 
34.57 
35.51 
29.93 
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*n=this is the weighted population number 
Vegetables • Low 
• Medium 
• High 
34.80 
32.78 
32.42 
32.10 
34.75 
33.15 
33.81 
33.77 
32.42 
Potatoes • Low 
• Medium 
• High 
35.15 
32.22 
32.63 
30.02 
35.52 
34.46 
34.62 
33.77 
31.62 
Dietary fat • Low 
• Medium 
• High 
33.09 
33.72 
33.19 
30.75 
30.67 
38.58 
36.99 
31.41 
31.60 
Soft drinks • Low 
• Medium 
• High 
29.73 
36.10 
34.17 
30.40 
35.62 
33.97 
30.87 
31.98 
37.15 
Water • Low 
• Medium 
• High 
30.46 
31.14 
38.40 
24.97 
40.29 
34.74 
23.09 
40.71 
36.20 
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4.1.3 Canada Food Guide 
Table 4.3 shows the overall descriptive statistics for the categories of Canada’s Food Guide 
for all Cycles. The variable “grains” was not included and presented within the description of 
Canada Food Guide since the cell size did not meet the minimum criteria based on Statistics 
Canada guidelines. Descriptive statistics of the Canada Food Guide classification by age group are 
located in Appendix 2. The following patterns were observed overall. 
• The proportion of participants who were within the “not meeting” Canada Food Guide 
requirement of vegetables and fruits increased by Cycles and greatest in Cycle 3.  
• The proportion of participants who were within the “not meeting” Canada Food Guide 
requirement of milk and milk alternatives showed an inverse U-shape pattern from Cycle 1 to 
Cycle 3. 
• The proportion of participants who were within the “not meeting” Canada Food Guide 
requirement of red meat and meat alternatives decreased from Cycle 1 to 3. Cycle 3 had some 
different dietary information compared to Cycle 1 and 2 may cause this variation.  
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Table 4.3 Descriptive statistics (overall) of Canada Food Guide 
Variables for Canada Food Guide Cycle 1 
Overall 
% 
Cycle 2 
Overall 
% 
Cycle 3 
Overall 
% 
Vegetables and fruits 
 
• 1- Not meeting 
• 2- Meeting 
89.39 
10.61 
91.01 
8.99 
96.38 
3.62 
Milk and Milk alternatives 
 
• 1- Not meeting 
• 2- Meeting 
74.05 
25.95 
77.78 
22.23 
67.84 
32.16 
Red Meat and meat 
alternatives 
 
• 1- Not meeting 
• 2- Meeting 
85.69 
14.31 
82.00 
18.00 
36.42 
63.58 
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4.1.4 Mediterranean Diet and modified Mediterranean Diet Score 
Table 4.4 shows the overall descriptive statistics for the variables of Mediterranean Diet 
Score for all Cycles. There was a large difference (>5% difference between Cycles) observed 
between Cycles in the categories of consuming meats, fish, fruits, pasta, rice, and milk. In addition, 
the proportion consuming a low amount of food was lowest while the proportion consuming the 
high amount of food was highest in all food group except fish (all Cycles), pasta (all Cycles), and 
rice (Cycle 3). The following patterns were observed.  
• Red meat consumption was higher in Cycles 1 and 3 compared to Cycle 2.  
• Higher or greater fish consumption per week was found in Cycle 3 compared to Cycles 1 and 
2. 
• Rice consumption was lowest in Cycle 3 compared to Cycles 1 and 2. In rice, most participants 
who consumed low rice was higher in Cycle 3 compared to Cycles 1 and 2.  
• Milk consumption was highest in Cycle 3. 
 
Table 4.5 shows the descriptive statistics of mean (95% confidence interval), median, 
mode, 75% percentile, and 25% percentile of the Mediterranean Diet Score. Overall, the score was 
consistent throughout the Cycles. Descriptive statistics by age group are located in Appendix 2. 
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Table 4.4 Descriptive statistics (overall) of Mediterranean Diet 
Variables for modified 
Mediterranean Diet 
Score 
Number of times per 
week 
(tertiles) 
Cycle 1 
Overall 
% 
Cycle 2 
Overall 
% 
Cycle 3 
Overall 
% 
Red meat • Low 
• Medium 
• High 
0.36 
4.90 
94.74 
9.71 
23.68 
66.60 
0.27 
0.93 
98.80 
     
Fish • Low 
• Medium 
• High 
37.58 
43.29 
19.12 
44.48 
33.02 
22.50 
10.97 
20.00 
69.03 
     
Fruits  • Low 
• Medium 
• High 
6.03 
11.50 
82.47 
5.85 
12.77 
81.37 
4.04 
9.05 
86.92 
     
Vegetables • Low 
• Medium 
• High 
- 
- 
- 
0.95 
3.68 
95.36 
0.44 
3.57 
95.98 
     
Cereal  • Low 
• Medium 
• High 
1.32 
4.30 
94.39 
1.99 
4.39 
93.63 
2.72 
5.35 
91.93 
     
Pasta • Low 
• Medium 
• High 
22.95 
53.63 
23.42 
26.08 
51.18 
22.74 
29.70 
51.22 
19.08 
     
Rice • Low 
• Medium 
• High 
27.01 
37.73 
35.25 
23.46 
37.89 
38.65 
76.57 
17.97 
5.46 
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Potatoes • Low 
• Medium 
• High 
19.35 
36.81 
43.84 
18.53 
36.41 
45.05 
19.95 
38.75 
41.29 
     
Milk • Low 
• Medium 
• High 
6.74 
8.11 
85.16 
8.11 
8.63 
83.26 
1.71 
5.34 
92.95 
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Table 4.5 Modified Mediterranean Diet Score (overall) for all Cycles 
Mediterranean 
Diet Score 
(total possible 
score=27) 
Cycle 1  Cycle 2  Cycle 3 
Overall score  Overall score  Overall score 
Mean  10.09  10.46  9.76 
(95% CI) (9.99-10.19)  (10.32-10.60)  (9.60-9.92) 
Median 10  11  10 
Mode 10  11  10 
75% percentile 11  12  11 
25% percentile 9  9  9 
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4.1.5 Biomarkers 
Table 4.6 shows the overall descriptive statistics for the biomarkers for all Cycles. On 
average, all of the mean values of biomarkers were within their normal ranges except total 
cholesterol in Cycle 1 and 2 where it was higher than recommended values (>5.19 mmol/L) and 
Vitamin D in Cycle 1, 2, and 3 where it was lower than recommended values (<75nmol/L) 
(138,139). The biomarker descriptive statistics are presented by age group in Appendix 2. 
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Table 4.6 Descriptive statistics (overall) of biomarkers for all Cycles 
Biomarkers Normal range Cycle 1 
(n*= 24,531,089) 
Overall 
(Mean, SE) 
Cycle 2 
(n*= 25,327,408) 
Overall 
(Mean, SE) 
Cycle 3 
(n*= 25,974,338) 
Overall 
(Mean, SE) 
Red blood cell folate (nmol/L) 317-1422 a 1355.80±43.23 1270.07±32.39 1269.26±44.71 
Vitamin D (nmol/L)  75-150 b 67.32±1.20 69.48±2.27 61.20±2.70 
Total protein (g/L)  60-80 b 73.50±0.19 72.48±0.20 71.64±0.32 
Chloride (mmol/L)  98-108 b 104.38±0.12 103.74±0.09 104.11±0.15 
Potassium (mmol/L)  Men: 3.5-4.5 b 
Women: 3.4-4.4 b 
4.31±0.02 4.47±0.01 4.37±0.02 
Sodium (mmol/L)  135-145 b 139.95±0.14 140.00±0.20 141.44±0.19 
Calcium (total) (mmol/L)  2.10-2.60 b 2.41±0.01 2.41±0.004 2.41±0.01 
High Density Lipoprotein (HDL) 
(mmol/L)  
Men: >0.99 b 
Women: >1.19 b 
1.33±0.02 1.41±0.02 1.38±0.02 
Total cholesterol (mmol/L)  2.0-5.19 b 7.26±0.64 5.78±0.25 4.82±0.05 
C-reactive protein (mg/L)  Intermediate risk:1.0-3.0 b 2.33±0.07 2.42±0.08 2.55±0.14 
Vitamin B12 (pmol/L)  153-655 b 334.08±3.99 347.10±6.45 322.31±8.28 
*n=this is the weighted population number 
aFischbach F, Dunning M. Manual of Laboratory and Diagnostic Tests. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins. 2008. 
b LifeLabs (Burnaby reference laboratory). Reference Ranges - Healthcare Providers. 2017.
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4.2 Research question 1 (What are the characteristics/status of lung function (FEV1, FVC, 
FEV1/FVC ratio, and FEF25-75%) in Canadian adults (18-79 years)?) 
Table 4.7 presents the descriptive statistics of absolute and percent predicted lung function 
status (FVC, FEV1, and FEV1/FVC ratio) by age group. Percent predicted variables were 
calculated by Statistics Canada and FEF25-75% did not have the variable for the percent predicted 
equation included in the CHMS, therefore only absolute values for this measure are presented. 
With regard to absolute values, it was observed that on average, younger adults had higher lung 
function status than the middle age adults. Similarly, the middle age adults had higher lung 
function status than the older adults. Therefore, as age increased, lung function decreased 
consistently throughout the Cycles (1, 2, and 3). In general, the same patterns occurred for percent 
predicted results with the exception of FEV1 (Cycle 3) and FEV1/FVC ratio (Cycles 1, 2, and 3). 
The percent predicted FEV1 showed an U-shaped pattern in Cycle 3. Again, in Cycles 2 and 3, the 
percent predicted FEV1/FVC increased with increasing of age.  
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Table 4.7 Descriptive statistics of lung function status by age group adjusted* for sex, height, and race in each Cycle 
Outcome variable Cycle 1 
(n*= 24,531,089) 
 Cycle 2 
(n*= 25,327,408) 
 Cycle 3 
(n*= 25,974,338) 
 Absolute 
(Mean/95% 
CI) 
% predicted 
(Mean/95% CI) 
 Absolute 
(Mean/95% 
CI) 
% predicted 
(Mean/95% 
CI) 
 Absolute 
(Mean/95% 
CI) 
% predicted 
(Mean/95% 
CI) 
FVC (L)         
Younger adult 
 
Middle age  
 
Older person 
4.35  
(4.27-4.43) 
3.86 
(3.78-3.94) 
3.24 
(3.14-3.34) 
101.16 
(100.22-102.11) 
97.59 
(96.59-98.58) 
96.23 
(93.65-98.80) 
 4.34 
(4.28-4.40) 
3.82 
(3.76-3.88) 
3.18 
(3.10-3.26) 
100.59 
(71.18-129.99) 
96.76 
(69.93-123.60) 
94.11 
(61.22-127.01) 
 4.39 
(4.31-4.47) 
3.81 
(3.71-3.91) 
3.26 
(3.18-3.34) 
 
100.97 
(99.74-102.21) 
95.74 
(93.92-97.56) 
94.40 
(93.04-95.77) 
FEV1 (L/s)         
Younger adult 
 
Middle age  
 
Older person 
3.53 
(3.47-3.59) 
2.96 
(2.88-3.04) 
2.35 
(2.27-2.43) 
97.60 
(96.46-98.73) 
94.41 
(93.09-95.74) 
93.37 
(90.70-96.04) 
 3.52 
(3.46-3.58) 
2.94 
(2.90-2.98) 
2.36 
(2.30-2.42) 
97.11 
(68.21-126.01) 
94.72 
(68.72-120.72) 
93.59 
(49.75-137.42) 
 3.53 
(3.47-3.59) 
2.93 
(2.85-3.01) 
2.42 
(2.36-2.48) 
96.78 
(95.48-98.09) 
93.67 
(91.76-95.58) 
94.05 
(92.23-95.86) 
FEV1/FVC ratio (%)         
Younger adult 
 
Middle age  
 
Older person 
0.82 
(0.81-0.83) 
0.77 
(0.76-0.78) 
0.73 
(0.72-0.74) 
96.69 
(96.00-97.39) 
96.28 
(95.63-96.93) 
96.33 
(95.72-96.94) 
 0.81 
(0.80-0.82) 
0.77 
(0.77-0.77) 
0.75 
(0.74-0.76) 
96.68 
(71.14-122.23) 
97.39 
(81.95-112.83) 
98.96 
(71.63-126.30) 
 0.81 
(0.80-0.82) 
0.77 
(0.76-0.78) 
0.75 
(0.74-0.76) 
96.02 
(94.98-97.05) 
97.34 
(96.38-98.30) 
99.10 
(97.96-100.24) 
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FEF25-75% (L/s)         
Younger adult 
 
Middle age 
 
Older person 
3.51 
(3.41-3.61) 
2.68 
(2.58-2.78) 
1.82 
(1.70-1.94) 
- 
 
- 
 
- 
 3.34 
(3.16-3.52) 
2.60 
(2.54-2.66) 
1.87 
(1.77-1.97) 
- 
 
- 
 
- 
 3.49 
(3.39-3.59) 
2.65 
(2.55-2.75) 
1.99 
(1.93-2.05) 
- 
 
- 
 
- 
*Adjusted for sex, height, and ethnicity 
% predicted values were based on Hankinson’s predictive equation 
*n=this is the weighted population number 
95% CI= 95% confidence interval
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4.3 Research question 2. A (Are dietary factors such as consumption of meat, fish, fruits, 
vegetables, grains, milk and milk products, dietary fat, and soft drinks associated with lung 
function levels based on spirometry in a nationally representative Canadian population of 
adults?) 
4.2 Dietary factors based on questionnaire 
Tables 4.8, 4.9, 4.10, and 4.11 show the results from the multivariate analysis of the main 
effects model for each of the four outcome variables (FVC, FEV1, FEV1/FVC ratio, and FEF25-
75%, respectively). The main effects models were fitted to investigate the association between each 
of the groups of nutrition markers with each outcome in independent models. The groups of 
nutritional markers included: 1) individual dietary variables, 2) variables based on the Canada 
Food Guide, and 3) the modified Mediterranean Diet Score. In Cycle 3, the variable “grains” of 
the Canada Food Guide had less than 10 observations in one of the categories and it was not 
included in any model for Cycle 3. All models were adjusted for age, sex, race, height, immigration 
status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinking, current asthma, other respiratory diseases, family history of asthma, physical activity, 
and sedentary activity. 
For the outcome of FVC (Table 4.8), statistically significant relationships (p<0.05) were 
found for beans, grains, vegetables, potatoes, dietary fat, and soft drinks.  
• High consumption of beans was associated with higher FVC (Cycle 3).  
• Medium consumption of grains was associated with higher FVC (Cycle 3).  
• Medium consumption of vegetables was associated with higher FVC (Cycle 3).  
• Medium and high consumption of potatoes were associated with lower FVC (Cycle 3).  
• High consumption of dietary fat was associated with higher FVC (Cycle 1, 2).  
• High consumption of soft drinks was associated with lower FVC (Cycle 2).  
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In Cycle 3, the Mediterranean Diet Score was statistically significant (p<0.05) and 
associated with lower FVC. There were no statistically significant associations observed for the 
variables of the Canada Food Guide. 
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Table 4.8 Multivariate analysis of dietary factors, Canada Food Guide, and modified Mediterranean Diet Score with FVC 
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error (SE) 
P-value  Β Standard 
error (SE) 
P-value  Β Standard 
error (SE) 
P-
value 
Dietary            
Red meat 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.042 
0.022 
 
- 
0.040 
0.041 
 
- 
0.29 
0.59 
  
- 
0.023 
0.020 
 
- 
0.034 
0.034 
 
- 
0.50 
0.56 
  
- 
-0.010 
0.017 
 
- 
0.058 
0.038 
 
- 
0.86 
0.65 
Fish consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.012 
-0.029 
 
- 
0.031 
0.034 
 
- 
0.71 
0.38 
  
- 
0.023 
0.042 
 
-   
0.038 
0.041 
 
- 
0.55 
0.31 
  
- 
-0.049 
  0.017 
 
- 
0.069 
0.051 
 
- 
0.48 
0.74 
Eggs consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.013 
0.074 
 
- 
0.058 
0.045 
 
- 
0.83 
0.10 
  
- 
  0.029   
-0.014 
 
- 
0.055 
0.041 
 
- 
0.59 
0.73 
  
- 
0.016 
-0.026 
 
- 
0.046 
0.032 
 
- 
0.73 
0.41 
Beans consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.002 
0.046 
 
- 
0.032 
0.051 
 
- 
0.95 
0.37 
  
- 
0.040 
-0.030 
 
- 
0.041 
0.043 
 
- 
0.34 
0.48 
  
- 
0.048 
0.108 
 
- 
0.037 
0.035 
 
- 
0.19 
0.002 
Milk consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.001 
  0.022 
 
- 
0.027 
0.025 
 
- 
0.98 
0.39 
  
- 
0.015 
0.003 
 
- 
0.036 
0.052 
 
- 
0.69 
0.95 
  
- 
0.054 
0.003 
 
- 
0.029 
0.041 
 
- 
0.06 
0.95 
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Grains consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.046 
-0.015 
 
- 
0.039 
0.028 
 
- 
0.23 
0.59 
  
- 
0.048 
0.057 
 
- 
0.037 
0.040 
 
- 
0.19 
0.15 
  
- 
0.124 
0.041 
 
- 
0.051 
0.066 
 
- 
0.015 
0.53 
Fruits consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.023 
0.016 
 
- 
0.031 
0.045 
 
- 
0.47 
0.72 
  
- 
  0.050 
  0.023 
 
- 
0.067 
0.036 
 
- 
0.46 
0.52 
  
- 
-0.033 
0.072 
 
- 
0.066 
0.049 
 
- 
0.62 
0.14 
Vegetables 
consumption 
• Low (ref) 
• Medium 
• High 
 
 
- 
-0.028 
-0.048 
 
 
- 
0.037 
0.029 
 
 
- 
0.45 
0.10 
  
 
- 
-0.014 
-0.008 
 
 
- 
0.038 
0.054 
 
 
- 
0.72 
0.88 
  
 
- 
0.087 
-0.010 
 
 
- 
0.026 
0.031 
 
 
- 
0.001 
0.74 
Potatoes 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.009 
-0.042 
 
- 
0.037 
0.037 
 
- 
0.82 
0.25 
  
- 
0.043 
0.011 
 
- 
0.046 
0.037 
 
- 
0.35 
0.76 
  
- 
-0.132 
-0.125 
 
- 
0.039 
0.060 
 
- 
0.001 
0.039 
Fat consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.028 
0.098 
 
- 
0.025 
0.043 
 
- 
0.27 
0.024 
  
- 
0.073 
0.132 
 
- 
0.039 
0.039 
 
- 
0.06 
0.001 
  
- 
0.063 
-0.0002 
 
- 
0.054 
0.045 
 
- 
0.24 
0.99 
Soft drinks 
consumption 
• Low (ref) 
• Medium 
• High 
 
 
- 
-0.016 
-0.014 
 
 
- 
0.041 
0.045 
 
 
- 
0.69 
0.76 
  
 
- 
-0.033 
-0.146 
 
 
- 
0.049 
0.045 
 
 
- 
0.51 
0.001 
  
 
- 
-0.012 
-0.001 
 
 
- 
0.043 
0.052 
 
 
- 
0.78 
0.99 
Water consumption            
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• Low (ref) 
• Medium 
• High 
- 
-0.002 
0.001 
- 
0.041 
0.045 
- 
0.95 
0.99 
- 
0.045 
0.022 
- 
0.049 
0.051 
- 
0.36 
0.67 
- 
0.006 
-0.061 
- 
0.032 
0.069 
- 
0.85 
0.38 
            
Canada Food 
Guide 
           
Vegetables and fruits 
• Not-meeting 
• Meeting 
 
-0.038 
- 
 
0.061 
- 
 
0.54 
- 
  
0.051 
- 
 
0.075 
- 
 
0.50 
- 
  
-0.104 
- 
 
0.062 
- 
 
0.09 
- 
Grains 
• Not-meeting 
• Meeting 
 
-0.185 
- 
 
0.394 
- 
 
0.64 
- 
  
0.236 
- 
 
0.366 
- 
 
0.52 
- 
  
- 
 
- 
 
- 
Milk 
• Not-meeting 
• Meeting 
 
-0.040 
- 
 
0.034 
- 
 
0.25 
- 
  
-0.005 
- 
 
0.051 
- 
 
0.92 
- 
  
-0.033 
- 
 
0.046 
- 
 
0.47 
- 
Meats 
• Not-meeting 
• Meeting 
 
-0.039 
- 
 
0.041 
- 
 
0.33 
- 
  
-0.002 
- 
 
0.033 
- 
 
0.95 
- 
  
0.008 
- 
 
0.030 
- 
 
0.78 
- 
            
Mediterranean Diet            
Modified 
Mediterranean Diet 
Score 
-0.003 0.007 0.63  0.001 0.008 0.89  -0.017 0.008 0.035 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance 
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For FEV1, (Table 4.9), within the dietary variables, statistically significant (p<0.05) 
associations were found for consuming eggs, beans, milk, grains, fruits, vegetables, potatoes, 
dietary fat, and soft drinks.  
• High consumption of eggs was associated with higher FEV1 in Cycle 1, while in Cycle 3, the 
high consumption of eggs was associated with lower FEV1. 
• High consumption of beans was associated with higher FEV1 (Cycle 3).  
• Medium consumption of milk was associated with higher FEV1 (Cycle 3).  
• Medium consumption of grains was associated with higher FEV1 (Cycle 3).  
• High consumption of fruits was associated with higher FEV1 (Cycle 3). 
• Medium consumption of vegetables was associated with higher FEV1 (Cycle 3). 
• High and medium consumption of potatoes were associated with lower FEV1 (Cycle 3). 
• High consumption of dietary fat was associated with higher FEV1 (Cycle 2). 
• High consumption of soft drinks was associated with lower FEV1 (Cycle 2). 
Using the Canada Food Guide, “not meeting” fruits and vegetables (Cycle 3) and meat 
(Cycle 1) requirements resulted in statistically significant (p<0.05) associations where both were 
associated with lower FEV1. The modified Mediterranean Diet Score (Cycle 3) was also 
statistically significant (p<0.05) and associated with the lower FEV1. 
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Table 4.9 Multivariate analysis of dietary factors, Canada Food Guide, and modified Mediterranean Diet Score with FEV1 
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error (SE) 
P-
value 
 β Standard 
error (SE) 
P-
value 
 β Standard 
error (SE) 
P-value  
Dietary            
Red meat 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.046 
0.016 
 
- 
0.031 
0.029 
 
- 
0.14 
0.58 
  
- 
0.010 
-0.011 
 
- 
0.040 
0.037 
 
- 
0.81 
0.76 
  
- 
-0.001 
0.054 
 
- 
0.049 
0.033 
 
- 
0.99 
0.10 
Fish consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.038 
-0.057 
 
- 
0.032 
0.038 
 
- 
0.23 
0.13 
  
- 
0.011 
0.024 
 
- 
0.033 
0.034 
 
- 
0.75 
0.48 
  
- 
-0.059 
-0.010 
 
- 
0.062 
0.044 
 
- 
0.34 
0.82 
Eggs consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.012 
0.071 
 
- 
0.035 
0.024 
 
- 
0.72 
0.004 
  
- 
0.023 
0.004 
 
- 
0.039 
0.038 
 
- 
0.56 
0.92 
  
- 
0.016 
-0.070 
 
- 
0.032 
0.035 
 
- 
0.60 
0.042 
Beans consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.015 
0.044 
 
- 
0.023 
0.040 
 
- 
0.51 
0.28 
  
- 
0.052 
-0.018 
 
- 
0.036 
0.032 
 
- 
0.15 
0.56 
  
- 
0.058 
0.082 
 
- 
0.030 
0.032 
 
- 
0.06 
0.010 
Milk consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.005 
0.009 
 
- 
0.027 
0.019 
 
- 
0.85 
0.65 
  
- 
0.002 
0.009 
 
- 
0.037 
0.034 
 
- 
0.96 
0.79 
  
- 
0.094 
0.016 
 
- 
0.032 
0.044 
 
- 
0.003 
0.72 
Grains consumption 
• Low (ref) 
 
- 
 
- 
 
- 
  
- 
 
- 
 
- 
  
- 
 
- 
 
- 
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• Medium 
• High 
-0.025 
-0.026 
0.026 
0.029 
0.33 
0.35 
0.013 
0.027 
0.029 
0.026 
0.66 
0.29 
0.086 
0.027 
0.045 
0.050 
0.047 
0.59 
Fruits consumption 
• Low (ref) 
• Medium 
• High 
 
 
- 
-0.004 
0.016 
 
 
- 
0.038 
0.035 
 
 
- 
0.91 
0.64 
  
 
- 
0.060 
0.059 
 
 
- 
0.050 
0.038 
 
 
- 
0.23 
0.12 
  
 
- 
-0.013 
0.096 
 
 
- 
0.055 
0.039 
 
 
- 
0.82 
0.015 
Vegetables 
consumption 
• Low (ref) 
• Medium 
• High 
 
 
- 
-0.044 
-0.031 
 
 
- 
0.031 
0.027 
 
 
- 
0.15 
0.26 
  
 
- 
-0.017 
-0.007 
 
 
- 
0.031 
0.042 
 
 
- 
0.57 
0.88 
  
 
- 
0.061 
-0.036 
 
 
- 
0.025 
0.029 
 
 
- 
0.016 
0.21 
Potatoes 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.022 
-0.029 
 
- 
0.043 
0.039 
 
- 
0.60 
0.46 
  
- 
0.046 
-0.001 
 
- 
0.034 
0.024 
 
- 
0.18 
0.96 
  
- 
-0.120 
-0.110 
 
- 
0.033 
0.043 
 
- 
<0.001 
0.011 
Fat consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.005 
0.062 
 
- 
0.024 
0.032 
 
- 
0.83 
0.05 
  
- 
0.046 
0.076 
 
- 
0.031 
0.035 
 
- 
0.14 
0.029 
  
- 
0.047 
-0.005 
 
- 
0.055 
0.042 
 
- 
0.40 
0.91 
Soft drinks 
consumption 
• Low (ref) 
• Medium 
• High 
 
 
- 
-0.012 
-0.033 
 
 
- 
0.028 
0.028 
 
 
- 
0.67 
0.24 
  
 
- 
-0.037 
-0.120 
 
 
- 
0.035 
0.036 
 
 
- 
0.29 
0.001 
  
 
- 
-0.035 
-0.014 
 
 
- 
0.036 
0.041 
 
 
- 
0.33 
0.74 
Water consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.023 
-0.035 
 
- 
0.032 
0.036 
 
- 
0.48 
0.32 
  
- 
0.063 
0.020 
 
- 
0.040 
0.036 
 
- 
0.11 
0.57 
  
- 
0.032 
0.011 
 
- 
0.033 
0.074 
 
- 
0.32 
0.88 
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Canada Food 
Guide 
           
Vegetables and 
fruits 
• Not-meeting 
• Meeting 
 
 
-0.011 
- 
 
 
0.044 
- 
 
 
0.81 
- 
  
 
0.037 
- 
 
 
0.062 
- 
 
 
0.55 
- 
  
 
-0.141 
- 
 
 
0.064 
- 
 
 
0.030 
- 
Grains 
• Not-meeting 
• Meeting 
 
-0.122 
- 
 
0.249 
- 
 
0.63 
- 
  
-0.019 
- 
 
0.219 
- 
 
0.93 
- 
  
- 
 
- 
 
- 
Milk 
• Not-meeting 
• Meeting 
 
-0.024 
- 
 
0.020 
- 
 
0.23 
- 
  
-0.021 
- 
 
0.034 
- 
 
0.53 
- 
  
-0.005 
- 
 
0.044 
- 
 
0.91 
- 
Meats 
• Not-meeting 
• Meeting 
 
-0.062 
- 
 
0.030 
- 
 
0.038 
- 
  
0.006 
- 
 
0.025 
- 
 
0.82 
- 
  
0.014 
- 
 
0.028 
- 
 
0.62 
- 
            
Mediterranean 
Diet 
           
Modified 
Mediterranean Diet 
Score 
-0.005 0.007 0.43  0.0001 0.007 0.98  -0.017 0.008 0.043 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance 
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Statistically significant (p<0.05) associations were observed between the FEV1/FVC ratio 
and the individual dietary variables including consumption of meats, milk, and fruits (Table 4.10).  
• High consumption of meats was associated with higher FEV1/FVC (Cycle 3).  
• Medium consumption of milk was associated with higher FEV1/FVC (Cycle 3).   
• High consumption of fruits was associated with higher FEV1/FVC (Cycle 2).   
Within the Canada Food Guide, “not meeting” grains (Cycle 2) and meats (Cycle 1) 
requirements were statistically significant (p<0.05) and associated with lower FEV1/FVC. There 
were no statistically significant associations observed within the modified Mediterranean Diet 
Score. 
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Table 4.10 Multivariate analysis of dietary factors, Canada Food Guide, and modified Mediterranean Diet Score with FEV1/FVC ratio 
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error (SE) 
P-
value 
 β Standard 
error (SE) 
P-
value 
 β Standard 
error (SE) 
P-value 
Dietary            
Red meat 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.002 
-0.001 
 
- 
0.005 
0.003 
 
- 
0.66 
0.88 
  
- 
-0.002 
-0.003 
 
- 
0.006 
0.004 
 
- 
0.73 
0.52 
  
- 
0.003 
0.009 
 
- 
0.004 
0.004 
 
- 
0.57 
0.032 
Fish consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.008 
-0.008 
 
- 
0.007 
0.005 
 
- 
0.22 
0.08 
  
- 
-0.004 
-0.006 
 
- 
0.004 
0.005 
 
- 
0.33 
0.25 
  
- 
-0.008 
-0.007 
 
- 
0.006 
0.004 
 
- 
0.20 
0.09 
Egg consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.003 
0.004 
 
- 
0.005 
0.004 
 
- 
0.61 
0.26 
  
- 
0.00004 
0.001 
 
- 
0.006 
0.005 
 
- 
0.99 
0.88 
  
- 
0.0001 
-0.012 
 
- 
0.003 
0.007 
 
- 
0.97 
0.10 
Bean consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.003 
0.003 
 
- 
0.004 
0.004 
 
- 
0.39 
0.42 
  
- 
0.006 
0.002 
 
- 
0.005 
0.004 
 
- 
0.28 
0.56 
  
- 
0.005 
-0.001 
 
- 
0.003 
0.005 
 
- 
0.18 
0.90 
Milk consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.002 
-0.003 
 
- 
0.004 
0.003 
 
- 
0.64 
0.34 
  
- 
-0.005 
0.0004 
 
- 
0.006 
0.004 
 
- 
0.46 
0.92 
  
- 
0.013 
0.005 
 
- 
0.005 
0.005 
 
- 
0.004 
0.38 
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Grain consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.001 
-0.006 
 
- 
0.005 
0.005 
 
- 
0.75 
0.25 
  
- 
-0.004 
-0.001 
 
- 
0.004 
0.003 
 
- 
0.32 
0.73 
  
- 
-0.002 
-0.001 
 
- 
0.006 
0.005 
 
- 
0.70 
0.90 
Fruit consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.003 
0.001 
 
- 
0.006 
0.005 
 
- 
0.60 
0.86 
  
- 
0.011 
0.013 
 
- 
0.009 
0.005 
 
- 
0.22 
0.013 
  
- 
0.002 
0.007 
 
- 
0.006 
0.005 
 
- 
0.77 
0.17 
Vegetable 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.005 
0.006 
 
- 
0.005 
0.004 
 
- 
0.25 
0.13 
  
- 
-0.001 
0.002 
 
- 
0.005 
0.004 
 
- 
0.86 
0.64 
  
- 
-0.003 
-0.005 
 
- 
0.005 
0.005 
 
- 
0.52 
0.26 
Potato consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.005 
0.001 
 
- 
0.003 
0.005 
 
- 
0.12 
0.88 
  
- 
0.004 
-0.004 
 
- 
0.005 
0.004 
 
- 
0.43 
0.31 
  
- 
-0.008 
-0.007 
 
- 
0.006 
0.005 
 
- 
0.17 
0.22 
Fat consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.003 
-0.003 
 
- 
0.005 
0.006 
 
- 
0.56 
0.58 
  
- 
-0.004 
-0.006 
 
- 
0.005 
0.007 
 
- 
0.48 
0.33 
  
- 
0.003 
-0.001 
 
- 
0.011 
0.007 
 
- 
0.79 
0.91 
Soft drinks 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.003 
-0.002 
 
- 
0.003 
0.005 
 
- 
0.35 
0.73 
  
- 
-0.004 
-0.003 
 
- 
0.003 
0.004 
 
- 
0.20 
0.49 
  
- 
-0.005 
-0.001 
 
- 
0.006 
0.007 
 
- 
0.38 
0.84 
Water consumption 
• Low (ref) 
• Medium 
 
- 
-0.002 
 
- 
0.003 
 
- 
0.56 
  
- 
0.006 
 
- 
0.003 
 
- 
0.05 
  
- 
0.007 
 
- 
0.006 
 
- 
0.25 
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• High -0.006 0.002 0.002 -0.002 0.005 0.70 0.014 0.007 0.06 
            
Canada Food 
Guide 
           
Vegetables and fruits 
• Not-meeting 
• Meeting 
 
-0.002 
- 
 
0.006 
- 
 
0.77 
- 
  
-0.004 
- 
 
0.007 
- 
 
0.52 
- 
  
-0.017 
- 
 
0.011 
- 
 
0.13 
- 
Grains 
• Not-meeting 
• Meeting 
 
0.004 
- 
 
0.025 
- 
 
0.87 
- 
  
-0.064 
- 
 
0.024 
- 
 
0.007 
- 
  
- 
 
- 
 
- 
Milk 
• Not-meeting 
• Meeting 
 
0.001 
- 
 
0.004 
- 
 
0.76 
- 
  
-0.002 
- 
 
0.005 
- 
 
0.71 
- 
  
0.005 
- 
 
0.006 
- 
 
0.36 
- 
Meats 
• Not-meeting 
• Meeting 
 
-0.008 
- 
 
0.004 
- 
 
0.031 
- 
  
0.003 
- 
 
0.005 
- 
 
0.63 
- 
  
0.003 
- 
 
0.005 
- 
 
0.51 
- 
            
Mediterranean Diet            
Modified 
Mediterranean Diet 
Score 
-0.001 0.001 0.65  -0.001 0.001 0.52  -0.001 0.001 0.30 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance
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Statistically significant (p<0.05) associations were observed between the FEF25-75% and the 
individual dietary variables including consumption of meats, eggs, milk, fruits, potatoes, and soft 
drinks (Table 4.11).  
• High consumption of meats was associated with higher FEF25-75% (Cycle 3).  
• High consumption of eggs was associated with higher FEF25-75% (Cycle 1). 
• Medium consumption of milk was associated with higher FEF25-75% (Cycle 3).  
• High consumption of fruits was associated with higher FEF25-75% (Cycle 2).  
• Medium and high consumption of potatoes was associated with lower FEF25-75% (Cycle 3).  
• High consumption of soft drinks was associated with lower FEF25-75% (Cycle 2).  
Within the Canada Food Guide, only “not meeting” the meats (Cycle 1) requirement were 
statistically significant (p<0.05) and associated with lower FEF25-75%. There were no statistically 
significant associations observed with the modified Mediterranean Diet Score. 
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Table 4.11 Multivariate analysis of dietary factors, Canada Food Guide, and modified Mediterranean Diet Score with FEF25-75% 
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error (SE) 
P-value  Β Standard 
error (SE) 
P-value  β Standard 
error (SE) 
P-value 
Dietary            
Red meat 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.005 
-0.005 
 
- 
0.069 
0.034 
 
- 
0.94 
0.89 
  
- 
0.003 
-0.038 
 
- 
0.078 
0.067 
 
- 
0.97 
0.57 
  
- 
0.082 
0.117 
 
- 
0.065 
0.055 
 
- 
0.20 
0.033 
Fish consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.070 
-0.127 
 
- 
0.089 
0.070 
 
- 
0.43 
0.07 
  
- 
-0.037 
0.006 
 
- 
0.055 
0.056 
 
- 
0.50 
0.91 
  
- 
-0.054 
-0.028 
 
- 
0.083 
0.060 
 
- 
0.51 
0.64 
Eggs consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.023 
0.104 
 
- 
0.061 
0.036 
 
- 
0.71 
0.004 
  
- 
0.003 
0.021 
 
- 
0.063 
0.070 
 
- 
0.96 
0.76 
  
- 
0.061 
-0.104 
 
- 
0.050 
0.093 
 
- 
0.22 
0.26 
Beans consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.077 
0.088 
 
- 
0.047 
0.052 
 
- 
0.10 
0.09 
  
- 
0.035 
-0.066 
 
- 
0.075 
0.057 
 
- 
0.64 
0.25 
  
- 
0.074 
0.060 
 
- 
0.056 
0.072 
 
- 
0.18 
0.40 
Milk consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.002 
0.026 
 
- 
0.067 
0.028 
 
- 
0.97 
0.35 
  
- 
0.010 
-0.013 
 
- 
0.058 
0.047 
 
- 
0.86 
0.78 
  
- 
0.175 
0.018 
 
- 
0.062 
0.080 
 
- 
0.005 
0.82 
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Grains consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.004 
-0.092 
 
- 
0.047 
0.066 
 
- 
0.93 
0.16 
  
- 
0.011 
0.035 
 
- 
0.050 
0.040 
 
- 
0.83 
0.37 
  
- 
0.093 
0.036 
 
- 
0.074 
0.063 
 
- 
0.20 
0.57 
Fruits consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.015 
-0.002 
 
- 
0.072 
0.063 
 
- 
0.83 
0.97 
  
- 
0.168 
0.125 
 
- 
0.140 
0.056 
 
- 
0.23 
0.026 
  
- 
-0.002 
0.103 
 
- 
0.082 
0.067 
 
- 
0.98 
0.13 
Vegetables 
consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.102 
-0.0004 
 
- 
0.059 
0.059 
 
- 
0.08 
0.99 
  
- 
-0.042 
-0.052 
 
- 
0.067 
0.068 
 
- 
0.53 
0.44 
  
- 
0.029 
-0.051 
 
- 
0.056 
0.054 
 
- 
0.60 
0.34 
Potato consumption 
• Low (ref) 
• Medium 
• High 
 
- 
0.134 
0.051 
 
- 
0.075 
0.063 
 
- 
0.08 
0.42 
  
- 
0.095 
-0.025 
 
- 
0.070 
0.036 
 
- 
0.17 
0.49 
  
- 
-0.183 
-0.136 
 
- 
0.062 
0.055 
 
- 
0.003 
0.014 
Fat consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.062 
-0.016 
 
- 
0.054 
0.055 
 
- 
0.25 
0.78 
  
- 
0.039 
0.015 
 
- 
0.047 
0.054 
 
- 
0.41 
0.79 
  
- 
0.081 
-0.040 
 
- 
0.119 
0.072 
 
- 
0.50 
0.58 
Soft drinks 
consumption 
• Low (ref) 
• Medium 
• High 
 
 
- 
0.005 
-0.064 
 
 
- 
0.044 
0.058 
 
 
- 
0.91 
0.27 
  
 
- 
-0.074 
-0.144 
 
 
- 
0.042 
0.059 
 
 
- 
0.08 
0.015 
  
 
- 
-0.094 
0.030 
 
 
- 
0.074 
0.083 
 
 
- 
0.20 
0.72 
Water consumption 
• Low (ref) 
• Medium 
• High 
 
- 
-0.064 
-0.135 
 
- 
0.036 
0.035 
 
- 
0.08 
<0.001 
  
- 
0.156 
0.059 
 
- 
0.060 
0.072 
 
- 
0.009 
0.41 
  
- 
0.059 
0.104 
 
- 
0.059 
0.109 
 
- 
0.31 
0.34 
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Canada Food 
Guide 
           
Vegetables and fruits 
• Not-meeting 
• Meeting 
 
-0.032 
- 
 
0.097 
- 
 
0.74 
- 
  
0.059 
- 
 
0.096 
- 
 
0.54 
- 
  
-0.246 
- 
 
0.156 
- 
 
0.12 
- 
Grains 
• Not-meeting 
• Meeting 
 
-0.090 
- 
 
0.256 
- 
 
0.72 
- 
  
-0.785 
- 
 
0.527 
- 
 
0.14 
- 
  
- 
 
- 
 
- 
Milk 
• Not-meeting 
• Meeting 
 
-0.025 
- 
 
0.042 
- 
 
0.55 
- 
  
-0.001 
- 
 
0.054 
- 
 
0.98 
- 
  
0.071 
- 
 
0.059 
- 
 
0.23 
- 
Meats 
• Not-meeting 
• Meeting 
 
-0.145 
- 
 
0.048 
- 
 
0.003 
- 
  
0.026 
- 
 
0.047 
- 
 
0.58 
- 
  
0.021 
- 
 
0.055 
- 
 
0.70 
- 
            
Mediterranean diet            
Modified 
Mediterranean Diet 
Score 
-0.011 0.014 0.43  -0.001 0.012 0.94  -0.017 0.017 0.30 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance 
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4.3 Biomarkers 
Tables 4.12, 4.13, 4.14, and 4.15 show the relationship between biomarkers with the four 
outcome variables of lung function (FVC, FEV1, FEV1/FVC ratio, and FEF25-75%, respectively). 
For the outcome FVC (Table 4.12), associations with chloride (Cycles 1, 2, 3), potassium 
(Cycle 2), C-reactive protein (Cycles 1, 3), total protein (Cycle 2), and Vitamin B12 (Cycle 3) 
were statistically significant (p<0.05).  
• The chloride levels were associated with higher FVC (Cycles 1, 2, 3).  
• The potassium levels were associated with lower FVC (Cycle 2). 
• The C-reactive protein levels were associated with lower FVC (Cycles 1, 3).  
• The total protein levels were associated with lower FVC (Cycle 2).  
• The Vitamin B12 levels were associated with lower FVC (Cycle 3). 
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Table 4.12 Multivariate analysis of biomarkers with FVC 
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error 
(SE) 
P-value  β Standard 
error 
(SE) 
P-value  β Standard 
error (SE) 
P-value 
Biomarkers            
Vitamin D (nmol/L)  0.002 0.001 0.06  0.001 0.001 0.16  0.002 0.001 0.12 
Chloride (mmol/L) 0.008 0.004 0.022  0.026 0.009 0.002  0.031 0.014 0.023 
Potassium (mmol/L) -0.069 0.036 0.05  -0.128 0.046 0.006  -0.028 0.052 0.59 
C-reactive protein 
(mg/L) 
-0.037 0.004 <0.001  -0.014 0.010 0.17  -0.027 0.007 <0.001 
Total protein (g/L) 0.002 0.006 0.71  -0.010 0.004 0.009  0.008 0.008 0.29 
Sodium (mmol/L) -0.004 0.009 0.67  -0.006 0.012 0.63  -0.019 0.021 0.36 
Calcium (mmol/L) 0.244 0.186 0.19  0.344 0.220 0.12  0.323 0.352 0.36 
High density 
lipoprotein (HDL) 
(mmol/L) 
0.105 0.067 0.12  0.061 0.047 0.19  0.023 0.078 0.77 
Total cholesterol 
(mmol/L) 
0.012 0.015 0.42  0.026 0.031 0.40  -0.003 0.022 0.87 
Red blood cell folate 
(nmol/L) 
0.00001 0.00002 0.46  -0.00004 0.00004 0.28  0.0001 0.0001 0.11 
Vitamin B12 (pmol/L) -0.0001 0.0002 0.39  0.0001 0.0001 0.43  -0.0002 0.0001 0.044 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance 
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For the outcome FEV1 (Table 4.13), associations with Vitamin D (Cycles 1, 3), chloride 
(Cycles 1, 2, 3), potassium (Cycle 2), C-reactive protein (Cycles 1, 3), calcium (Cycle 2), red blood 
cell folate (Cycle 3), and Vitamin B12 (Cycles 1, 3) were statistically significant (p<0.05). 
• The Vitamin D levels were associated with higher FEV1 (Cycles 1, 3). 
• The chloride levels were associated with higher FEV1 (Cycles 1, 2, 3).  
• The potassium levels were associated with lower FEV1 (Cycle 2).  
• The C-reactive protein levels were associated with lower FEV1 (Cycles 1, 3).  
• The calcium levels were associated with higher FEV1 (Cycle 2).  
• The red blood cell folate levels were associated with higher FEV1 (Cycle 3).  
• The Vitamin B12 levels were associated with lower FEV1 (Cycle 1, 3).
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Table 4.13 Multivariate analysis of biomarkers with FEV1 
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error 
(SE) 
P-
value 
 β Standard 
error 
(SE) 
P-
value 
 β Standard 
error 
(SE) 
P-
value 
Biomarkers            
Vitamin D (nmol/L)  0.001 0.001 0.007  0.001 0.0005 0.17  0.002 0.001 0.048 
Chloride (mmol/L) 0.013 0.006 0.046  0.022 0.008 0.006  0.027 0.009 0.004 
Potassium (mmol/L) -0.089 0.053 0.09  -0.090 0.038 0.018  -0.050 0.050 0.32 
C-reactive protein (mg/L) -0.032 0.003 <0.001  -0.011 0.010 0.28  -0.033 0.007 <0.001 
Total protein (g/L)  0.005 0.006 0.43  -0.005 0.004 0.13  0.011 0.006 0.07 
Sodium (mmol/L) -0.008 0.007 0.21  -0.012 0.010 0.27  -0.009 0.013 0.48 
Calcium (mmol/L) 0.139 0.161 0.39  0.527 0.164 0.001  -0.013 0.276 0.96 
High density lipoprotein 
(HDL) (mmol/L) 
0.061 0.051 0.23  0.005 0.027 0.86  -0.013 0.071 0.86 
Total cholesterol 
(mmol/L) 
0.015 0.018 0.41  0.018 0.021 0.40  0.001 0.020 0.97 
Red blood cell folate 
(nmol/L) 
-7.80e-06 0.00002 0.63  -0.00003 0.00003 0.18  0.0001 0.0001 0.047 
Vitamin B12 (pmol/L) -0.0002 0.0001 0.009  -0.00005 0.0001 0.60  -0.0002 0.0001 0.006 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance
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For the outcome FEV1/FVC ratio (Table 4.14), associations with Vitamin D (Cycle 3), 
calcium (Cycle 3), red blood cell folate (cycle 2), and Vitamin B12 (Cycle 2) were statistically 
significant (p<0.05). 
• The Vitamin D levels were associated with lower FEV1/FVC ratio (Cycle 3).  
• The calcium levels were associated with higher FEV1/FVC ratio (Cycle 3).  
• The red blood cell folate levels were associated with lower FEV1/FVC ratio (Cycle 2).  
• The Vitamin B12 levels were associated with higher FEV1/FVC ratio (Cycle 2).
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Table 4.14 Multivariate analysis of biomarkers with FEV1/FVC ratio  
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error 
(SE) 
P-
value 
 β Standard 
error 
(SE) 
P-
value 
 β Standard 
error 
(SE) 
P-
value 
Biomarkers            
Vitamin D (nmol/L)  -0.00004 0.00002 0.08  -0.00001 0.00002 0.62  -0.0001 0.00003 0.025 
Chloride (mmol/L) 0.00005 0.00005 0.33  3.48e-06 0.00002 0.87  -9.58e-06 0.00001 0.38 
Potassium (mmol/L) 0.0001 0.0001 0.19  0.00005 0.0001 0.33  0.0001 0.00007 0.28 
C-reactive protein (mg/L) 0.002 0.001 0.07  0.003 0.002 0.12  0.002 0.002 0.29 
Total protein (g/L) -0.004 0.005 0.38  -0.011 0.008 0.16  -0.005 0.007 0.51 
Sodium (mmol/L) 0.002 0.003 0.535  -0.001 0.002 0.59  -0.0001 0.003 0.97 
Calcium (mmol/L)  0.001 0.001 0.13  0.001 0.001 0.12  0.002 0.0005 <0.001 
High density lipoprotein 
(HDL) (mmol/L) 
0.0001 0.0003 0.73  0.0004 0.0003 0.21  -0.001 0.0004 0.06 
Total cholesterol (mmol/L) 4.49e-06 6.12e-06 0.46  6.23e-06 0.00002 0.74  6.89e-06 0.00002 0.66 
Red blood cell folate 
(nmol/L) 
-0.002 0.001 0.21  -0.003 0.001 0.031  0.001 0.002 0.56 
Vitamin B12 (pmol/L) -0.010 0.016 0.53  0.087 0.029 0.003  -0.071 0.041 0.08 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance
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For the outcome FEF25-75% (Table 4.15), associations with Vitamin D (Cycle 1), chloride 
(Cycle 2), C-reactive protein (Cycles 1, 3), total protein (Cycle 3), sodium (Cycle 2), calcium 
(Cycle 2), and Vitamin B12 (Cycle 1) were statistically significant (p<0.05). 
• The Vitamin D levels were associated with higher FEF25-75% (Cycle 1).  
• The chloride levels were associated with higher FEF25-75% (Cycle 2). 
• The C-reactive protein levels were associated with lower FEF25-75% (Cycles 1, 3). 
• The total protein levels were associated with higher FEF25-75% (Cycle 3).  
• The sodium levels were associated with lower FEF25-75% (Cycle 2).  
• The calcium levels were associated with higher FEF25-75% (Cycle 2).  
• The Vitamin B12 levels were associated with lower FEF25-75% (Cycle 1).
           
 
        
7
9
 
 
Table 4.15 Multivariate analysis of biomarkers with FEF25-75%  
Variables Cycle 1  Cycle 2  Cycle 3 
Β Standard 
error 
(SE) 
P-
value 
 β Standard 
error 
(SE) 
P-
value 
 β Stand
ard 
error 
(SE) 
P-value 
Biomarkers            
Vitamin D (nmol/L)  0.002 0.001 0.036  0.00002   0.001 0.97  0.001 0.001 0.47 
Chloride (mmol/L) 0.016 0.017 0.35  0.028 0.013 0.034  0.034 0.022 0.12 
Potassium (mmol/L) -0.067 0.141 0.64  -0.069 0.098 0.49  -0.100 0.109 0.36 
C-reactive protein (mg/L) -0.034 0.008 <0.001  -0.020 0.017 0.22  -0.046 0.011 <0.001 
Total protein (g/L) 0.010 0.011 0.34  0.001 0.007 0.91  0.026 0.006 <0.001 
Sodium (mmol/L) -0.013 0.019 0.49  -0.034 0.014 0.012  -0.002 0.018 0.91 
Calcium (mmol/L) -0.094 0.164 0.57  1.034 0.266 <0.001  -0.564 0.392 0.15 
High density lipoprotein 
(HDL) (mmol/L) 
-0.013 0.077 0.86  -0.113 0.058 0.05  -0.033 0.094 0.73 
Total cholesterol (mmol/L) 0.045 0.045 0.32  0.018 0.023 0.43  0.001 0.037 0.97 
Red blood cell folate 
(nmol/L) 
-0.00004 0.00004 0.34  -0.0001 0.00005 0.11  0.0001 0.000
1 
0.27 
Vitamin B12 (pmol/L) -0.0004 0.0002 0.027  -0.0002 0.0002 0.32    -0.0002 0.000
1 
0.07 
N. B. Adjusted for age, sex, race, height, immigration status, marital status, education, income, BMI, smoking status, smoking exposure, alcohol 
drinker, current asthma, other respiratory diseases, family history of asthma, physical activity, and sedentary activity 
Bold text indicates statistical significance 
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4.4 Assessment of effect modification 
The effect modification between dietary factors and asthma was tested. Some effect 
modification was found to be statistically significant (Table 4.16). However, the inclusion of the 
interaction term to the model caused the model to become unstable (bootstrapping could not 
replicate enough times for the convergence of the model). Therefore, interaction terms were 
excluded from further evaluation. The effect modification between dietary factors and COPD was 
not tested because there were not enough observations (<1%) of COPD to meet the criteria of 
minimum observations required by Statistics Canada. 
Table 4.16 List of significant interaction terms Cycle by Cycle 
Lung function Cycle 1 Cycle 2 Cycle 3 
FVC asthma_c*pot1 asthma_c*f1 
asthma_c*f2 
asthma_c*pot2 
asthma_c*f3 
asthma_c*veg2 
asthma_c*pot1 
asthma_c*sf1 
asthma_c*sf3 
asthma_c*w2 
    
FEV1 asthma_c*gr1 
asthma_c*gr2 
asthma_c*frt1 
asthma_c*f2 
asthma_c*veg1 
asthma_c*sf1 
asthma_c*f3 
asthma_c*pot1 
asthma_c*sf1 
    
FEV1/FVC ratio asthma_c*egg3 
asthma_c*gr1 
asthma_c*m3 
asthma_c*sf1 
asthma_c*m2 
    
FEF25-75% asthma_c*egg3 asthma_c*m3 
asthma_c*f2 
asthma_c*sf1 
asthma_c*m2 
asthma_c*f3 
Current asthma = asthma_c 
Meats (low, medium, high tertile) = m1, m2, m3 
Fishes (low, medium, high tertile) = f1, f2, f3 
Potatoes (low, medium, high tertile) = pot1, pot2, pot3 
Vegetables (low, medium, high tertile) = veg1, veg2, veg3 
Grains (low, medium, high tertile) = gr1, gr2, gr3 
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Eggs (low, medium, high tertile) = egg1, egg2, egg3 
Fruits (low, medium, high tertile) = frt1, frt2, frt3 
Soft drinks (low, medium, high tertile) = sf1, sf2, sf3 
Water (low, medium, high tertile) = w1, w2, w3 
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Chapter 5 : Discussion 
5.1 Summary 
The purpose of this thesis was to explore lung function status and its association with 
dietary factors among Canadian adults (18-79 years). The Canadian Health Measures Survey 
(CHMS) was a repeated cross-sectional survey with health assessments and an excellent source 
for obtaining information regarding the demographics, dietary factors, biomarkers, and spirometry 
from a representative sample of Canadian adults. Below, the findings of this thesis are summarized. 
Following this summary, a more in-depth discussion of the results is provided. A full results 
summary by food group is located in Appendix 4. 
Research question 1: What are the characteristics/status of lung function (FEV1, FVC, FEV1/FVC 
ratio, and FEF25-75%) in Canadian adults (18-79 years)? 
• On average, the percent predicted mean for FVC was approximately 98%, FEV1 was 
approximately 95.5%, and the absolute FEV1/FVC ratio was approximately 0.78 (overall 
in Cycles 1, 2, and 3). These values suggest good lung function of the overall general 
population. 
• As expected, the lung function decreased gradually from the younger adults to the older 
adults (e.g. in Cycle 1, FVC: 100.9% vs. 97.4% vs. 96.1%). 
Research question 2. A: Are dietary factors (e.g. food types), dietary patterns (e.g. Mediterranean 
Diet), or biomarkers associated with lung function levels based on spirometry in a nationally 
representative Canadian population of adults? 
Research question 2. B: Is there effect modification between dietary factors and asthma or COPD 
in the relationship with lung function? 
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Individual food, Canada Food Guide, and Mediterranean Diet Score: 
• The associations between the exposure of interest (dietary consumption of individual food, 
Canada Food Guide, and Mediterranean Diet Score) and the outcome (lung function: FEV1, 
FVC, FEV1/FVC ratio, and FEF25-75%) were somewhat inconsistent by Cycle, food group, 
and outcome.  
• While inconsistent, general findings suggest that dietary fat was associated with higher 
lung function among the individual food groups. Not meeting the Canada Food Guide 
requirements was associated with lower lung function. Modified Mediterranean Diet Score 
was associated with lower lung function. 
Biomarkers: 
• The association between biomarkers and lung function were more consistent than food 
consumption throughout the Cycles. 
• Among the more consistent associations for biomarkers, chloride was associated with 
higher FVC and FEV1 for all three Cycles (p<0.05). C-reactive protein was associated with 
lower FVC, FEV1, and FEF25-75% (Cycles 1 and 3. p<0.05). Vitamin D was associated with 
higher FEV1 (Cycles 1 and 3. p<0.05). Finally, Vitamin B12 was associated with lower 
FEV1 (Cycles 1 and 3. p<0.05). 
Effect modification between dietary factors and asthma or COPD  
Some effect modification was found to be statistically significant. However, the inclusion 
of the interaction term to the model caused the model to become unstable (bootstrapping could not 
replicate enough times for the convergence of the model). Therefore, interaction terms were 
excluded from further evaluation. 
           
84 
    
5.2 Comparing findings with the previous studies 
5.2.1 Individual food consumption and lung function 
Red meats 
 A study conducted in 2014 in the UK among adults (Hertfordshire cohort study) showed 
that processed meat consumption had been associated with lower FVC, FEV1, and the FEV1/FVC 
ratio (140). Another study conducted in 2007 in the U.S among adults aged 45 years or older (The 
Third National Health and Nutrition Examination Survey (NHANES III)) also showed that cured 
meat consumption had been associated with lower FEV1 and the FEV1/FVC ratio (84). Results 
from the current study, which included overall red meat consumption, indicated that meat is 
associated with higher FEV1/FVC (p<0.05) and higher FEF25-75% (p<0.05) but only in Cycle 3. We 
did not classify the meat type neither “processed” vs “not processed” nor included “chicken meat” 
within the total meat consumption as this information was not available, which may lead to 
differences between ours and the previous studies.  
Fish 
The association between the consumption of fish and lung function in previous studies has 
not been consistent (85,88). A cross-sectional study conducted in 1994 in the U.S among adults 
(aged 30-70 years) (The First National Health and Nutrition Examination Survey (NHANES I)) 
showed that consumption of fish was associated with higher FEV1 (88). In a prospective study 
conducted in 2000 among men (aged 45-59 years) it was shown that the frequency of fatty fish 
intake was not significantly associated with lung function (85). In our study, no statistically 
significant association was observed between fish consumption and lung function. We included 
all fish consumption (total fish consumption including shellfish) together as a single variable 
instead of separating as fatty and non-fatty fish and also, used a wide range of age (18-79 years) 
which might cause the non-significant association in results. 
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Grains 
A study in 2001 in the Netherlands among adults (20-59 years) reported that consumption 
of whole grains was associated with higher FEV1 (22). The current study supports this result to 
some degree. In Cycle 3, medium consumption of grains was associated with higher FVC and 
higher FEV1. Grains are mostly carbohydrate rich food. Higher consumption of carbohydrate may 
lead to overweight and obesity (141,142) while lower grain consumption or low carbohydrate has 
been associated with all-cause mortality and may be unsafe for health (143). Obesity has been 
considered as a predisposing factor for asthma (144). Either higher or lower consumption of grains 
could be detrimental to lung health. This could, therefore, explain why medium consumption of 
grains could be beneficial for lung function. 
Fruits 
A study conducted in 1998 among adult residents of England, Scotland, and Wales (87) 
and another study in 2001 in the Netherlands among adults (20-59 years) (22) showed that 
consumption of fruits was associated with higher FEV1. In the current study, high consumption of 
fruits was associated with higher FEV1 (Cycle 3), FEV1/FVC ratio (Cycle 2), and FEF25-75% (Cycle 
2). As such, the current results support the previous research. 
Vegetables 
Again, in 2001 in the Netherlands among adults (20-59 years) (22) it was reported that 
consumption of vegetables has been associated with higher FEV1. In Cycle 3, medium 
consumption of vegetables was associated with higher FVC and higher FEV1. These results 
support the previous research to some degree. It is interesting that medium consumption of 
vegetables could be beneficial for lung function, but not high consumption. The current study did 
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not look at the dark green vegetables specifically which is beneficial for lung health (95,96). 
Inclusion of total vegetables might be the possible reason for this medium consumption being 
significant. 
Milk 
A study in 2013 in the US among adults (45-84 years) reported that total dairy consumption 
has been associated with higher FVC and high-fat dairy has been associated with lower FEV1/FVC 
(134). In Cycle 3, this study similarly provided evidence that medium consumption of milk is 
associated with higher FEV1, higher FEV1/FVC ratio, and higher FEF25-75% complementing the 
previous work. Milk is considered as an anti-Mediterranean Diet (93) so a high consumption of 
milk may not be beneficial for health. However, Canada is a cold country and in winter sun is often 
covered with cloud. For this reason, milk consumption is necessary for obtaining Vitamin D and 
other nutritional content. Thus, this medium consumption of milk may be beneficial for lung 
health. 
Dietary fat 
A higher proportion of dietary fat has been associated with lower FVC and FEV1 as 
reported in a study in 2010 in Australia by using adult participants (55-85 years) (145). In Cycles 
1 and 2 of the current study, high consumption of dietary fat was associated with higher FVC 
which does not support the findings of the previous study. The possible reason for this discrepancy 
might be due to the inclusion of only regular fat salad dressing and regular fat potato chips together 
in the dietary fat variable in this study. This current study did not include the other varieties of fat 
due to lack of available data specifically on fat consumption. We should be cautious in the 
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conclusion that high intake of fat was associated with higher lung function based on this limited 
information.  
Eggs 
There has not been a previous study examining the effects of eggs on lung function. 
However, a 2009 study from Auckland stated that consumption of eggs has been associated with 
decreased risk of wheeze in children (6-7 years) (146). In our study, eggs consumption provided 
controversial results where egg intake was associated with higher FEV1 in Cycle 1, while egg 
intake was associated with lower FEV1 in Cycle 3. Part of this inconsistency could be due to the 
fact that eggs consumption had specific information such as “egg enriched with ω-3 fatty acid” in 
Cycle 3 instead of only “eating eggs or eggs dishes” which was used in the other Cycles.  
Beans and nuts 
There has not been a previous study which reported the effect of bean consumption 
specifically on lung function. A study conducted in 2013 in India among the adult Indians (20-49 
years) (Third National Family Health Survey (NFHS)) (147) and in another study conducted in 
2010 in the UK among adults (16-50 years) investigated bean consumption as a part of dietary 
patterns associated with asthma (148). Both studies found that less or no intake of beans was 
associated with the development of asthma (147) (148). In Cycle 3, a high consumption of beans 
was associated with higher FVC and higher FEV1 which supports the evidence despite the 
differences in outcome.  
Potatoes 
No previous research investigating potato consumption and lung function among adults 
has been completed. A study in 2003 in the Netherlands among children (1-3 years) reported that 
           
88 
    
diets rich with potatoes were associated with lower lung function (149). In Cycle 3, medium and 
high consumption of potatoes were associated with lower FVC and lower FEV1. These results 
support the past evidence. 
Soft drinks 
There has not been a study reporting the impact of soft drinks on lung function. However, 
a study conducted in 2012 in Australia among adults (≥16 years) showed that increased 
consumption of soft drinks was associated with asthma/COPD (14). In Cycle 2, high consumption 
of soft drinks was associated with lower FVC and lower FEV1 which supports the previous study 
though their outcome was asthma/COPD. 
5.2.2 Canada Food Guide 
 There has not been a previous Canadian study that has explored the association between 
following the Canada Food Guide and lung function. The Canada Food Guide is a guideline for 
consuming food for the Canadian people. Dietary consumption based on the Canada Food Guide 
was categorized as “meeting” and “not-meeting” daily requirement except for grains in Cycle 3 
due to the absence of the minimum required observations. Overall most participants were not 
meeting the requirements set out by the Canada Food Guide. The Canada Food Guide has 
suggested eating more vegetables and fruits, whole grains, drinking skimmed milk (1% or 2%), 
and consuming a small amount of fat each day (89). Analysis of the associations between dietary 
recommendations based on the Canada Food Guide and lung function allowed me to investigate 
overall relationships between diet and lung function not focussed on individual components of the 
diet. Although, I found inconsistencies in the results throughout Cycles, “not meeting” the 
requirements of meats were associated with lower FEV1 and lower FEV1/FVC in Cycle 1. And in 
Cycle 3, “not meeting” the requirements of vegetables and fruits were associated with lower FEV1. 
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These results indicate that meeting the Canada Food Guide requirements may be beneficial for 
lung health. 
5.2.3 Mediterranean Diet 
 Mediterranean like diet patterns have been shown to be protective for lung function (78). 
A study in 2016 in Spain showed that Mediterranean like diet pattern was associated with 
preserved lung function among adults (35-70 years) (78). In our study, we found inconsistent 
results by Cycles and results that were in the opposite direction that we expected between the 
Mediterranean Diet Score and lung function in Cycle 3 where the modified Mediterranean Diet 
Score was associated with lower FVC and lower FEV1. In our study, we had a lack of information 
about olive oil, fast food, saturated and unsaturated fat intake in developing the Mediterranean 
Diet Score. This may have led to finding opposite results than the previous studies. 
5.2.4 Biomarkers 
Chloride 
 There are a limited number of studies looking at biomarkers on lung function. A previous 
study published in 2008 among non-institutionalized US adults (17 years and older) showed that 
normal levels of calcium, chloride, β-cryptoxanthin, lutein/zeaxanthin, lycopene, selenium, and 
iron were associated with higher FEV1 (150). We found consistent results where blood chloride 
level was associated with higher FVC and higher FEV1 (Cycles 1, 2, 3), complementing this 
previous research.  
C-reactive protein (CRP) 
A study published in 2008 in Denmark among adults (20-29 years) reported that a high 
level of CRP has been associated with lower lung function (151). CRP is a systemic inflammation 
marker. A higher systemic inflammation level has been associated with lower lung function (104). 
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Our study found similar results consistently in Cycles 1 and 3 where CRP was associated with 
lower FVC, FEV1, and FEF25-75% supporting the previous work showing that inflammation can 
negatively affect lung function. 
Vitamin D 
A study published in 2011 in Britain among adults (at age 45 years) (152) and another 
study in 2011 in the US among non-institutionalized civilians (12-59 years) (153) showed that 
serum Vitamin D has been associated with higher lung function. Vitamin D protects the airway by 
reducing the susceptibility and severity of the respiratory infections (98). Consistent results were 
obtained in the current study where Vitamin D level was associated with higher FEV1 (Cycle 1, 
3). 
Serum folate  
A study published in 2010 in Denmark among adults (30-60 years) has shown significant 
associations between higher serum folate and decreased risk of reduced lung function (reduced 
lung function: FEV1 <80%), while low dietary consumption of folate has been significantly 
associated with reduced lung function (107). In addition, higher levels of serum folate have been 
associated with self-reported doctor diagnosed asthma and lowered airway symptoms (107). Folate 
deficiency may be associated with altering the cell mediated immunity leading to increased 
susceptibility to infection and decreased resistance to infection (154). Consistent with these 
previous studies, results were observed in our study where red blood cell folate is associated with 
higher FEV1 in Cycle 3. However, the results were inconsistent in Cycle 2 where red blood cell 
folate was associated with lower a FEV1/FVC ratio.  
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Vitamin B12 
Serum levels of Vitamin B12 were not associated with lung function in a previous study 
conducted in 2010 in Denmark among the adults (30-60 years) (107). Vitamin B12 interacts with 
folate metabolism and deficiencies may increase a person’s susceptibility to infection (154). In the 
current study, Vitamin B12 was associated inconsistently with lower FEV1 (Cycles 1, 3), lower 
FEF25-75% (Cycle 1), and the higher FEV1/FVC ratio of the current study (Cycle 2). These results 
were also inconsistent with the previous study suggesting that the relationship between Vitamin 
B12 and lung function may be complex. 
Calcium 
Again, in another study in 2011 in the US among non-institutionalized civilians (12-59 
years) calcium level has not been associated with lung function (153) while normal levels of 
Calcium were associated with higher FEV1 as discussed previously (150). Calcium plays a key 
role in calcium dependent excitation-contraction linked together in airway smooth muscle (155). 
Lack of intracellular calcium may cause inappropriate contraction of smooth muscle (inappropriate 
contraction associated with higher resistance which is one of the symptoms of acute asthma) (155). 
Our study calcium level was associated with higher FEV1 (Cycle 2), higher FEV1/FVC ratio (Cycle 
3), and higher FEF25-75% (Cycle 2).  
Potassium and Sodium 
A study in 2008 among non-institutionalized US adults (17 years and older) showed that 
potassium and sodium has been associated with lower FEV1 (150). Sodium is an important marker 
in regulating smooth muscle tone (20). A higher influx of sodium and potassium within the smooth 
muscle of the airway may cause hyperpolarization which leads to airway diseases, specifically 
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airway hyper-reactivity (156) (157). Our study found similar results where potassium levels were 
associated with lower FVC and FEV1, while sodium level was associated with lower FEF25-75%, 
both in Cycle 2. Though these results have not been consistent throughout the Cycles it supports 
the previous study. 
5.3 Internal and external validity of the findings 
5.3.1 Internal validity 
The CHMS developed quality assurance and quality control protocols in every aspect of 
fieldwork to maximize the reliability and validity of the data and to reduce systemic bias (125). 
Quality assurance included supervision of household interviewing by an interviewer manager for 
ensuring quality control. Quality assurance for the Mobile Examination Center included staff 
selection and training, instructions to respondents (pre-testing guidelines), and issues related to 
data collection. All staff had appropriate education and training for their respective positions. To 
ensure consistent measurement techniques, procedure manuals and training guides were developed 
by expert review and consultation (125).  
5.3.1.1 Selection bias 
Selection bias has been considered in the CHMS (125). The CHMS had an excellent 
participation rates for all Cycles (Cycle 1: 85%, Cycle 2: 81.7%, Cycle 3: 79%) (124–126). 
It is possible that less healthy people were less likely to go to the Mobile Examination 
Centers (124–126). Likewise, bias may be caused by the oversampling of those aged 20-39 who 
were living with children (6-11 years old). The survey weights and bootstrap weights were created 
using post-stratification by age group and sex, with an additional adjustment for individuals who 
were 20-39 years old living with and without children (aged 3-11 years) to account for any 
potential bias due to oversampling (124–126). 
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5.3.1.2 Non-response bias 
The CHMS experienced several levels of potential non-response (124–126). First, the 
selected house may deny providing the household composition. Second, the selected participants 
among the household members may refuse to answer the questionnaire. Third, the individual may 
reject participating in the Mobile Examination Center visit. Finally, the individual may decline to 
provide blood and/or urine for the laboratory tests for analysis (125). At each level of non-response 
(available for respondents and non-respondents), Statistics Canada used a logistic regression 
model to identify variables which explained the most non-response. The non-response 
modifications were applied within these groups to adjust the survey weights. Using the survey 
weights to create estimates should minimize non-response bias due to differences in the survey 
variables between respondents and non-respondents (124–126). 
5.3.1.3 Information bias 
 Information bias should be considered in this study. Information bias may arise from the 
measurement methods or credibility of the exposure (dietary information) and/or outcomes (lung 
function). Information was collected by direct interviewing, which could be subject to errors in 
recall or problems in reporting sensitive information.  
 Regarding the exposure measures, all dietary frequency information that was used in this 
study was collected by asking about the frequency of consuming that dietary factor per year. People 
may have the tendency to over-state that they were eating a healthy diet. Also, people may have 
difficulty in recall the number of servings of the food. In an attempt to overcome this, CHMS data 
was collected using validated standardized questionnaires and objective biomarkers. 
 The outcome considered (lung function) was a strength as it was objectively measured 
using standardized methods and an external reviewer reviewed the lung function results. The role 
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of the external reviewer was to identify unacceptable efforts based on the testing criteria of the 
American Thoracic Society in order to assist both the participants and the data analyst. All 
acceptable trials were reviewed to determine whether the test results for FVC and FEV1 
represented a maximal effort by the respondent (quality) and met the reproducibility criteria of 150 
ml. Only acceptable efforts were included. 
5.3.1.4 Confounding 
 In our study, we attempted to adjust for a number of potential confounders by using 
multivariate analyses. The thesis was focused on respiratory health and the common and important 
known risk factors and confounders were considered. To enhance this, we fitted the model based 
on confounding in the data as well as confounding in the literature. 
5.3.1.5 Cross-sectional design and causality 
 We must consider causality based on Hill’s criteria (158). The most important of Hill’s 
criteria include: temporality, strength, consistency, plausibility, and dose response. As the nature 
of this study was a cross-sectional design, temporality is difficult to establish and is a limitation. 
The β-coefficients tended to be weak (only bean, meat, grains, dietary fat, eggs, milk, fruits, soft 
drinks, and potato have a β-coefficient of 0.10-0.17) and these β-coefficients were inconsistent 
throughout the Cycles and food groups. This study demonstrated statistically significant 
associations between some of the dietary factors and lung function though it was not consistent 
throughout the Cycles.  Some findings were consistent (e.g. vegetables, fruits, potatoes) when 
compared to previous literature while some findings were not (e.g. meats, fish, dietary fat) based 
on the previous study. There were some differences in the questionnaire (e.g. meats, fish) 
specifically in Cycle 3. The dietary fat food group did not include all types of fat (e.g. oil 
consumption). These are the reasons that might explain the inconsistency of some results. A dose 
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response relationship was seen for some of the dietary variables (e.g. bean, dietary fat, soft drinks, 
eggs, fruits, and meats). However, it was also common to see associations only with the middle 
tertile suggesting that the associations may not only be linear. 
5.3.2 External Validity 
Our findings can be generalized to the Canadian adult population as Statistics Canada 
developed the study to be representative of the Canadian population. Despite this, not all provinces 
were included in data collection (e.g. Saskatchewan). Also, while Statistics Canada sampled and 
weighted the data to be representative of the total Canadian adult population, the actual sample 
size of data collected was much smaller (approximately 3,600 adults), which may lead to criticisms 
about the true representativeness. Many provinces have regional differences in culture, population, 
religion, and governance. Variations in these factors could modify their dietary choices. Another 
limitation may be the applicability of these findings to non-Caucasian adults’ due to a large 
proportion of the respondents being Caucasian adults (82.3%, 77.6%, and 75.1% for Cycle 1, 2, 
and 3 respectively). Furthermore, due to eating habits varying from country to country, or even 
within different regions within countries, the global generalization of the findings should also be 
carefully considered. 
5.4 Other Strengths and Limitations 
The other strengths of this study include it was a large population based study with a 
representative sample using standardized questionnaires, standard measures of spirometry, and 
objective biomarkers which can reduce the potential for measurement error. Using objective 
biomarkers was the major strength of this study since it could capture the normal or diseased 
processes in the body (106) with a reduction in the potential for bias, which allows for stronger, 
more valid results. 
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The analysis was adjusted for socioeconomic status (SES) (i.e. income and education) 
which is a strength for this study. SES is an important measure for the dietary assessment as it 
could modify the dietary selections, availability, and affordability of healthy food. Low SES may 
lead to cheap and unhealthy food selection which is responsible for many nutrition related diseases 
(159). In this study, there were many different dietary measures considered including several that 
had never been researched independently in relation to lung function previously such as beans and 
nuts consumption. Although the data was improved by collecting more detailed information in 
Cycle 3, this led to variability within the questionnaires between Cycles for exposure 
measurement, which, may have caused potential bias in the observed results and inconsistency 
between Cycles.  
Some food groups may not fully represent the information being sought. For instance, 
within the meats category, only red meat information was available but no information about 
chicken. Dietary fat had a very limited assessment.  It included only salad dressing, potato chips 
(Cycles 1 and 2), and margarine (Cycle 3) which does not provide information on total dietary fat 
consumption. All foods within a grouping were combined to create a single variable which may 
lead to some issues in assessing the associations. For example, French fried potatoes can be 
considered as fast food and might not be good as baked or mashed potatoes. If French fried potatoes 
have a harmful effect and mashed potatoes have a beneficial effect, then it is possible to get a 
neutral result. Inclusion of different subcategories of food (e.g. French fried and mashed potatoes 
grouped together, or different types of vegetables grouped together) may lead to misclassification 
within food groups. The information collected for the food groups also differ by cycles and 
methods causing inconclusive results.  
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The original Canada Food Guide suggested daily serving sizes (89) as the dietary 
recommendation. Unfortunately, we did not have serving size information. In the CHMS, only 
“number of times” for each food type was available. Again, the adult dietary recommendation 
started from 19 years for the Canada Food Guide, whereas our study included those 18 years of 
age as the beginning of adult age group. However, absence of serving sizes and a 1-year age 
overlap may affect the results and was a limitation for this study. Specifically, without considering 
the size of servings, there is potential for misclassification in consumption assessment. The results 
of the Mediterranean Diet were somewhat unexpected. The score was constructed as a modified 
Mediterranean Diet Score due to the absence of some important dietary components (e.g. olive oil, 
fast food, saturated and unsaturated lipids, ethanol) in the CHMS. This may have led to differences 
in associations compared to other studies (78,90). 
In the past, researchers have included β-carotene (Vitamin A), Vitamin E, and Vitamin C 
as both dietary assessment and biomarkers (86) or assessed through the food frequency 
questionnaires only (82,85). However, in this study, we could not include these due to a lack of 
available information. Although, Vitamin C was available only in Cycle 3, it was excluded from 
the analysis for consistency between Cycles. 
This study was an exploratory study with many analyses completed. A potential concern 
is alpha inflation error due to multiple comparisons. To overcome this, a Bonferroni test could be 
performed to help control for potentially false positive results (type I error) (160). Nevertheless, 
the multiple comparisons were not performed because in a practical situation, Bonferroni 
corrections could be extremely conservative and lead to a high rate of false negatives (type II error) 
(160) and given the exploratory nature of the study, it was decided to avoid this process. 
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5.5 Recommendations and Applications 
Based on the findings in this thesis, several hypotheses can be generated regarding the 
relationship between diet and lung function. In our study, we found that eating healthy diets (e.g. 
higher fruits, lower soft drinks intake) leads to higher lung function among adults. Even though 
this association has not been proven to be causal, the findings of protective effects of diets (grains, 
fruits, and vegetables) were consistent in many countries. Identifying the possible protective 
effects on lung function suggests possible future prevention consideration. 
5.6 Future Research Directions 
There are several suggestions/recommendations for future research that can be provided. 
1) In order to unravel the direction of exposures leading to diseases, there is a need for more 
sophisticated and appropriate research designs used such as longitudinal studies (e.g. birth cohorts) 
looking at the timing of dietary exposures in relation to lung function and respiratory disease 
development. 2) It would also be worthwhile to perform similar studies in other rural and urban 
communities, and with more ethnically diverse study populations in order to further assess the 
generalizability of the current study findings. 3) It is recommended that more comprehensive 
exposure measurement methods be used such as objective measures of antioxidant levels (Vitamin 
A, E, and C) to identify which factors are responsible for the associations with lung function and 
respiratory diseases. 4) Population-based studies including children, adolescents, and adults are 
required to assess the etiologic fraction, which is an important measure for the lung diseases 
attributable to exposures of interests (e.g. nutritional exposures). 5) Considering lower limit of 
normal (LLN) while analyzing the lung function measurements (161). 6) Assessment of dietary 
status using other dietary markers such as the Healthy Eating Index (HEI) in relation to lung 
function is recommended for further studies (81). The HEI, 2010 is an improved diet quality index 
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for Canadians measured by calculating the nutrients from the dietary intake and it could be helpful 
for making dietary recommendation for chronic diseases including lung function (81,162) because 
it will directly assess nutrients as opposed to food types. 7) Dietary factors could be classified by 
specifying the function of the food group (e.g. anti-inflammatory food) as well as by measuring 
inflammatory makers from blood could be conducted to observe the anti-inflammatory effect of 
diets on lung function. 8) Studies reported that fast foods are associated with increased risk of 
asthma (116,163). Therefore, investigation of fast food and fats could be done to observe the 
impact on lung function as a practical public health importance. 9) Assessment of Canada Food 
Guide by adding dietary consumption by daily serving sizes. 10) A community-based intervention 
program can be implemented by focusing on participants experienced improvements in dietary 
quality, lung function, and indicators of chronic lung diseases. 11) By training and educating the 
health-care professionals on the relationship between diet and lung function for preventing 
diseases and promoting lung health. 
5.7 Conclusion 
This thesis examined the association between dietary factors and lung function along with 
an exploration of the relationship with lung function using objectively measured biomarkers 
among a large, representative population of adults in Canada. Lung function is effort dependent 
and reflects only current lung function. There were a lot of inconsistencies, but the study does 
provide good information for potential hypotheses. Findings suggest that dietary exposures and 
lung function have an association; however, there were some inconsistencies throughout the 
Cycles, mostly with the report of dietary intake. Further studies (e.g. cohort designs or similar to 
this study) and innovative methods (e.g. a collection of dietary information more accurately, 
dividing diet by nutrients, use of nutritional marker especially designed for dietary assessment) 
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designed specially to investigate the effects of independent associations of nutrients and dietary 
factors on lung function. 
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Appendix 1 
Variables and Questionnaires:  
1. Age: Age at clinic interview 
2. Sex 
3. Marital status: What is your marital status? Are you married, living common-law, 
widowed, separated, divorced, or single, never married? 
4. Educational status DHH_ED4: Highest degree, certificate or diploma obtained 
5. Has anyone in your immediate family ever had asthma?  
6. Smoking: At the present time, do you smoke cigarettes daily, occasionally or not at all? 
Type of smoker - (D) 
7. Exposure to second hand smoke 
8. Alcohol drinker: Type of alcohol drinker. Regular, occasional, former, and never. 
9. BMI: Calculated from height and weight measurement 
10. Physical activities (by activity monitor): An activity monitor is a small battery-operated 
electronic device that is worn on a belt around the waist, on the right hip bone. The monitor 
records all daily activities as electronic signals. It is pre-programmed. To start recording 
tomorrow morning, there is no activation required and it does not need to be turned on or 
off. 
11. Blood measurement 
12. Educational status 
13. Family income 
14. Food frequency questionnaire (per week):  
Meat consumption: How often do you usually eat: 
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1) Red meat, such as beef, hamburger, pork or lamb?? MFC_B11 
2) Liver, including all types of liver such as beef, veal, pork or chicken? MFC_B12 
3) Other organ meats such as kidneys, heart or giblets? MFC_B13 (absent in Cycle 3) 
4) Beef or pork hot dogs? MFC_B14 
5) Sausage or bacon, including all types of sausages such as breakfast, pepperoni and Kielbasa 
but excluding low-fat, light or turkey varieties? MFC_B15 
Egg consumption: How often do you usually eat: 
1) Eggs and egg dishes including the yolk (excluding all egg dishes made with only egg 
whites)? Egg dishes could include such things as eggs, omelette, frittata or quiche. 
MFC_B19A 
2) Eggs and egg dishes that are made with omega-3 enriched eggs? Exclude dishes made with 
only egg whites. MFC_B19B 
Beans and nuts consumption: How often do you usually eat: 
1) Cooked dried beans, such as refried beans, baked beans, pea soup or kidney beans, 
excluding green and yellow beans? MFC_B20 
2) Peanuts, walnuts, seeds, or other nuts, excluding nut butters such as peanut butter? 
Milk and dairy product consumption: How often do you usually eat: 
1) Drink milk or enriched milk substitutes or use them on cereal? 
2) Cottage cheese? 
3) Yogurt, excluding frozen yogurt? 
4) Ice cream or frozen yogurt? 
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Grains consumption: How often do you usually eat? 
1) Hot or cold cereal? GFV_B11 
2) Whole grain bread such as whole wheat, rye or pumpernickel including bread made with 
oats or buckwheat? Please include bagels, rolls, pita bread or tortillas. GFV_B12 
3) White bread, including bagels, rolls, pita bread or tortillas? GFV_B13 
4) Any kind of pasta, including spaghetti, noodles, macaroni & cheese or pasta salad? 
GFV_B14 
5) Any kind of rice? GFV_B14 (absent in Cycle 3) 
6) Instant, seasoned or wild rice, such as Minute Rice®, Dainty Rice®, or Rice-a-Roni®? 
GFV_B16 
7) Flax seeds, whole or ground, including flax seeds eaten in foods such as breakfast cereal, 
yogurt, muffins, bread or any other dishes? GFV_B24 (Cycle 3 only) 
Fruits consumption: How often do you usually eat? 
1) Fruit (fresh, frozen or canned)? 
2) Citrus fruit such as oranges or grapefruits, fresh, frozen or canned? GFV_B17A (Cycle 3 
only) 
3) Strawberries, fresh, frozen or canned, in the summer? GFV_Q17B (Cycle 3 only) 
4) Strawberries (fresh, frozen or canned) during the rest of the year? GFV_Q17C (Cycle 3 
only) 
5) Other types of fruit; fresh, frozen or canned? GFV_B17D (Cycle 3 only) 
Vegetables consumption: How often do you usually eat? 
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1) Tomatoes or tomato sauce, including salsa, tomato soup and spaghetti sauce but excluding 
tomato paste, ketchup or pizza sauce? GFV_B18 
2) Lettuce or green leafy salad with or without other vegetables? Do not include spinach. 
GFV_B19 
3) Spinach, mustard greens, cabbage or collards, excluding kale? GFV_B20 
Potatoes consumption: How often do you usually eat? 
1) French fries, home fries, or hash brown potatoes? GFV_B21 
2) Other potatoes including baked, boiled, mashed or in potato salad, but excluding sweet 
potatoes? GFV_B22 
Water and soft drink consumption: How often do you usually drink: 
1) Water?  
2) Diet soft drinks?  
3) Regular soft drinks?  
4) Sport drinks, such as Gatorade® or Powerade®?  
5) Vitamin-added water, such as Aquafina Plus Vitamins® or Vitamin Water®? Do not 
include flavoured water or other types of water that are not fortified with vitamins. 
6) Orange or grapefruit juice?  
7) Other 100% fruit juices, for example, apple, grape or mixed fruit juice?  
8) How often do you usually drink juice with calcium and Vitamin D added?  
9) Fruit-flavoured drinks?  
10) Vegetable juices?  
Dietary fat consumption: 
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1) How often do you usually eat? Regular-fat salad dressing or mayonnaise, including on 
salads and sandwiches? DFC_B11 
2) Regular-fat potato chips, tortilla chips or corn chips, excluding low fat chips and pretzels? 
DFC_B12 
3) Margarine? DFC_B13 (Cycle 3) 
4) Omega-3 enriched margarine? DFC_B14 (Cycle 3) 
Fish and shellfish consumption: 
1) Salt water fish such as salmon, tuna or fish sticks? 
2) Fresh water fish such as trout, walleye or pickerel? 
3) Shellfish, such as shrimp, mussels, scallops, lobster, clams, oysters or crab? 
           
 
     
1
2
6
 
 
Variables and definitions: 
Variable name Definition/Question Category and code Notes 
Age (CLC_AGE) Age at clinic interview  Cycle 1, 2, 3 
Sex (DHH_SEX) Gender 1. Male: 1 
2. Female: 2 
Cycle 1, 2, 3 
Height (HWM_11CM) Record the standing 
height in centimeters. 
 Cycle 1, 2, 3  
Weight (HWM_13KG) When the 
measurement is stable, 
record the weight in 
kilograms. 
 Cycle 1, 2, 3 
BMI (HWMDBMIA) 
 
BMI norms for 
respondents 18 or 
older - (D) 
 
HWMDBMIA Cycle 1: 
1. Underweight: 1 
2. Normal weight: 2 
3. Overweight: 3 
4. Obese: 4 
5. Very obese: 5 
6. Severely obese: 6 
7. Not applicable: 96 
8. Not stated: 99 
HWMDBMIA Cycle 2, 3: 
1. Underweight 
2. Normal weight 
3. Overweight 
4. Obese-class I 
5. Obese-class II 
6. Obese-class III  
7. Not applicable: 96 
8. Not stated: 99 
Finally, categorized as: 
1. Obese 
2. Overweight 
3. Not overweight 
or obese 
Race/ethnicity 
(SDCDCGT) 
Cultural or racial 
group 
1. White: 1 
2. Black: 2 
3. Korean: 3 
4. Filipino: 4 
5. Japanese: 5 
6. Chinese: 6 
7. South Asian: 7 
8. Southest Asian: 8 
9. Arab: 9 
10. West Asian: 10 
11. Latin American: 11 
12. Other racial or cultural 
origin: 12 
13. Multiple racial or 
cultural origin: 13 
14. Not applicable: 96 
15. Not stated: 99 
Cycle 1, 2: same 
Cycle 3: variable name: 
PGDCGT 
 
Finally, categorized as: 
1. Caucasian 
2. other 
Province (DHH_PRN) Province of residence 
of the respondent 
 
Cycle 1: Cycle 2: 
1. Newfoundland 
and Labrador 
Cycle 3:  
1. Nova 
scotia: 12 
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1. New 
Brunswick: 
13 
2. Quebec: 24 
3. Ontario: 35 
4. Alberta: 48 
5. British 
Columbia: 
59 
2. Nova 
scotia:12 
3. Quebec 
4. Ontario 
5. Manitoba 
6. Alberta 
7. British 
Columbia 
2. New 
Brunswick: 
13 
3. Quebec: 24 
4. Ontario: 35 
5. Alberta: 48 
6. British 
Columbia: 
59 
Marital status 
(DHH_MS) 
What is your marital 
status? Are you 
married, living 
common-law, 
widowed, separated, 
divorced, or single, 
never married? 
1. Married: 1 
2. Common-law: 2 
3. Widowed: 3 
4. Separated: 4 
5. Divorced: 5 
6. Single, never married: 6 
7. Don’t know: 97 
8. Refusal: 98 
Cycle 1, 2, 3: same 
 
Finally, categorized as: 
 
1. Married/common 
law 
2. other 
Highest level of 
education (respondent) 
(EDUDR04) 
 
 
 a) Less than secondary school graduation: 1 
b) Secondary school graduation: 2 
c) Some post-secondary: 3 
d) Post-secondary graduation: 4 
e) Not stated: 9 
Cycle 1, 2, 3 
Total household 
income (INCDHH) 
Total household 
income from all 
sources (amount in 
dollars) 
1. No income: 1 
2. <5,000: 2 
3. 5,000 to <10,000: 3 
4. 10,000 to <15,000: 4 
5. 15,000 to <20,000: 5 
6. 20,000 to <30,000: 6 
7. 30,000 to <40,000: 7 
8. 40,000 to <50,000: 8 
9. 50,000 to <60,000: 9 
10. 60,000 to <80,000: 10 
11. 80,000 to <100,000: 
11 
12. 100,000 or more: 12 
Cycle 1, 2 
Variable name for Cycle 
3: THID14 
Finally, categorized as: 
1. ≥80,000 
2. ≥50,000-<80,000 
3. ≥30,000-<50,000 
4. <30,000 
Physical activity 
(mins/d) 
a) Average daily light 
physical activity  
Cycle 1: 
Variables 
name: 
Cycle 2: 
Variables name: 
AMSDLA 
Cycle 3:  
Variables name 
different: 
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b) Average daily 
moderate physical 
activity  
c) Average daily 
mod-to-vig 
physical activity  
d) Average daily 
vigorous physical 
activity  
e) Average daily 
sedentary time  
AMSDLA 
AMSDMA 
AMSDMVA 
AMSDVA 
AMSDXSA 
AMSDMA 
AMSDMVA 
AMSDVA 
AMSDXSA 
AMMDLA 
AMMDMA 
AMMDMVA 
AMMDVA 
AMMDXSA 
Smoking (SMKDSTY) Type of smoker 
Respondents aged 12 
and older 
1. Daily smoker: 1 
2. Occasional smoker (former daily smoker): 2 
3. Always an occasional smoker: 3 
4. Former daily smoker: 4 
5. Former occasional smoker: 5 
6. Never smoked: 6 
7. Not applicable: 96 
8. Not stated: 99 
Cycle 1, 2, 3 
 
Exposure to second 
hand smoke (ETS_17) 
 
 
Exposed to second-
hand smoke - overall 
in past month. 
Overall, (excluding 
your own smoking,) 
(and) (excluding inside 
your own home), in the 
past month were you 
exposed to second-
hand smoke: (… every 
day, … almost every 
day, … at least once a 
week, … at least once 
1. Every day: 1 
2. Almost every day: 2 
3. At least once a week: 3 
4. At least once in the past month: 4 
5. Never: 5 
6. Don’t know: 7 
7. Refusal: 8 
Cycle 1, 2 same: 
(ETS_17) 
 
Cycle 3:  
Variable name ETS_24 
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in the past month or … 
never)? 
Alcohol drinker 
(ALCDTYP) 
Type of drinker 
Respondents aged 12 
and older 
1. Regular drinker: 1 
2. Occasional drinker: 2 
3. Former drinker: 3 
4. Never drink: 4 
5. Not applicable: 6 
6. Not stated: 9 
Cycle 1, 2, 3 
Chronic respiratory 
conditions 
(conditions diagnosed by 
a health professional): 
a) Ever asthma 
(CCC_11) 
b) Current asthma 
(CCC_13) 
c) Chronic 
bronchitis 
(CCC_41) 
d) Emphysema 
(CCC_43) 
e) Chronic 
Obstructive 
Pulmonary 
Disease (COPD) 
(CCC_45) 
a) Ever asthma: Do 
you have asthma? 
b) Current asthma: 
Have you had any 
asthma symptoms 
or asthma attacks 
in the past 12 
months? 
c) Chronic bronchitis: 
do you have 
chronic bronchitis? 
d) Emphysema: Do 
you have 
emphysema? 
Respondents aged 
30 and older 
e) COPD: Do you 
have COPD? 
Respondents aged 
30 and older 
1. Yes: 1 
2. No: 2 
3. Don't know:7 
Cycle 1, 2, 3 
Family history of 
asthma (FMH_23) 
Has anyone in your 
immediate family ever 
had asthma? 
1. Yes: 1 
2. No: 2 
3. Not applicable: 6 
4. Don't know: 7 
5. Refusal: 8 
Universe  
Cycle 1, 2: One 
respondent unless 
multiple family 
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Cycle 3: yes, no, don’t know household (1 rep per 
family) 
Cycle 3: All respondents 
Dietary variables 
Meats: 
Eat red meat 
(MFCD11Y) 
Eats liver (MFCD12Y) 
Other organ meat 
(MFC_13N) 
Beef or pork hot dogs 
(MFCD14Y) 
Sausage or bacon 
(MFCD15Y) 
Eats meat – total 
number of times per 
year 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
Cycle 1, 2 same 
 
Cycle 3: variable 
MFC_13N: not found.  
Fish: (Cycle 1) 
Salt water fish 
(MFCD16Y) 
Fresh water fish 
(MFCD17Y) 
Shellfish (MFCD18Y) 
Eats fish– total number 
of times per year 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
All three Cycles are 
different. 
Eggs and egg dishes 
(MFCD19Y) 
Eggs and egg dishes – 
total number of times 
per year 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
Cycle 1, 2: same 
Cycle 3: different 
(MFC_19AN) 
Concept Eats 
egg/includes the yolk- 
reporting period 
 
Beans and Nuts: 
Cooked dried beans 
(MFCD20Y) 
total number of times 
per year 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
a) MFC_20N: same at 
all 3 Cycles. 
b) MFC_21N: 
Cycle 1:  
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Peanuts, walnuts, seeds 
or other nuts 
(MFCD21Y) 
Concept Eats peanuts, 
walnuts, seeds or other 
nuts -reporting period 
Cycle 2 & 3:  
Concept Eats nuts - 
reporting period 
Milk: 
Drinks milk 
(MDCD11Y) 
Cottage cheese 
(MDCD13Y) 
Yogurt (MDCD14Y) 
Ice cream or frozen 
yogurt (MDCD15Y) 
total number of times 
per year 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
a) (MDC_11N): Cycle 
1, 2 same. But, 
Cycle 3 different 
Cycle 3: variable 
MDCD11Y divided into 
4 subgroups (otherwise 
same): 
MDCD01Y 
MDCD02Y 
MDCD04Y 
MDCD05Y 
Grains: 
Hot or cold cereal 
(GFVD11Y) 
Brown bread 
(GFVD12Y) 
White bread 
(GFVD13Y) 
Any kind of Pasta 
(GFVD14Y) 
Any kind of rice 
(GFVD15Y) 
Instant, seasoned or wild 
rice (GFVD16Y) 
total number of times 
per year 
 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
a) GFV_11N: all 3 
Cycles are same. 
b) GFV_15N: 
Cycle 1 & 2: same. But 
Cycle 3: variable 
GFV_15N not found 
Fruits: 
Eats fruits (GFVD17Y) 
 
total number of times 
per year 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
a) GFVD17Y: 
Cycle 1 & 2: same. But 
Cycle 3 different. 
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Cycle 3 has 4 different 
variables for fruits 
GFVD17AY 
GFVD17BY 
GFVD17CY 
GFVD17DY 
Vegetables: 
Lettuce or green leafy 
salad (GFVD19Y)  
Spinach, mustard greens 
or collards (GFVD20Y) 
Other vegetables 
(GFVD23Y) 
Tomatoes or tomato 
sauce (GFVD18Y) 
total number of times 
per year 
 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
a) GFVD19Y: all 3 
Cycles are same. 
b) GFVD20Y: 
Cycle 1&2: Concept 
Eats spinach, mustard 
greens or collards 
Cycle 3: Concept Eats 
spinach, mustard greens 
or cabbage 
Potatoes: 
French/home fries or 
hash brown potatoes 
(GFVD21Y) 
Other potatoes 
(GFVD22Y) 
total number of times 
per year 
 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
All 3 Cycles are same. 
Dietary fat: 
Regular fat salad 
dressing (DFCD11Y) 
Regular fat potato 
chips/tortilla/corn chips 
(excluding low fat and 
pretzels) (DFCD12Y) 
total number of times 
per year 
 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
 
Soft drinks: 
Drinks regular soft 
drinks (WSDD11Y) 
Diet soft drinks 
(WSDD12Y) 
total number of times 
per year 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
Cycle 3: variable name, 
WSDD31Y 
Cycle 3: variable name, 
WSDD30Y 
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Sport drinks 
(WSDD13Y) 
 Cycle 3: variable name, 
WSDD32Y 
Fruit juices: 
Drink fruit juices 
(WSDD14Y) 
Fruit flavored drinks 
(WSDD15Y) 
Vegetable juices 
(WSDD16Y) 
total number of times 
per year 
 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
Cycle 1&2: same. But 
Cycle 3 different (no 
variable) 
Water (WSDD21Y) total number of times 
per year 
 
 
 
 
The total number of yearly consumption was divided 
by 52 to get the weekly values. Then the weekly 
values were divided into tertiles. 
Cycle 1&2: same. Cycle 
3 variable name 
different  
BIOMARKERS 
a) Red blood cell folate 
(nmol/L) 
(LABDRBCF) 
b) Vitamin D (nmol/L) 
(LAB_VITD) 
c) Total protein (g/L) 
(LAB_TP) 
d) Chloride (mmol/L) 
(LAB_CL) 
e) Potassium (mmol/L) 
(LAB_K) 
f) Sodium (mmol/L) 
(LAB_NA) 
g) Calcium (total) 
(mmol/L) 
(LAB_CA) 
a) LABDRBCF: 
Same 1, 2, 3. 
b) Cycle 2 & 3: 
Concept Vitamin D [25(OH)] (nmol/L) 
Cycle 3: variable name LAB_VIDS 
c) LAB_TP: 
Same 1, 2, 3. 
d) LAB_CL: 
same 1, 2, 3  
e) LAB_K: same 1, 2, 3 
f) LAB_NA: same 1, 2, 3 
g) LAB_CA: same 1, 2, 3 
h) LAB_CRP: 
Cycle 1: Concept C-reactive protein (mg/L) 
Cycle 2, 3: Concept High Sensitivity C reactive protein (mg/L) 
i) LAB_B12: same 1, 2, 3 
j) LAB_HDL: 
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h) C-reactive protein 
(mg/L) (LAB_CRP) 
i) Vitamin B12 
(pmol/L) 
(LAB_B12) 
j) High Density 
Lipoprotein (HDL) 
(mmol/L) 
(LAB_HDL) 
k) Total cholesterol 
(mmol/L) 
(LAB_CHOL) 
 
Universe:  
Cycle 1: Respondents with ATGD12 = 1 and PHBDELG = 1 
Cycle 2, 3: Respondents with PHBDELG = 1 
k) LAB_CHOL: Universe: 
Cycle 1: Respondents with ATGD12 = 1 and PHBDELG = 1 
Cycle 2, 3: Respondents with PHBDELG = 1 
 
Dependent variables: 
Name Definition Notes 
FEV1 (L) 
a) Absolute (SPM_B1) 
b) Percent predicted (SPM_PV1) 
a) Largest FEV1 (L) from acceptable 
trials 
b) Respondent's predicted FEV1 (L) 
a) SPM_B1: Universe: 
Cycle 1: Respondents with SPM_NUME 
> 0 
Cycle 2, 3: Respondents with SPCDELG 
= 1 
FVC (L) 
a) Absolute (SPM_BFVC) 
b) Percent predicted (SPM_PFVC) 
a) Largest FVC (L) from acceptable 
trials 
b) Respondent's predicted FVC (L) 
a) SPM_BFVC: 
Concept: 
Cycle 1: Largest FVC (L) from acceptable 
trials 
Cycle 2, 3: Largest FVC (L) from 
acceptable efforts 
Universe:  
Cycle 1: Respondents with SPM_NUME 
> 0 
Cycle 2, 3: Respondents with SPCDELG 
= 1 
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FEV1/FVC (%) 
a) Absolute (SPM_B1F) 
b) Predicted (SPM_PV1F) 
a) Best FEV1/FVC from acceptable 
trials 
b) Respondent's predicted FEV1/FVC 
(%) 
a) SPM_B1F: 
Concept: 
Cycle 1: Best FEV1/FVC from acceptable 
trials 
Cycle 2, 3: Best FEV1/FVC (%) from 
acceptable efforts 
Universe:  
Cycle 1: Respondents with SPM_NUME 
> 0 
Cycle 2, 3: Respondents with SPCDELG 
= 1 
FEF25-75% 
Absolute 
Acceptable trials and large sum of 
FVC+FEV1 (L/s) 
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Appendix 2 
Descriptive statistics by age group: 
Tables 4.1 (Cycle 1), 4.2 (Cycle 2), and 4.3 (Cycle 3) present the demographic, behavioral, 
and personal factors by age group. There were statistically significant (p-value<0.05) differences 
between age groups for race/ethnicity (Cycles 1, 2, 3), marital status (Cycles 1, 2, 3), educational 
status (Cycles 1, 2, 3), family income (Cycles 1, 2, 3), height (in Cycles 1, 2, 3), weight (Cycles 1, 
2, 3), BMI (Cycles 1, 2, 3), smoking status (Cycles 1, 2, 3), exposure to second hand smoke (Cycles 
1, 2, 3), total physical activity (Cycles 1, 2, 3), sedentary activity (Cycles 1, 2, 3), alcohol drinker 
(Cycles 1, 2), other respiratory disease (Cycles 1, 3), ever asthma (Cycle 3), current asthma (Cycle 
3), and immigrant (Cycle 3). The results were consistent when comparing the Cycles. The 
following patterns were observed when comparing the age group. 
• The proportion of participants who were in “Caucasian” ethnicity increased as the age 
group increased while the proportion of participants who were in “other” ethnicity 
decreased as the age group increased (Cycles 1, 2, 3). 
• The proportion of participants who were “married/ common law” showed an inverse U-
shaped pattern as the age group increased where the highest proportion was in the middle 
age group. The proportion of participants who were “Widowed, Separated, Divorced, 
Single, never married” showed a U-shaped pattern as the age group increased (Cycles 1, 2, 
3). 
• The proportion of participants with a “post-secondary graduation” showed an inverse U-
shaped pattern as the age group increased where the highest proportion was in the middle 
age group (Cycles 1, 2, 3). 
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• The proportion of participants with a total family income “CAD ≥80,000” showed an 
inverse U-shaped pattern as the age group increased where the highest proportion was in 
the middle age group (Cycles 1, 2, 3). 
• The proportion of participants of mean “height” decreased as the age group increased 
(Cycles 1, 2, 3). 
• The proportion of participants of mean “weight” showed an inverse U-shaped pattern as 
the age group increased where the highest proportion was in the middle age group (Cycles 
1, 2, 3). 
• The proportion of participants who were “obese” BMI increased as the age group increased 
(Cycles 1, 2) while the proportion of participants who were in “not overweight or obese” 
BMI decreased as the age group increased (Cycles 1, 2, 3). 
• The proportion of participants who were in “daily smoker” smoking status decreased as the 
age group increased while the proportion of participants in “former smoker” smoking status 
increased as the age group increased (Cycles 1, 2, 3). 
• The proportion of participants who were in “everyday” and “occasional” exposure to 
second hand smoke decreased as the age group increased while the proportion of 
participants who were in “never” exposure to second hand smoke increased as the age 
group increased (Cycles 1, 2, 3). 
• The proportion of participants who were in “regular” alcohol drinker decreased as the age 
group increased (Cycles 1, 2). 
• The proportion of participants of mean “total activity” showed an inverse U-shaped pattern 
as the age group increased while the proportion of participants of mean “sedentary activity” 
increased as the age group increased (Cycles 1, 2, 3). 
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Table 4.1: Descriptive statistics (Cycle 1) of socio-demographic, behavioral, and personal characteristics by age groups 
Characteristics Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult  
(>=65) 
% 
P-value 
Sex • Male 
• Female 
49.31 
50.69 
49.83 
50.17 
49.17 
50.83 
48.20 
51.80 
0.42 
Race/ethnicity  • Caucasian 
• Other 
82.29 
17.71 
77.32 
22.68 
 
84.02 
15.98 
91.60 
8.40 
<0.001 
Immigrant • Yes 
• No 
23.26 
76.74 
20.80 
79.20 
24.26 
75.74 
27.28 
72.72 
0.15 
Region • New Brunswick 
• British Columbia 
• Ontario 
• Alberta 
• Quebec 
7.21 
13.55 
38.92 
16.73 
23.59 
6.67 
13.34 
39.50 
18.30 
22.19 
7.19 
13.68 
38.79 
15.84 
24.51 
9.02 
13.70 
37.57 
15.12 
24.59 
0.44 
Marital status • Married/ Common-
law 
• Widowed, 
Separated, Divorced, 
Single, never 
married 
66.18 
33.82 
53.88 
46.12 
76.37 
23.63 
67.07 
32.93 
<0.001 
Educational 
status 
• Post-secondary 
graduation 
• Some post-
secondary 
• Secondary school 
graduation 
• Less than secondary 
school graduation 
59.09 
9.42 
18.76 
12.73 
60.20 
13.00 
18.72 
8.08 
62.15 
6.73 
19.32 
11.81 
43.74 
7.94 
16.77 
31.56 
<0.001 
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Family income • CAD ≥80,000 
• CAD ≥50,000 to 
<80,000 
• CAD ≥30,000 to 
<50,000 
• CAD <30,000 
39.97 
25.86 
18.86 
15.31 
39.39 
28.19 
17.93 
14.49 
46.42 
25.33 
15.75 
12.51 
17.66 
20.46 
33.44 
28.44 
<0.001 
Height • Mean (cm)/ Standard 
error (SE) 
168.62± 0.27 170.00± 0.33 168.50± 0.33 164.67± 0.37 <0.001 
Weight • Mean (kilogram)/ 
Standard error (SE) 
77.35± 0.72 75.44± 0.87 79.25± 0.84 76.25± 0.69 <0.001 
BMI • Obese 
• Overweight 
• Not overweight or 
obese 
23.92 
36.72 
39.36 
19.05 
29.68 
51.27 
26.32 
41.68 
31.10 
30.05 
40.01 
29.94 
<0.001 
Smoking • Daily smoker 
• Former smoker 
• Never 
21.71 
29.68 
48.62 
25.10 
17.27 
57.63 
21.68 
36.22 
42.10 
10.96 
44.65 
44.38 
<0.001 
Exposure to 
second hand 
smoking 
• Every day 
• Occasional 
• Never 
16.11 
36.51 
47.38 
22.70 
43.12 
34.18 
13.15 
33.69 
53.16 
6.32 
26.16 
67.53 
<0.001 
Alcohol 
drinker 
• Regular drinker 
• Occasional drinker 
• Former drinker 
• Never drunk 
68.69 
16.83 
8.92 
5.57 
71.18 
16.84 
6.11 
5.88 
68.80 
16.09 
9.85 
5.25 
60.34 
19.57 
14.32 
5.77 
0.004 
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Ever asthma • Yes 
• No 
7.63 
92.37 
8.45 
91.55 
6.97 
93.03 
7.52 
92.48 
0.39 
Current asthma • Yes 
• No 
4.28 
95.72 
4.46 
96. 54 
4.41 
95.59 
3.26 
95. 74 
0.64 
Obstructive 
lung disease 
(Chronic 
bronchitis, 
Emphysema, 
COPD) 
• Yes 
• No 
3.24 
96.76 
2.87 
97.13 
2.31 
97.69 
7.29 
92.71 
<0.001 
Family history 
of asthma 
• Yes (1) 
• No (2) 
22.23 
77.77 
22.02 
77.98 
23.34 
76.66 
18.72 
81.28 
0.21 
Total Physical 
activity 
• Mean (minutes/day)/ 
Standard error (SE) 
248.58± 4.44 249.75± 7.04 261.42± 4.61 196.38± 5.83 <0.001 
Sedentary 
activity 
• Mean (minutes/day)/ 
Standard error (SE) 
188.48± 2.81 176.10± 3.59 194.21± 3.10 205.02± 3.11 <0.001 
Bold text indicates statistical significance
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Table 4.2: Descriptive statistics (Cycle 2) of socio-demographic, behavioral, and personal characteristics by age groups  
Characteristics Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
Sex • Male 
• Female 
49.48 
50.52 
49.82 
50.18 
49.54 
50.46 
48.23 
51.77 
0.57 
Race/ethnicity • Caucasian 
• Other 
77.64 
22.36 
71.97 
28.03 
79.28 
20.72 
88.75 
11.25 
<0.001 
Immigrant • Yes 
• No 
27.30 
72.70 
26.13 
73.87 
27.56 
72.44 
29.91 
70.09 
0.73 
Region • Alberta 
• British Columbia 
• Manitoba 
• Ontario 
• Newfoundland and 
Labrador 
• Nova Scotia 
• Quebec 
12.70 
13.47 
4.46 
38.83 
3.59 
3.34 
23.61 
14.77 
13.16 
4.09 
39.08 
3.75 
2.35 
22.81 
12.31 
13.66 
4.60 
38.33 
3.56 
3.92 
23.63 
7.92 
13.73 
5.04 
39.89 
3.22 
4.25 
25.96 
0.68 
Marital status • Married/ Common-law 
• Widowed, Separated, 
Divorced, Single, never 
married 
63.95 
36.05 
47.47 
52.53 
75.56 
24.44 
71.29 
28.71 
<0.001 
Educational 
status 
• Post-secondary graduation 
• Some post-secondary 
• Secondary school 
graduation 
• Less than secondary 
school graduation 
60.22 
10.50 
15.83 
13.45 
58.79 
17.81 
13.86 
9.54 
64.95 
6.21 
17.34 
11.50 
47.61 
3.93 
16.38 
32.09 
<0.001 
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Family income • CAD ≥80,000 
• CAD ≥50,000 to <80,000 
• CAD ≥30,000 to <50,000 
• CAD <30,000 
41.14 
24.97 
17.74 
16.15 
44.45 
25.20 
13.42 
16.92 
45.03 
24.82 
18.16 
11.99 
16.94 
24.84 
29.20 
29.02 
<0.001 
Height • Mean (cm)/ Standard error 
(SE) 
168.45± 0.34 170.32± 0.51 
 
167.84± 0.41 165.02± 0.34 <0.001 
Weight • Mean (kilogram)/ 
Standard error (SE) 
77.61± 0.92 75.24± 1.38 79.49± 0.92 77.89± 0.67 <0.001 
BMI • Obese 
• Overweight 
• Not overweight or obese 
26.23 
34.22 
39.55 
18.69 
28.45 
52.86 
29.86 
37.87 
32.27 
35.28 
37.99 
26.73 
<0.001 
Smoking • Daily smoker 
• Former smoker 
• Never 
20.65 
28.73 
50.62 
22.63 
19.05 
58.32 
21.26 
31.04 
47.70 
12.44 
49.65 
37.91 
<0.001 
Exposure to 
second hand 
smoking 
• Every day 
• Occasional 
• Never 
15.71 
38.81 
45.49 
18.76 
48.52 
32.72 
16.07 
33.68 
50.25 
5.21 
28.23 
66.56 
<0.001 
Alcohol drinker • Regular drinker 
• Occasional drinker 
• Former drinker 
• Never drunk 
67.11 
15.47 
10.53 
6.89 
69.18 
14.48 
6.85 
9.49 
66.59 
16.53 
12.24 
4.63 
62.74 
14.60 
15.40 
7.26 
0.003 
Ever asthma • Yes 
• No 
10.07 
89.93 
11.85 
88.15 
9.34 
90.66 
7.37 
92.63 
0.43 
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Current asthma • Yes 
• No 
4.54 
95.46 
4.32 
95.68 
4.99 
95.01 
3.59 
96.41 
0.67 
Obstructive lung 
disease (Chronic 
bronchitis, 
Emphysema, 
COPD) 
• Yes 
• No 
4.22 
95.78 
3.62 
96.38 
3.98 
96.02 
5.87 
94.13 
0.48 
Family history of 
asthma 
• Yes 
• No 
23.65 
76.35 
24.61 
75.39 
24.42 
75.58 
17.87 
82.13 
0.37 
Total Physical 
activity 
• Mean (minutes/day)/ 
Standard error (SE) 
217.47± 4.55 220.28± 6.94 228.88± 4.15 168.26± 4.71 <0.001 
Sedentary 
activity 
• Mean (minutes/day)/ 
Standard error (SE) 
493.80± 4.83 456.51± 7.34 512.04± 6.87 536.72± 7.38 <0.001 
Bold text indicates statistical significance
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Table 4.3: Descriptive statistics (Cycle 3) of socio-demographic, behavioral, and personal characteristics by age groups  
Characteristics Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to 
<65) 
% 
Older adult 
(>=65) 
% 
P-value 
Sex • Male 
• Female 
49.64 
50.36 
50.38 
49.62 
49.58 
50.42 
47.74 
52.26 
0.23 
Race/ethnicity  • Caucasian 
• Other 
75.13 
24.87 
70.90 
29.10 
75.59 
24.41 
85.67 
14.33 
0.003 
Immigrant • Yes 
• No 
27.54 
72.46 
22.48 
77.52 
30.04 
69.96 
33.50 
66.50 
0.004 
Region • New Brunswick 
• British Columbia 
• Ontario 
• Alberta 
• Nova Scotia 
• Quebec 
3.41 
13.54 
39.24 
17.23 
3.37 
23.21 
1.55 
13.40 
39.81 
18.98 
4.24 
22.02 
3.98 
13.61 
39.44 
16.53 
3.00 
23.44 
6.76 
13.68 
36.92 
14.62 
2.17 
25.85 
0.72 
Marital status • Married/ Common-law 
• Widowed, Separated, 
Divorced, Single, never 
married 
62.93 
37.07 
45.48 
54.52 
75.88 
24.12 
68.43 
31.57 
<0.001 
Educational 
status 
• Post-secondary graduation 
• Secondary school 
graduation 
• Less than secondary school 
graduation 
62.31 
25.02 
12.67 
61.34 
30.35 
8.31 
66.10 
22.63 
11.27 
51.93 
18.24 
29.83 
<0.001 
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Family income • CAD ≥80,000 
• CAD ≥50,000 to <80,000 
• CAD ≥30,000 to <50,000 
• CAD <30,000 
41.58 
23.02 
20.34 
15.06 
38.48 
24.95 
22.57 
14.00 
49.81 
20.18 
16.43 
13.58 
22.18 
27.25 
27.37 
23.20 
<0.001 
Height • Mean (cm)/ Standard error 
(SE) 
168.91± 0.40 170.58± 0.49 168.67± 0.36 164.94± 0.83 <0.001 
Weight • Mean (kilogram)/ Standard 
error (SE) 
78.35± 1.16 77.09± 1.61 79.96± 1.24 76.42± 1.25 <0.001 
BMI • Obese 
• Overweight 
• Not overweight or obese 
26.39 
35.60 
38.00 
21.48 
31.14 
47.38 
30.56 
34.96 
34.47 
26.02 
50.44 
23.54 
<0.001 
Smoking • Daily smoker 
• Former smoker 
• Never 
22.92 
26.10 
50.97 
25.72 
15.40 
58.88 
23.61 
30.33 
46.06 
12.52 
42.31 
45.17 
<0.001 
Exposure to 
second hand 
smoking 
• Every day 
• Occasional 
• Never 
22.48 
37.59 
39.94 
31.10 
39.16 
29.74 
20.07 
38.32 
41.61 
6.03 
30.58 
63.39 
<0.001 
Alcohol 
drinker 
• Regular drinker 
• Occasional drinker 
• Former drinker 
• Never drunk 
69.68 
12.77 
9.91 
7.63 
69.99 
12.13 
9.33 
8.54 
71.82 
12.84 
8.41 
6.93 
61.45 
14.34 
16.74 
7.47 
0.15 
Ever asthma • Yes 
• No 
9.35 
90.65 
13.47 
86.53 
6.51 
93.49 
7.32 
92.68 
0.014 
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Current asthma • Yes 
• No 
4.44 
95.56 
6.80 
93.20 
3.25 
96.75 
1.80 
98.20 
0.015 
Obstructive 
lung disease 
(Chronic 
bronchitis, 
Emphysema, 
COPD) 
• Yes 
• No 
2.98 
97.02 
0.67 
99.33 
3.03 
96.97 
5.83 
94.17 
<0.001 
Family history 
of asthma 
• Yes 
• No 
21.98 
78.02 
22.00 
78.00 
23.04 
76.96 
18.23 
81.77 
0.62 
Total Physical 
activity 
• Mean (minutes/day)/ 
Standard error (SE) 
228.33± 6.40 228.46± 10.78 241.94± 5.69 180.30± 9.00 <0.001 
Sedentary 
activity 
• Mean (minutes/day)/ 
Standard error (SE) 
502.55± 4.92 450.27± 7.31 532.04± 7.08 547.87± 6.57 <0.001 
Bold text indicates statistical significance 
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Tables 4.4, 4.5, and 4.6 show the distribution of dietary consumption by age group. The 
relationship between dietary factors and age group were statistically significant (p-value <0.05) 
for meats (Cycles 1, 2, 3), grains (Cycles 1, 2, 3), fruits (Cycles 1, 2, 3), potatoes (Cycles 1, 2, 3), 
milk (Cycles 1, 2), dietary fat (Cycles 1, 2), soft drinks (Cycles 1, 2), fishes (Cycles 2, 3), and 
water (Cycles 1, 3), beans (Cycle 1), vegetables (Cycle 1). The following patterns were observed: 
• The proportion of participants who consumed low amount of meats increased as age 
group increased while the proportion of participants who consumed higher meats 
decreased as the age group increased (Cycles 1, 2, 3).  
• The proportion of participants who consumed low (Cycles 1, 2, 3) and medium (Cycle 
3) amount of fish decreased as age group increased. However, the proportion of 
participants who consumed high (Cycles 1, 2, 3) and medium (Cycles 1, 2) amount of 
fish increased as the age group increased.  
• The proportion of participants who consumed low (Cycles 1, 2) and medium (Cycle 2) 
amount of beans decreased as the age group increased. However, in Cycles 1, 2, and 3 
the proportion participants who consumed high amount increased as the age group 
increased. 
• The proportion of participants who consumed medium amount of milk increased as the 
age group increased in Cycle 2. 
• The proportion of participants who consumed medium (Cycle 2) and high (Cycle 3) 
amount of grains increased as the age group increased. However, the proportion of 
participants who consumed medium (Cycle 3) and high (Cycle 2) amount decreased as 
the age group increased. 
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• The proportion of participants who consumed low (Cycles 1, 2, 3) amount of fruits 
decreased as the age group increased. However, the proportion of participants who 
consumed high (Cycles 1, 2, 3) amount increased as the age group increased.  
• The proportion of participants who consumed low (Cycles 1, 2, 3) amount of vegetables 
decreased as the age group increased. However, the proportion of participants who 
consumed medium (Cycles 2) amount increased as the age group increased.  
• The proportion of participants who consumed low (Cycle 1) and medium (Cycles 2, 3) 
amount of potatoes decreased as the age group increased. However, the proportion of 
participants who consumed high (Cycle 3) amount increased as the age group 
increased.  
• The proportion of participants who consumed low amount of dietary fat (Cycles 1, 2) 
increased as the age group increased. However, the proportion of participants who 
consumed medium (Cycles 1, 2) and higher (Cycle 1) amount decreased as the age 
group increased.  
• The proportion of participants who consumed lower (Cycles 1, 2, 3) amount of soft 
drinks increased as the age group increased. However, in Cycles 1, 2, and 3 the 
proportion of participants who consumed medium and high amount decreased as the 
age group increased. 
• The proportion of participants who consumed low (Cycles 1, 3) and medium (Cycle 2) 
amount of water increased as the age group increased. However, in Cycles 1, 2, and 3 
the proportion of participants who consumed higher amount decreased as the age group 
increased. 
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Table 4.4: Descriptive statistics (Cycle 1) of dietary factors (tertiles) by age group 
Dietary factors  Tertiles 
Times/week 
Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
 
Red meat • Low 
• Medium 
• High 
32.97 
31.55 
35.48 
29.37 
29.61 
41.02 
35.13 
32.89 
31.99 
36.32 
32.73 
30.95 
0.001 
Fish • Low 
• Medium 
• High 
33.61 
31.11 
35.28 
38.00 
28.55 
33.45 
30.93 
32.67 
36.40 
29.72 
33.38 
36.90 
0.027 
Eggs and eggs dishes • Low 
• Medium 
• High 
24.67 
26.82 
48.51 
23.87 
25.63 
50.50 
25.27 
27.90 
46.83 
24.94 
26.54 
48.52 
0.79 
Beans and nuts • Low 
• Medium 
• High 
31.36 
36.35 
32.30 
32.24 
40.77 
26.98 
31.30 
33.34 
35.36 
28.76 
33.55 
37.70 
0.001 
Milk and dairy products • Low 
• Medium 
• High 
33.89 
33.05 
33.05 
30.41 
32.53 
37.06 
36.47 
33.65 
29.88 
35.31 
32.46 
32.23 
0.045 
Grains • Low 
• Medium 
• High 
33.66 
32.83 
33.50 
29.34 
31.38 
39.27 
37.05 
34.12 
28.82 
34.67 
32.61 
32.72 
<0.001 
Fruits • Low 
• Medium 
• High 
30.04 
38.65 
31.31 
33.49 
39.51 
27.00 
28.74 
37.18 
34.08 
23.94 
41.41 
34.66 
0.023 
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Vegetables • Low 
• Medium 
• High 
34.80 
32.78 
32.42 
40.42 
29.10 
30.47 
31.87 
35.49 
32.64 
27.91 
34.31 
37.77 
<0.001 
Potatoes • Low 
• Medium 
• High 
35.15 
32.22 
32.63 
38.09 
31.24 
30.67 
35.70 
33.71 
30.59 
23.77 
29.77 
46.46 
<0.001 
Dietary fat • Low 
• Medium 
• High 
33.09 
33.72 
33.19 
26.64 
39.21 
34.16 
35.60 
30.70 
33.69 
44.15 
27.60 
28.25 
<0.0001 
Soft drinks • Low 
• Medium 
• High 
29.73 
36.10 
34.17 
17.21 
39.02 
43.77 
34.74 
35.33 
29.92 
50.72 
29.66 
19.62 
<0.001 
Water • Low 
• Medium 
• High 
30.46 
31.14 
38.40 
28.40 
31.30 
40.30 
30.87 
29.91 
39.22 
35.43 
35.26 
29.31 
0.002 
Bold text indicates statistical significance
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Table 4.5: Descriptive statistics (Cycle 2) of dietary factors (tertiles) by age group 
Dietary factors  Tertiles 
Times/week 
Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
 
Red meat • Low 
• Medium 
• High 
32.42 
31.33 
36.25 
26.68 
28.20 
45.11 
34.54 
33.53 
31.93 
41.96 
32.74 
25.30 
<0.001 
Fish • Low 
• Medium 
• High 
31.01 
33.32 
35.66 
38.64 
31.40 
29.96 
26.43 
34.10 
39.48 
24.75 
36.31 
38.94 
<0.001 
Eggs and eggs dishes • Low 
• Medium 
• High 
20.98 
24.58 
54.43 
20.48 
23.31 
56.21 
21.22 
24.78 
54.00 
21.66 
27.70 
50.65 
0.62 
Beans and nuts • Low 
• Medium 
• High 
30.49 
32.80 
36.70 
32.64 
31.49 
35.86 
29.46 
33.87 
36.68 
27.78 
32.88 
39.35 
0.65 
Milk and dairy products • Low 
• Medium 
• High 
37.26 
32.14 
30.60 
35.96 
29.17 
34.87 
40.03 
32.26 
27.71 
31.11 
40.64 
28.25 
0.006 
Grains • Low 
• Medium 
• High 
33.07 
31.30 
35.63 
28.15 
30.46 
41.39 
36.42 
31.67 
31.91 
35.69 
32.47 
31.84 
0.006 
Fruits • Low 
• Medium 
• High 
32.48 
4.48 
63.04 
36.16 
5.50 
58.33 
31.54 
4.02 
64.44 
24.84 
3.08 
72.08 
0.013 
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Vegetables • Low 
• Medium 
• High 
32.10 
34.75 
33.15 
34.60 
32.21 
33.20 
31.38 
34.90 
33.72 
27.22 
41.89 
30.89 
0.20 
Potatoes • Low 
• Medium 
• High 
30.02 
35.52 
34.46 
29.27 
37.51 
33.23 
31.60 
36.66 
31.74 
26.54 
25.41 
48.05 
<0.001 
Dietary fat • Low 
• Medium 
• High 
30.75 
30.67 
38.58 
27.34 
33.40 
39.26 
30.90 
29.38 
39.72 
40.51 
27.14 
32.36 
0.011 
Soft drinks • Low 
• Medium 
• High 
30.40 
35.62 
33.97 
18.01 
37.65 
44.35 
34.73 
36.13 
29.14 
51.98 
27.67 
20.35 
<0.001 
Water • Low 
• Medium 
• High 
24.97 
40.29 
34.74 
24.47 
37.23 
38.30 
25.93 
40.77 
33.30 
22.97 
47.73 
29.30 
0.07 
Red color text indicates statistical significance
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Table 4.6: Descriptive statistics (Cycle 3) of dietary factors (tertiles) by age group 
Dietary factors  Tertiles 
Times/week 
Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
 
Red meat • Low 
• Medium 
• High 
35.55 
32.05 
32.40 
29.55 
32.15 
38.30 
38.36 
31.83 
29.82 
43.12 
32.54 
24.34 
<0.001 
Fish • Low 
• Medium 
• High 
30.97 
34.42 
34.60 
32.10 
42.28 
25.62 
30.56 
29.37 
40.07 
29.15 
29.29 
41.56 
<0.001 
Eggs and eggs dishes • Low 
• Medium 
• High 
21.41 
40.65 
37.93 
18.92 
39.07 
42.02 
22.29 
43.01 
34.69 
25.54 
37.09 
37.37 
0.22 
Beans and nuts • Low 
• Medium 
• High 
33.31 
33.35 
33.34 
33.69 
33.91 
32.40 
33.04 
34.16 
32.80 
33.15 
28.99 
37.86 
0.76 
Milk and dairy products • Low 
• Medium 
• High 
35.19 
33.16 
31.65 
32.76 
31.88 
35.37 
37.20 
34.40 
28.40 
35.25 
32.61 
32.14 
0.24 
Grains • Low 
• Medium 
• High 
34.48 
35.48 
30.03 
34.22 
39.20 
26.58 
35.82 
33.65 
30.52 
30.63 
31.13 
38.24 
0.013 
Fruits • Low 
• Medium 
• High 
34.57 
35.51 
29.93 
37.93 
36.89 
25.17 
33.74 
33.37 
32.89 
27.74 
38.89 
33.37 
0.048 
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Vegetables • Low 
• Medium 
• High 
33.81 
33.77 
32.42 
35.37 
34.54 
30.09 
33.04 
32.73 
34.23 
31.96 
35.14 
32.90 
0.80 
Potatoes • Low 
• Medium 
• High 
34.62 
33.77 
31.62 
33.68 
38.51 
27.81 
36.70 
32.86 
30.44 
30.15 
23.28 
46.58 
<0.001 
Dietary fat • Low 
• Medium 
• High 
36.99 
31.41 
31.60 
34.97 
31.19 
33.83 
38.92 
32.45 
28.63 
36.14 
28.46 
35.41 
0.51 
Soft drinks • Low 
• Medium 
• High 
30.87 
31.98 
37.15 
15.82 
37.49 
46.69 
38.68 
28.83 
32.49 
47.10 
27.02 
25.87 
<0.001 
Water • Low 
• Medium 
• High 
23.09 
40.71 
36.20 
17.56 
34.09 
48.36 
23.44 
45.54 
31.02 
37.78 
43.04 
19.17 
<0.001 
Bold text indicates statistical significance  
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Tables 4.7, 4.8, and 4.9 show the descriptive statistics for the Canada Food Guide by age 
group for Cycles 1, 2, and 3, respectively. Statistically significant (p-value <0.05) relationships 
were observed only between milk and milk alternatives and age group (Cycles 1, 2, 3). The 
proportion of participants who were within the “not meeting” Canada food requirement of milk 
and milk alternatives increased as the age group increased (Cycles 1, 2, 3). However, in Cycles 1, 
2, and 3 opposite patterns was observed within the participants of “meeting” Canada food 
requirement where the proportion of participants were decreased as the age group increased. 
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Table 4.7: Descriptive statistics (Cycle 1) of Canada Food Guide by age group 
Variables for Canada Food Guide Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
Vegetables and 
fruits 
• 1- Not meeting 
• 2- Meeting 
89.39 
10.61 
90.86 
9.14 
87.94 
12.06 
90.15 
9.85 
0.07 
 
Milk and Milk 
alternatives 
• 1- Not meeting 
• 2- Meeting 
74.05 
25.95 
62.94 
37.06 
79.71 
20.29 
88.15 
11.85 
<0.001 
Meat and meat 
alternatives 
• 1- Not meeting 
• 2- Meeting 
85.69 
14.31 
84.39 
15.61 
86.95 
13.05 
85.14 
14.86 
0.18 
Bold text indicates statistical significance 
Table 4.8: Descriptive statistics (Cycle 2) of Canada Food Guide by age group 
Variables for Canada Food Guide Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
Vegetables and 
fruits 
• 1- Not meeting 
• 2- Meeting 
91.01 
8.99 
91.36 
8.64 
91.27 
8.73 
88.99 
11.01 
0.48 
 
Milk and Milk 
alternatives 
• 1- Not meeting 
• 2- Meeting 
77.78 
22.23 
67.79 
32.21 
82.43 
17.57 
90.88 
9.12 
<0.001 
Meat and meat 
alternatives 
• 1- Not meeting 
• 2- Meeting 
82.00 
18.00 
82.07 
17.93 
81.62 
18.38 
83.20 
16.80 
0.86 
Bold text indicates statistical significance 
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Table 4.9: Descriptive statistics (Cycle 3) of Canada Food Guide by age group 
Variables for Canada Food Guide Overall 
% 
Young adult 
(=>18 to <40) 
% 
Middle age  
(=>40 to <65) 
% 
Older adult 
(>=65) 
% 
P-value 
Vegetables and 
fruits 
• 1- Not meeting 
• 2- Meeting 
96.38 
3.62 
97.13 
2.87 
95.96 
4.04 
95.73 
4.23 
0.43 
  
Milk and Milk 
alternatives 
• 1- Not meeting 
• 2- Meeting 
67.84 
32.16 
54.58 
45.42 
74.08 
25.92 
84.39 
15.61 
<0.001 
Meat and meat 
alternatives 
• 1- Not meeting 
• 2- Meeting 
36.42 
63.58 
37.67 
62.33 
35.55 
64.45 
35.82 
64.18 
0.75 
Bold text indicates statistical significance 
Table 4.10: Scoring of Mediterranean Diet 
Variables Low 
<1 times per week 
Medium 
≥1 to <3 times per week 
High 
≥3 times per week 
Meat 2 1 0 
Fish 0 1 2 
Vegetables 0 1 2 
Fruits 0 1 2 
Cereal 0 1 2 
Pasta 0 1 2 
Rice 0 1 2 
Potatoes 0 1 2 
Milk 2 1 0 
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Table 4.11 shows the descriptive statistics of mean, median, mode, 75% percentile, and 
25% percentile of the modified Mediterranean Diet Score. Overall the score was consistent 
throughout the Cycles and age group. 
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Table 4.11: Modified Mediterranean Diet Score for all Cycles by age group 
Modified 
Mediterranean 
Diet Score 
(total possible 
score=27) 
Cycle 1  Cycle 2  Cycle 3 
Young 
adult 
(=>18 to 
<40) 
Middle 
age  
(=>40 to 
<65) 
Older 
adult  
(>=65) 
 Young 
adult 
(=>18 to 
<40) 
Middle 
age  
(=>40 to 
<65) 
Older 
adult  
(>=65) 
 Young 
adult 
(=>18 to 
<40) 
Middle 
age  
(=>40 
to <65) 
Older 
adult  
(>=65) 
Mean  10.09  10.46  9.76 
(95% CI) (9.99-10.19)  (10.32-10.60)  (9.60-9.92) 
Median 10 10 10  11 11 10  10 10 10 
Mode 10 10 10  11 11 10  10 10 10 
75% percentile 12 11 11  12 12 11  11 11 11 
25% percentile 9 9 9  9 9 9  9 9 9 
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Tables 4.12, 4.13, and 4.14 show the descriptive statistics for the biomarkers by age group 
for Cycle 1, 2, and 3, respectively. Statistically significant (p-value <0.05) relationships were 
observed between biomarkers and the age group including red blood cell folate (Cycles 1, 2, 3), 
Vitamin D (Cycles 1, 2, 3), total protein (Cycles 1, 2, 3), potassium (Cycles 1, 2, 3), serum 
creatinine (Cycles 1, 2, 3), calcium (Cycles 1, 2, 3), urine creatinine (Cycles 1, 2, 3), c-reactive 
protein (Cycles 1, 2), Vitamin B12 (Cycles 1, 3), sodium (Cycles 1, 2), chloride (Cycles 1, 3), high 
density lipoprotein (Cycle 3), and total cholesterol (Cycle 3). 
• The mean values of red blood cell folate were increased as the age group increased 
(Cycles 1, 2, 3).  
• The mean values of Vitamin D were increased as the age group increased (Cycles 1, 3) 
while the proportion of participants showed a U-shaped pattern in Cycle 2. 
• The mean values of total protein were gradually decreased as the age group increased 
(Cycles 1, 2, 3). 
• The mean values of potassium were gradually increased as the age group increased 
(Cycles 1, 2, 3). 
• The mean values of C-reactive protein were gradually increased as the age group 
increased (Cycles 1, 2).  
• The mean values of Vitamin B12 were gradually increased as the age group increased 
(Cycles 1, 3). 
• The mean values of high density lipoprotein (HDL) were gradually increased as the age 
group increased (Cycles 1, 3).  
• The mean values of total cholesterol showed an inverse U-shaped pattern as the age 
group increased (Cycle 3). 
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Table 4.12: Descriptive statistics (Cycle 1) of biomarkers by age groups 
Biomarkers Normal range Overall 
(Mean, SE) 
Young adult 
(=>18 to <40) 
 (Mean, SE) 
Middle age 
(=>40 to <65) 
 (Mean, SE) 
Older adult 
(>=65) 
 (Mean, SE) 
P-value 
Red blood cell folate 
(nmol/L) 
317-1422a 1355.80± 43.23 1249.90± 36.29 1403.53± 50.72 1516.00± 74.72 <0.001 
Vitamin D (nmol/L)  75-150b 67.32± 1.20 65.58± 2.05 67.11± 1.23 73.61± 1.57 <0.001 
Total protein (g/L)  60-80b 73.50± 0.19 74.64± 0.25 72.91± 0.21 72.15± 0.27 <0.001 
Chloride (mmol/L)  98-108b 104.38± 0.12 104.36± 0.11 104.56± 0.15 103.74± 0.19 <0.001 
Potassium (mmol/L)  Men: 3.5-4.5b 
Women: 3.4-4.4b 
4.31± 0.02 4.27± 0.02 4.32± 0.02 4.37± 0.02 <0.001 
Sodium (mmol/L)  135-145b 139.95± 0.14 139.89± 0.15 140.04± 0.15 139.75± 0.13 0.015 
Calcium (total) 
(mmol/L) 
2.10-2.60b 2.41± 0.01 2.41± 0.01 2.40± 0.01 2.41± 0.01 <0.001 
C-reactive protein 
(mg/L) 
Intermediate 
risk:1.0-3.0b 
2.33± 0.07 2.04± 0.13 2.45± 0.08 2.73± 0.13 <0.001 
Total protein (g/L) 60-80b 73.50±0.19 74.64±0.25 72.91±0.21 72.15±0.27 <0.001 
High density 
lipoprotein (HDL) 
(mmol/L) 
Men: >0.99b 
Women: >1.19b 
1.33±0.02 1.32±0.02 1.33±0.03 1.36±0.03 0.12 
Total cholesterol 
(mmol/L) 
2.0-5.19b 7.26±0.64 7.81±0.86 6.91±0.72 6.81±1.02 0.16 
Vitamin B12 (pmol/L) 153-655b 334.08± 3.99 322.10± 4.66 339.65± 5.77 351.60± 7.98 <0.001 
Bold text indicates statistical significance 
 aFischbach F, Dunning M. Manual of Laboratory and Diagnostic Tests. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins. 2008. 
b LifeLabs (Burnaby reference laboratory). Reference Ranges - Healthcare Providers. 2017.
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Table 4.13: Descriptive statistics (Cycle 2) of biomarkers by age groups 
Biomarkers Normal range Overall 
(Mean, SE) 
Young adult 
(=>18 to <40) 
 (Mean, SE) 
Middle age 
(=>40 to <65) 
 (Mean, SE) 
Older adult 
(>=65) 
 (Mean, SE) 
P-value 
Red blood cell 
folate (nmol/L) 
317-1422a 1270.07± 32.39 1179.49± 36.10 1297.25± 33.98 1451.05± 44.98 <0.001 
Vitamin D 
(nmol/L) 
75-150b 69.48± 2.28 68.96± 3.32 67.41± 2.34 78.59± 3.97 0.020 
Total protein (g/L)  60-80b 72.48± 0.20 73.48± 0.29 71.94± 0.23 71.42± 0.27 <0.001 
Chloride (mmol/L)  98-108b 103.74± 0.09 103.75± 0.09 103.78± 0.12 103.54± 0.13 0.11 
Potassium 
(mmol/L)  
Men: 3.5-4.5b 
Women: 3.4-4b 
4.47± 0.01 4.44± 0.01 4.48± 0.01 4.53± 0.02 <0.001 
Sodium (mmol/L)  135-145b 140.00± 0.20 140.03± 0.20 139.91± 0.22 140.25± 0.21 0.003 
Calcium (total) 
(mmol/L) 
2.10-2.60b 2.42± 0.01 2.42± 0.01 2.41± 0.01 2.42± 0.01 <0.001 
C-reactive protein 
(mg/L) 
Intermediate 
risk:1.0-3.0b 
2.42± 0.08 2.11± 0.13 2.56± 0.11 2.82± 0.14 <0.001 
Total protein (g/L) 60-80 72.48±0.20 73.48±0.29 71.94±0.23 71.42±0.27 <0.001 
High density 
lipoprotein (HDL) 
(mmol/L) 
Men: >0.99b 
Women: >1.19b 
1.41±0.02 1.40±0.03 1.41±0.02 1.41±0.02 0.92 
Total cholesterol 
(mmol/L) 
2.0-5.19b 5.78±0.25 5.38±0.29 6.11±0.37 5.76±0.27 0.07 
Vitamin B12 
(pmol/L) 
153-655b 347.10± 6.45 341.08± 8.23 353.44± 9.09 341.72± 11.41 0.05 
Bold text indicates statistical significance 
aFischbach F, Dunning M. Manual of Laboratory and Diagnostic Tests. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins. 2008. 
b LifeLabs (Burnaby reference laboratory). Reference Ranges - Healthcare Providers. 2017.
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Table 4.14: Descriptive statistics (Cycle 3) of biomarkers by age groups 
Biomarkers Normal range Overall 
(mean, SE) 
Young adult  
(=>18 to <40) 
 (mean, SE) 
Middle age 
(=>40 to <65) 
 (mean, SE) 
Older adult 
(>=65) 
 (mean, SE) 
P-value 
Red blood cell folate 
(nmol/L) 
317-1422a 1269.26± 44.71 1206.72± 47.87 1288.06± 43.70 1380.51± 55.39 <0.001 
Vitamin D (nmol/L) 75-150b 61.20± 2.70 58.16± 3.89 60.64± 2.43 71.62± 2.17 <0.001 
Total protein (g/L)  60-80b 71.63± 0.32 73.13± 0.36 70.78± 0.32 70.32± 0.44 <0.001 
Chloride (mmol/L)  98-108b 104.11± 0.15 104.09± 0.17 104.24± 0.18 103.71± 0.15 <0.001 
Potassium (mmol/L)  Men: 3.5-4.5b 
Women: 3.4-4.4b 
4.37± 0.02 4.33± 0.02 4.37± 0.02 4.46± 0.04 <0.001 
Sodium (mmol/L)  135-145b 141.44± 0.19 141.39± 0.22 141.48± 0.22 141.42± 0.18 0.56 
Calcium (total) 
(mmol/L) 
2.10-2.60b 2.41± 0.01 2.41± 0.01 2.40± 0.01 2.41± 0.01 0.005 
C-reactive protein 
(mg/L) 
Intermediate 
risk:1.0-3.0b 
2.55± 0.14 2.61± 0.26 2.49± 0.13 2.57± 0.16 0.56 
Total protein (g/L) 60-80b 71.63±0.32 73.13±0.36 70.78±0.32 70.32±0.44 <0.001 
High density 
lipoprotein (HDL) 
(mmol/L) 
Men: >0.99b 
Women: >1.19b 
1.38±0.02 1.35±0.03 1.39±0.02 1.42±0.03 0.003 
Total cholesterol 
(mmol/L) 
2.0-5.19b 4.82±0.05 4.57±0.07 5.03±0.06 4.41±0.08 <0.001 
Vitamin B12 (pmol/L) 153-655b 322.31± 8.28 313.61± 18.61 318.89± 6.93 358.62± 13.77 <0.001 
Bold text indicates statistical significance 
aFischbach F, Dunning M. Manual of Laboratory and Diagnostic Tests. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins. 2008. 
b LifeLabs (Burnaby reference laboratory). Reference Ranges - Healthcare Providers. 2017.
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Table 4.15: Distribution of the dietary factors by region (Cycle 1) 
Dietary variables Alberta 
% 
British 
Columbia 
% 
Ontario 
% 
Quebec 
% 
New Brunswick 
% 
p-value 
Red meat      0.1 
Low  27.7 36.0 39.2 25.8 29.5  
Medium  29.9 30.1 29.7 34.0 40.0  
High  42.4 33.9 31.2 40.1 30.6  
       
Fish      0.002 
Low  35.4 28.5 38.6 27.8 31.5  
Medium  38.1 31.4 31.1 27.7 25.3  
High  26.5 40.1 30.3 44.5 43.2  
       
Eggs      0.4 
Low  24.8 24.3 27.1 19.8 27.6  
Medium  29.8 21.5 26.4 28.2 27.1  
High  45.3 54.2 46.4 52.0 45.3  
       
Beans      <0.001 
Low  31.5 20.2 32.9 32.0 41.9  
Medium  35.4 34.2 36.7 37.7 36.0  
High  33.1 45.6 30.4 30.3 22.1  
       
Milk      0.7 
Low  29.8 39.6 35.3 33.0 28.2  
Medium  37.0 32.7 32.0 32.7 31.0  
High  33.2 27.6 32.7 34.3 40.7  
       
Grains      0.8 
Low  32.2 37.6 32.9 32.3 38.3  
Medium  36.5 31.5 32.4 33.2 28.0  
High  31.3 30.8 34.7 34.5 33.7  
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Fruits      0.1 
Low  31.5 31.1 29.5 27.7 35.3  
Medium  37.7 41.2 41.4 34.8 33.8  
High  30.8 27.7 29.1 37.6 30.9  
       
Vegetables      0.5 
Low  32.9 31.0 36.6 32.5 44.2  
Medium  34.5 34.5 33.8 29.4 31.1  
High  32.6 34.5 29.6 38.2 24.7  
       
Potatoes      0.7 
Low  32.6 45.8 37.1 29.7 28.2  
Medium  34.7 27.2 32.1 33.9 31.0  
High  32.7 27.0 30.7 36.4 40.7  
       
Dietary fat      0.008 
Low  31.0 34.0 36.1 27.6 38.1  
Medium  37.7 31.4 33.6 33.7 29.4  
High  31.3 34.6 30.3 38.7 32.5  
       
Soft drinks      0.1 
Low  23.7 37.0 28.7 33.0 24.9  
Medium  40.5 38.8 36.3 30.9 36.8  
High  35.8 24.1 35.0 36.1 38.2  
       
Water      <0.001 
Low  23.9 25.2 35.1 29.6 33.4  
Medium  27.6 27.9 30.9 35.5 32.6  
High  48.5 46.9 34.0 35.0 33.9  
Bold text indicates statistical significance 
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Table 4.16: Distribution of the dietary factors by region (Cycle 2) 
Dietary variables Alberta 
% 
British 
Columbia 
% 
Ontario 
% 
Quebec 
% 
Manitoba 
% 
Newfoundland 
and Labrador 
% 
Nova 
Scotia 
% 
P-value 
Red meat        0.01 
Low  33.9 27.4 37.2 26.1 21.1 46.2 36.3  
Medium  25.4 34.9 30.3 34.1 40.5 23.2 28.6  
High  40.8 37.6 32.6 39.7 38.4 30.6 35.1  
         
Fish        0.3 
Low  36.0 26.6 30.2 29.7 41.7 29.6 35.7  
Medium  29.7 32.7 30.8 37.5 37.7 41.5 35.2  
High  34.3 40.8 39.0 32.8 20.7 29.0 29.0  
         
Eggs        0.02 
Low  18.2 20.6 21.4 21.2 19.8 25.6 23.8  
Medium  23.6 15.5 24.8 30.0 26.4 17.8 28.5  
High  58.1 63.9 53.8 48.8 53.8 56.7 47.7  
         
Beans        <0.001 
Low  28.0 31.7 26.5 31.2 41.4 43.0 49.2  
Medium  38.6 25.9 32.5 34.4 26.2 40.4 32.0  
High  33.5 42.4 41.1 34.4 32.5 16.6 18.7  
         
Milk        0.04 
Low  40.5 45.2 34.6 39.3 30.0 29.3 28.3  
Medium  26.4 31.5 34.4 31.7 33.4 31.9 32.0  
High  33.1 23.2 31.1 29.0 36.5 38.8 39.8  
         
Grains        0.3 
Low  36.4 32.8 33.3 29.1 37.2 31.6 43.2  
Medium  27.7 28.4 31.7 32.5 42.9 31.7 28.0  
High  35.9 38.8 35.1 38.4 19.9 36.7 28.9  
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Fruits        0.02 
Low-medium 35.1 34.7 37.1 37.5 41.4 42.5 36.3  
High  65.0 65.3 62.9 62.6 58.5 57.5 63.7  
         
Vegetables        <0.001 
Low  32.2 31.3 28.6 34.5 25.0 46.5 52.1  
Medium  35.5 34.6 35.0 35.5 42.4 23.4 26.4  
High  32.3 34.1 36.4 30.0 32.6 30.1 21.5  
         
Potatoes        <0.001 
Low  30.6 43.9 32.6 23.5 21.5 13.2 17.7  
Medium  41.4 31.6 36.0 33.3 35.9 44.5 29.0  
High  28.0 24.6 31.4 43.2 42.5 42.2 53.2  
         
Dietary fat        0.06 
Low  28.5 33.9 34.3 22.5 30.3 39.0 35.3  
Medium  31.5 28.5 31.6 31.0 30.3 26.0 28.5  
High  40.1 37.7 34.0 46.5 39.3 35.0 36.3  
         
Soft drinks        <0.001 
Low  23.6 36.3 34.7 28.6 18.5 21.5 20.9  
Medium  40.6 41.4 36.1 28.7 33.2 30.7 45.4  
High  35.8 22.3 29.2 42.7 48.4 47.8 33.7  
         
Water        0.007 
Low  21.0 26.0 22.2 32.4 16.0 24.5 28.0  
Medium  43.6 36.7 40.9 35.7 52.6 52.6 37.3  
High  35.4 37.3 36.9 31.9 31.4 22.8 34.6  
Bold text indicates statistical significance 
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Table 4.17: Distribution of the dietary factors by region (Cycle 3) 
Dietary variables Alberta 
% 
British 
Columbia 
% 
Ontario 
% 
Quebec 
% 
New 
Brunswick 
% 
Nova 
Scotia 
% 
p-value 
Red meat       <0.001 
Low  33.4 39.1 42.9 23.3 18.2 49.1  
Medium  35.6 34.4 26.3 36.7 44.0 26.9  
High  31.0 26.5 30.8 39.9 37.8 24.1  
        
Fish       0.05 
Low  34.2 29.4 28.2 35.3 22.3 31.9  
Medium  31.6 40.5 35.3 35.0 19.7 25.6  
High  34.2 30.1 36.5 29.7 58.0 42.4  
        
Eggs       0.15 
Low  26.9 13.8 22.7 20.0 21.2 18.9  
Medium  35.7 37.4 40.3 48.5 33.1 36.7  
High  37.3 48.7 37.1 31.5 45.7 44.4  
        
Beans       0.01 
Low  27.8 22.6 35.5 36.0 45.5 48.8  
Medium  33.0 33.1 34.0 35.0 28.0 23.6  
High  39.2 44.4 30.6 29.0 26.5 27.6  
        
Milk       0.35 
Low  30.3 42.7 36.9 34.1 30.0 23.5  
Medium  37.4 28.6 32.3 34.7 33.2 29.2  
High  32.3 28.7 30.8 31.2 36.8 47.3  
        
Grains       <0.001 
Low  42.6 30.7 39.7 24.6 19.8 30.3  
Medium  29.6 37.6 34.0 39.3 42.5 41.0  
High  27.8 31.8 26.3 36.1 37.7 28.7  
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Fruits       0.05 
Low  33.9 26.6 35.4 36.4 37.8 44.8  
Medium  35.4 41.5 36.8 29.8 34.4 37.6  
High  30.7 31.9 27.9 33.8 27.8 17.6  
        
Vegetables       <0.001 
Low  31.2 21.0 39.0 32.3 49.7 33.1  
Medium  35.0 38.4 30.9 33.8 33.2 42.4  
High  33.7 40.6 30.1 34.0 17.1 24.5  
        
Potatoes       0.01 
Low  43.8 47.0 34.7 23.2 8.9 41.4  
Medium  32.2 26.6 34.1 42.3 20.5 21.4  
High  23.9 26.4 31.2 34.5 70.6 37.3  
        
Dietary fat       0.24 
Low  40.3 50.1 39.8 27.0 22.5 18.3  
Medium  29.6 33.1 28.4 36.9 22.4 41.0  
High  30.1 16.9 31.8 36.1 55.1 40.7  
        
Soft drinks       0.21 
Low  27.7 40.7 29.5 31.3 32.0 19.2  
Medium  35.4 32.4 34.1 26.1 28.5 32.4  
High  36.9 26.9 36.4 42.7 39.4 48.4  
        
Water       0.03 
Low  14.3 23.6 22.2 30.0 25.8 26.7  
Medium  46.4 41.9 36.8 44.2 38.9 29.4  
High  39.4 34.5 41.0 25.8 35.3 43.9  
Bold text indicates statistical significance 
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Appendix 3 
Analysis of demographic variables (without exposure of interest) with the outcomes/Main effects model 
Table 4.18: Analysis of demographic variables (without exposure of interest) with FVC 
Variables Cycle 1 Cycle 2 Cycle 3 
Β Standard 
error 
(SE) 
P-
value 
β Standard 
error 
(SE) 
P-
value 
β Standard 
error 
(SE) 
P-
value 
Age -.026 .002 <0.001 -.026 .001 <0.001 -.025 .002 <0.001 
Sex (2) -.573 .062 <0.001 -.576 .057 <0.001 -.508 .052 <0.001 
Race (2) -.334 .065 <0.001 -.404 .066 <0.001 -.300 .127 0.018 
Height .057 .002 <0.001 .053 .003 <0.001 .058 .005 <0.001 
Immigrant (2) -.003 .024 0.91 -.028 .044 0.53 .054 .105 0.61 
Marital status (2) -.027 .034 0.44 .061 .033 0.07 -.043 .045 0.34 
Education 
• Post-secondary graduation 
• Some post-secondary 
• Secondary 
• Less than secondary (ref) 
 
.024 
-.020 
.088 
 
.042 
.060 
.039 
 
 
0.57 
0.74 
0.022 
 
 
.007 
.099 
.028 
 
.041 
.098 
.065 
 
0.87 
0.31 
0.67 
 
.086 
- 
.003 
 
.057 
- 
.078 
 
0.14 
- 
0.96 
Income 
• CAD >80,000 
• CAD ≥ 50,000 to <80,000 
• CAD ≥ 30,000 to <50,000 
• CAD <30,000 (ref) 
 
.099 
.030 
.035 
 
 
.045 
.045 
.046 
 
 
0.028 
0.51 
0.45 
 
 
.038 
.032 
-.062 
 
.054 
.051 
.066 
 
0.48 
0.53 
0.35 
 
-.114 
-.038 
-.171 
 
.064 
.086 
.044 
 
0.08 
0.66 
<0.001 
BMI 
• Obese 
• Overweight 
• Not overweight or obese (ref) 
 
-.195 
-.021 
 
 
.069 
.048 
 
 
0.005 
0.65 
 
 
-.215 
-.058 
 
.054 
.043 
 
<0.001 
0.18 
 
-.215 
-.049 
 
.052 
.056 
 
<0.001 
0.38 
Smoking          
               
 
 
1
7
1
 
 
• Daily smoker 
• Former smoker 
• Never (ref) 
-.046 
-.050 
 
.048 
.036 
 
0.34 
0.16 
 
-.074 
-.047 
.052 
.028 
0.15 
0.09 
-.093 
-.082 
.058 
.055 
0.11 
0.14 
Exposure to second hand smoking 
• Every day  
• Occasional  
• Never (ref) 
 
-.010 
-.016 
 
 
.041 
.035 
 
 
0.81 
0.65 
 
 
-.059 
.015 
 
.057 
.042 
 
0.30 
0.73 
 
.028 
.058 
 
.058 
.045 
 
0.63 
0.20 
Alcohol drinker 
• Regular drinker  
• Occasional drinker  
• Former drinker  
• Never drunk (ref) 
 
.118 
.098 
.062 
 
 
.115 
.107 
.095 
 
0.31 
0.36 
0.51 
 
.239 
.141 
.163 
 
.058 
.071 
.076 
 
<0.001 
0.047 
0.033 
 
.106 
-.019 
-.014 
 
.091 
.062 
.072 
 
0.24 
0.76 
0.85 
Current asthma (2) .026 .070 0.71 .205 .071 0.004 .068 .121 0.57 
Obstructive lung disease (Chronic 
bronchitis, Emphysema, COPD) (2) 
.213 .069 0.002 .283 .075 <0.001 .156 .086 0.07 
Family history of asthma (2) -.024 .028 0.40 -.016 .030 0.60 .099 .046 0.032 
Total Physical activity (minutes/day) .001 .0002 0.001 .001 .0002 0.004 .0004 .0002 0.031 
Sedentary activity (minutes/day) -.0002 .0002 0.43 -.0003 .0002 0.27 .0001 .0002 0.61 
Bold text indicates statistical significance 
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Table 4.19: Analysis of demographic variables (without exposure of interest) with FEV1 
Variables Cycle 1 Cycle 2 Cycle 3 
Β Standard 
error 
(SE) 
P-
value 
β Standard 
error 
(SE) 
P-
value 
β Standard 
error 
(SE) 
P-value 
Age -.028 .001 <0.001 -.026 .001 <0.001 -.024 .002 <0.001 
Sex (2) -.479 .037 <0.001 -.452 .047 <0.001 -.384 .049 <0.001 
Race (2) -.208 .061 0.001 -.268 .050 <0.001 -.171 .079 0.031 
Height .036 .002 <0.001 .035 .003 <0.001 .041 .003 <0.001 
Immigrant (2) -.007 .021 0.75 -.029 .030 0.33 .015 .070 0.83 
Marital status (2) -.029 .034 0.39 .067 .027 0.013 -.020 .029 0.50 
Education 
• Post-secondary graduation 
• Some post-secondary 
• Secondary 
• Less than secondary (ref) 
 
.053 
.014 
.110 
 
.042 
.076 
.054 
 
0.21 
0.85 
0.041 
 
-.028 
.085 
-.017 
 
.040 
.099 
.051 
 
0.48 
0.39 
0.75 
 
.059 
- 
-.013 
 
.059 
- 
.070 
 
0.32 
- 
0.85 
Income 
• CAD >80,000 
• CAD ≥ 50,000 to <80,000 
• CAD ≥ 30,000 to <50,000 
• CAD <30,000 (ref) 
 
.076 
-.001 
.001 
 
.041 
.043 
.032 
 
0.07 
0.98 
0.99 
 
 
.054 
.065 
-.043 
 
 
.043 
.042 
.060 
 
0.21 
0.12 
0.48 
 
.012 
.026 
-.033 
 
.073 
.081 
.063 
 
0.87 
0.75 
0.60 
BMI 
• Obese 
• Overweight 
• Not overweight or obese 
(ref) 
 
-.066 
.034 
 
.041 
.027 
 
0.11 
0.21 
 
-.080 
.008 
 
.043 
.032 
 
0.06 
0.81 
 
-.118 
-.0005 
 
.055 
.049 
 
0.031 
0.99 
Smoking 
• Daily smoker 
• Former smoker 
• Never (ref) 
 
-.211 
-.068 
 
.053 
.033 
 
<0.001 
0.038 
 
-.204 
-.098 
 
.052 
.033 
 
<0.001 
0.003 
 
-.217 
-.087 
 
.058 
.044 
 
<0.001 
0.048 
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Exposure to second hand smoking 
• Every day  
• Occasional  
• Never (ref) 
 
.002 
.010 
 
.049 
.026 
 
0.97 
0.70 
 
-.035 
.040 
 
.059 
.034 
 
0.55 
0.24 
 
.059 
.056 
 
.070 
.042 
 
0.40 
0.18 
Alcohol drinker 
• Regular drinker  
• Occasional drinker  
• Former drinker  
• Never drunk (ref) 
 
.081 
.074 
.032 
 
.076 
.084 
.059 
 
0.29 
0.38 
0.58 
 
.200 
.121 
.129 
 
.052 
.064 
.063 
 
<0.001 
0.06 
0.043 
 
.106 
.067 
.025 
 
.073 
.059 
.057 
 
0.15 
0.25 
0.67 
Current asthma (2) .152 .095 0.11 .233 .069 0.001 .176 .133 0.18 
Obstructive lung disease (Chronic 
bronchitis, Emphysema, COPD) (2) 
.214 .059 <0.001 .386 .062 <0.001 .338 .085 <0.001 
Family history of asthma (2) .017 .025 0.49 .021 .025 0.39 .085 .039 0.028 
Total Physical activity 
(minutes/day) 
.0002 .0002 0.19 .0004 .0002 0.07 .0001 .0002 0.67 
Sedentary activity (minutes/day) .00004 .0002 0.84 -.0001 .0002 0.44 -7.32e-
06 
.0001 0.95 
Bold text indicates statistical significance 
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Table 4.20: Analysis of demographic variables (without exposure of interest) with FEV1/FVC 
Variables Cycle 1 Cycle 2 Cycle 3 
Β Standar
d error 
(SE) 
P-
value 
β Standar
d error 
(SE) 
P-
value 
β Standar
d error 
(SE) 
P-value 
Age -.002 .0001 <0.001 -.002 .0002 <0.001 -.001 .0003 <0.001 
Sex (2) -.005 .005 0.33 .001 .004 0.87 -.001 .008 0.95 
Race (2) .013 .006 0.030 .015 .007 0.038 .022 .006 <0.001 
Height -.001 .0004 0.002 -.001 .0003 <0.001 -.001 .001 0.06 
Immigrant (2) -.006 .003 0.047 -.003 .006 0.60 -.003 .005 0.48 
Marital status (2) -.006 .004 0.10 .006 .005 0.22 .0002 .005 0.98 
Education 
• Post-secondary graduation 
• Some post-secondary 
• Secondary 
• Less than secondary (ref) 
 
.011 
.014 
.015 
 
.007 
.012 
.007 
 
0.11 
0.25 
0.033 
 
-.012 
-.0004 
-.012 
 
.006 
.009 
.005 
 
 
0.04 
0.96 
0.026 
 
-.003 
- 
-.002 
 
.008 
- 
.007 
 
0.72 
- 
0.77 
Income 
• CAD >80,000 
• CAD ≥ 50,000 to <80,000 
• CAD ≥ 30,000 to <50,000 
• CAD <30,000 (ref) 
 
-.0003 
-.006 
-.006 
 
.005 
.006 
.005 
 
0.96 
0.32 
0.24 
 
.010 
.012 
.004 
 
.008 
.007 
.009 
 
0.20 
0.06 
0.64 
 
.023 
.012 
.025 
 
.011 
.010 
.012 
 
0.035 
0.22 
0.034 
BMI 
• Obese 
• Overweight 
• Not overweight or obese 
(ref) 
 
.025 
.013 
 
.005 
.004 
 
<0.001 
0.003 
 
.025 
.015 
 
.005 
.003 
 
<0.001 
<0.001 
 
.011 
.006 
 
.006 
.005 
 
0.09 
0.28 
Smoking 
• Daily smoker 
• Former smoker 
• Never (ref) 
 
-.046 
-.010 
 
 
.006 
.004 
 
<0.001 
0.006 
 
-.039 
-.018 
 
.007 
.005 
 
<0.001 
<0.001 
 
-.043 
-.010 
 
.006 
.005 
 
<0.001 
0.06 
               
 
 
1
7
5
 
 
Exposure to second hand smoking 
• Every day  
• Occasional  
• Never (ref) 
 
.004 
.007 
 
.006 
.003 
 
0.51 
0.004 
 
.002 
.007 
 
.008 
.003 
 
0.82 
0.011 
 
.008 
.003 
 
.010 
.006 
 
0.43 
0.66 
 
Alcohol drinker 
• Regular drinker  
• Occasional drinker  
• Former drinker  
• Never drunk (ref) 
 
-.004 
-.002 
-.005 
 
.008 
.006 
.007 
 
0.65 
0.67 
0.44 
 
-.001 
-.001 
-.002 
 
.010 
.011 
.013 
 
0.95 
0.95 
0.91 
 
.006 
.020 
.011 
 
.006 
.007 
.011 
 
0.37 
0.005 
0.34 
Current asthma (2) .033 .017 0.05 .022 .011 0.05 .036 .018 0.048 
Obstructive lung disease (Chronic 
bronchitis, Emphysema, COPD) (2) 
.028 .012 0.020 .068 .015 <0.001 .074 .016 <0.001 
Family history of asthma (2) .007 .005 0.14 .007 .007 0.26 -.002 .004 0.68 
Total Physical activity (minutes/day) -.00003 .00002 0.12 -7.87e-
06 
.00002 0.71 -.0001 .00002 0.011 
Sedentary activity (minutes/day) .00004 .00004 0.38 9.76e-
06 
.00002 0.61 -5.88e-06 .00001 0.60 
Bold text indicates statistical significance 
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Table 4.21: Analysis of demographic variables (without exposure of interest) with FEF25-75% 
Variables Cycle 1 Cycle 2 Cycle 3 
Β Standard 
error 
(SE) 
P-
value 
β Standard 
error 
(SE) 
P-
value 
β Standard 
error 
(SE) 
P-
value 
Age -.043 .002 <0.001 -.035 .002 <0.001 -.036 .003 <0.001 
Sex (2) -.509 .055 <0.001 -.433 .061 <0.001 -.438 .086 <0.001 
Race (2) -.090 .109 0.41 -.068 .098 0.49 -.0004 .050 0.99 
Height .017 .005 0.001 .017 .005 0.001 .020 .003 <0.001 
Immigrant (2) -.041 .042 0.33 .001 .067 0.99 -.042 .055 0.45 
Marital status (2) -.066 .043 0.13 .119 .060 0.046 -.010 .070 0.88 
Education 
• Post-secondary graduation 
• Some post-secondary 
• Secondary 
• Less than secondary (ref) 
 
.058 
.085 
.162 
 
.079 
.141 
.112 
 
0.46 
0.55 
0.15 
 
-.092 
.073 
-.085 
 
.100 
.149 
.101 
 
0.36 
0.62 
0.40 
 
-.004 
- 
-.004 
 
.117 
- 
.095 
 
0.97 
- 
0.97 
Income 
• CAD >80,000 
• CAD ≥ 50,000 to <80,000 
• CAD ≥ 30,000 to <50,000 
• CAD <30,000 (ref) 
 
.036 
-.044 
-.053 
 
.056 
.054 
.048 
 
0.52 
0.41 
0.27 
 
.118 
.136 
.016 
 
.061 
.055 
.085 
 
0.06 
0.013 
0.85 
 
.171 
.130 
.138 
 
.124 
.106 
.124 
 
0.17 
0.22 
0.27 
BMI 
• Obese 
• Overweight 
• Not overweight or obese (ref) 
 
.127 
.139 
 
.055 
.042 
 
0.021 
0.001 
 
.209 
.197 
 
.062 
.046 
 
0.001 
<0.001 
 
.026 
.055 
 
.086 
.078 
 
0.76 
0.47 
Smoking 
• Daily smoker 
• Former smoker 
• Never (ref) 
 
-.523 
-.147 
 
.080 
.064 
 
<0.001 
0.022 
 
-.525 
-.208 
 
.082 
.074 
 
<0.001 
0.005 
 
-.523 
-.150 
 
.103 
.067 
 
<0.001 
0.025 
Exposure to second hand smoking          
               
 
 
1
7
7
 
 
• Every day  
• Occasional  
• Never (ref) 
.016 
.097 
.065 
.039 
0.802 
0.012 
.026 
.119 
.095 
.053 
0.782 
0.026 
.057 
.052 
.123 
.073 
0.645 
0.477 
Alcohol drinker 
• Regular drinker  
• Occasional drinker  
• Former drinker  
• Never drunk (ref) 
 
-.002 
-.003 
-.123 
 
.094 
.101 
.092 
 
0.981 
0.976 
0.184 
 
.270 
.218 
.190 
 
.100 
.118 
.130 
 
0.007 
0.065 
0.143 
 
.196 
.294 
.212 
 
.086 
.097 
.097 
 
0.024 
0.002 
0.028 
Current asthma (2) .301 .198 0.128 .344 .125 0.006 .405 .236 0.086 
Obstructive lung disease (Chronic 
bronchitis, Emphysema, COPD) (2) 
.207 .095 0.029 .574 .113 <0.001 .598 .155 <0.001 
Family history of asthma (2) .070 .054 0.195 .084 .066 0.202 .085 .060 0.162 
Total Physical activity (minutes/day) -.0003 .0003 0.305 .00004 .0003 0.904 -.0004 .0002 0.098 
Sedentary activity (minutes/day) .0005 .0003 0.200 -.00001 .0003 0.961 -.00004 .0002 0.811 
Bold text indicates statistical significance 
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Appendix 4 
Results summary by food group 
Individual Dietary Factors: 
• Red meats 
Consumption of red meat (high) was associated with higher FEV1/FVC ratio (Cycle 3: β= 
0.009, p<0.05) and higher FEF25-75% (Cycle 3: β= 0.117, p<0.05).  
• Fish 
There was no statistically significant association observed in between fish and lung 
function (FEV1, FVC, FEV1/FVC ratio, and FEF25-75%) in any of the Cycles (Cycle 1, 2, 
3).  
• Eggs 
Consumption of eggs (high) was associated with higher FEV1 (Cycle 1: β= 0.071, p<0.05) 
and higher FEF25-75% (Cycle 1: β= 0.104, p<0.05) but Consumption of eggs (high) was 
associated with lower FEV1 in Cycle 3 (β= -0.070, p<0.05). 
• Beans 
Consumption of eggs (high) was associated with higher FVC (Cycle 3: β= 0.108, p<0.05) 
and higher FEV1 (Cycle 3: β= 0.082, p<0.05). 
• Milk 
Consumption of milk (medium) was associated with higher FEV1 (Cycle 3: β= 0.094, 
p<0.05), higher FEV1/FVC ratio (Cycle 3: β= 0.013, p<0.05), and higher FEF25-75% (Cycle 
3: β= 0.175, p<0.05). 
• Grains 
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Consumption of grains (medium) was associated with higher FVC (Cycle 3: β= 0.124, 
p<0.05) and higher FEV1 (Cycle 3: β= 0.086, p<0.05).  
• Fruits 
Consumption of fruits (high) was associated with higher FEV1 (Cycle 3: β= 0.096, p<0.05), 
higher FEV1/FVC ratio (Cycle 2: β= 0.013, p<0.05), and higher FEF25-75% (Cycle 2: β= 
0.125, p<0.05).  
• Vegetables 
Consumption of vegetables (medium) was associated with higher FVC (Cycle 3: β= 0.087, 
p<0.05) and higher FEV1 (Cycle 3: β= 0.061, p<0.05).  
• Potatoes 
Consumption of potatoes (medium & high) was associated with lower FVC (Cycle 3: β= -
0.132 (medium), p<0.05 and β= -0.125 (high), p<0.05), lower FEV1 (Cycle 3: β= -0.120 
(medium), p<0.05 and β= -0.110 (high), p<0.05), and lower FEF25-75% (Cycle 3: β= -0.183 
(medium), p<0.05 and β= -0.136 (high), p<0.05). 
• Dietary fat 
Consumption of dietary fat (high) was associated with higher FVC (Cycle 1: β= 0.098, 
p<0.05, Cycle 2: β= 0.132, p<0.05) and FEV1 (Cycle 2: β= 0.076, p<0.05).  
• Soft drinks 
Consumption of soft drinks (high) was associated with lower FVC (Cycle 2: β= -0.146, 
p<0.05), FEV1 (Cycle 2: β= -0.120, p<0.05), and lower FEF25-75% (Cycle 2: β= -0.144, 
p<0.05).  
• Water 
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Consumption of water (high) was associated with lower FEV1/FVC ratio (Cycle 1: β= -
0.006, p<0.05) and lower FEF25-75% (Cycle 1: β= -0.135, p<0.05). But Consumption of 
water (medium) was associated with higher FEF25-75% in Cycle 2 (β= 0.156, p<0.05). 
Canada Food Guide: 
• Vegetables and fruits 
“Not meeting” the requirement of vegetables and fruits was associated with lower FEV1 
(Cycle 3: β= -0.141, p<0.05). 
• Grains 
“Not meeting” the requirement of grains was associated with lower FEV1/FVC ratio (Cycle 
2: β= -0.064, p<0.05). 
• Milk 
There was no statistically significant association observed in between “Not meeting” the 
requirement of milk and lung function (FEV1, FVC, FEV1/FVC ratio, and FEF25-75%) in 
any of the Cycles (Cycle 1, 2, 3). 
• Meats 
“Not meeting” the requirement of meats was associated with lower FEV1 (Cycle 1: β= -
0.062, p<0.05), lower FEV1/FVC ratio (Cycle 1: β= -0.008, p<0.05), and lower FEF25-75% 
(Cycle 1: β= -0.145, p<0.05). 
Modified Mediterranean Diet Score 
 Modified Mediterranean Diet Score was associated with lower FVC (Cycle 3: β= -0.017, 
p<0.05) and lower FEV1 (Cycle 3: β= -0.017, p<0.05). 
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Biomarkers 
• Vitamin D (nmol/L) 
Vitamin D was associated with higher FEV1 (Cycle 1: β= 0.001, p<0.05. Cycle 2: β= 0.002, 
p<0.05) and higher FEF25-75% (Cycle 1: β= 0.002, p<0.05) whereas associated with lower 
FEV1/FVC ratio (Cycle 3: β= -0.0001, p<0.05). 
• Chloride (mmol/L) 
Chloride was associated with higher FVC (Cycle 1: β= 0.008, p<0.05. Cycle 2: β= 0.026, 
p<0.05. Cycle 3: 0.031, p<0.05), higher FEV1 (Cycle 1: β= 0.013, p<0.05. Cycle 2: β= 
0.022, p<0.05. Cycle 3: 0.027, p<0.05), and higher FEF25-75% (Cycle 2: β= 0.028, p<0.05). 
• Potassium (mmol/L) 
Potassium was associated with lower FVC (Cycle 2: β= -0.128, p<0.05) and lower FEV1 
(Cycle 2: β= -0.090, p<0.05). 
• C-reactive protein (mg/L) 
C-reactive protein was associated with lower FVC (Cycle 1: β= -0.037, p<0.05. Cycle 3: 
β= -0.027, p<0.05), lower FEV1 (Cycle 1: β= -0.032, p<0.05. Cycle 3: β= -0.033, p<0.05), 
and lower FEF25-75% (Cycle 1: -0.034, p<0.05. Cycle 3: -0.046, p<0.05). 
• High density lipoprotein (HDL) (moml/L) 
There was no statistically significant association observed in between HDL and lung 
function (FEV1, FVC, FEV1/FVC ratio, and FEF25-75%) in any of the Cycles (Cycle 1, 2, 
3). 
• Total cholesterol (mmol/L) 
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There was no statistically significant association observed in between total cholesterol and 
lung function (FEV1, FVC, FEV1/FVC ratio, and FEF25-75%) in any of the Cycles (Cycle 1, 
2, 3). 
• Total protein (g/L) 
Total protein was associated with lower FVC (Cycle 2: β= -0.010, p<0.05) and higher 
FEF25-75% (Cycle 3: β= 0.026, p<0.05). 
• Sodium (mmol/L) 
Sodium was associated with lower FEF25-75% (Cycle 2: β= -0.34, p<0.05). 
• Calcium (mmol/L) 
Calcium was associated with higher FEV1 (Cycle 2: β= 0.537, p<0.05), higher FEV1/FVC 
ratio (Cycle 3: β= 0.002, p<0.05), and higher FEF25-75% (Cycle 2: β= 1.034, p<0.05). 
• Red blood cell folate (nmol/L) 
Red blood cell folate was associated with higher FEV1 (Cycle 3: β= 0.0001, p<0.05) and 
lower FEV1/FVC ratio (Cycle 2: β= -0.003, p<0.05). 
• Vitamin B12 (pmol/L) 
Vitamin B12 was associated with lower FVC (Cycle 3: β= -0.0002, p<0.05), lower FEV1 
(Cycle 1: β= -0.0002, p<0.05. Cycle 3: β= -0.0002, p<0.05), higher FEV1/FVC ratio (Cycle 
2: β= 0.087, p<0.05), and lower FEF25-75% (Cycle 1: β= -0.0004, p<0.05). 
 
 
